id sid tid token lemma pos dpc-4289 1 1 dermatology dermatology NOUN dpc-4289 1 2 : : PUNCT dpc-4289 1 3 practical practical ADJ dpc-4289 1 4 and and CCONJ dpc-4289 1 5 conceptual conceptual ADJ dpc-4289 1 6 original original ADJ dpc-4289 1 7 article article NOUN dpc-4289 1 8 | | ADV dpc-4289 1 9 dermatol dermatol ADJ dpc-4289 1 10 pract pract NOUN dpc-4289 1 11 concept concept NOUN dpc-4289 1 12 . . PUNCT dpc-4289 2 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 2 2 1 1 NUM dpc-4289 2 3 elevated elevated ADJ dpc-4289 2 4 serum serum NOUN dpc-4289 2 5 levels level NOUN dpc-4289 2 6 of of ADP dpc-4289 2 7 osteopontin osteopontin NOUN dpc-4289 2 8 in in ADP dpc-4289 2 9 patients patient NOUN dpc-4289 2 10 with with ADP dpc-4289 2 11 psoriasis psoriasis NOUN dpc-4289 2 12 : : PUNCT dpc-4289 2 13 is be AUX dpc-4289 2 14 it it PRON dpc-4289 2 15 associated associate VERB dpc-4289 2 16 with with ADP dpc-4289 2 17 ocular ocular ADJ dpc-4289 2 18 comorbidities comorbiditie NOUN dpc-4289 2 19 ? ? PUNCT dpc-4289 3 1 hala hala PROPN dpc-4289 3 2 m. m. PROPN dpc-4289 3 3 elsadek1 elsadek1 PROPN dpc-4289 3 4 , , PUNCT dpc-4289 3 5 radwa radwa VERB dpc-4289 3 6 o. o. PROPN dpc-4289 3 7 m. m. PROPN dpc-4289 3 8 kamel1 kamel1 PROPN dpc-4289 3 9 , , PUNCT dpc-4289 3 10 marwa marwa PROPN dpc-4289 3 11 abdallah abdallah PROPN dpc-4289 3 12 elsaid2 elsaid2 PROPN dpc-4289 3 13 , , PUNCT dpc-4289 3 14 rasha rasha PROPN dpc-4289 3 15 muhammad muhammad PROPN dpc-4289 3 16 rashed3 rashed3 PROPN dpc-4289 3 17 , , PUNCT dpc-4289 3 18 mona mona PROPN dpc-4289 3 19 s. s. PROPN dpc-4289 3 20 ali1 ali1 PROPN dpc-4289 3 21 1 1 NUM dpc-4289 3 22 department department NOUN dpc-4289 3 23 of of ADP dpc-4289 3 24 dermatology dermatology NOUN dpc-4289 3 25 and and CCONJ dpc-4289 3 26 venereology venereology NOUN dpc-4289 3 27 , , PUNCT dpc-4289 3 28 faculty faculty NOUN dpc-4289 3 29 of of ADP dpc-4289 3 30 medicine medicine NOUN dpc-4289 3 31 for for ADP dpc-4289 3 32 girls girl NOUN dpc-4289 3 33 , , PUNCT dpc-4289 3 34 al al PROPN dpc-4289 3 35 - - PUNCT dpc-4289 3 36 azhar azhar PROPN dpc-4289 3 37 university university PROPN dpc-4289 3 38 , , PUNCT dpc-4289 3 39 cairo cairo PROPN dpc-4289 3 40 , , PUNCT dpc-4289 3 41 egypt egypt PROPN dpc-4289 3 42 2 2 NUM dpc-4289 3 43 department department NOUN dpc-4289 3 44 of of ADP dpc-4289 3 45 clinical clinical ADJ dpc-4289 3 46 pathology pathology NOUN dpc-4289 3 47 , , PUNCT dpc-4289 3 48 faculty faculty NOUN dpc-4289 3 49 of of ADP dpc-4289 3 50 medicine medicine NOUN dpc-4289 3 51 for for ADP dpc-4289 3 52 girls girl NOUN dpc-4289 3 53 , , PUNCT dpc-4289 3 54 al al PROPN dpc-4289 3 55 - - PUNCT dpc-4289 3 56 azhar azhar PROPN dpc-4289 3 57 university university PROPN dpc-4289 3 58 , , PUNCT dpc-4289 3 59 cairo cairo PROPN dpc-4289 3 60 , , PUNCT dpc-4289 3 61 egypt egypt PROPN dpc-4289 3 62 3 3 NUM dpc-4289 3 63 department department PROPN dpc-4289 3 64 of of ADP dpc-4289 3 65 ophthalmology ophthalmology NOUN dpc-4289 3 66 , , PUNCT dpc-4289 3 67 faculty faculty NOUN dpc-4289 3 68 of of ADP dpc-4289 3 69 medicine medicine NOUN dpc-4289 3 70 for for ADP dpc-4289 3 71 girls girl NOUN dpc-4289 3 72 , , PUNCT dpc-4289 3 73 al al PROPN dpc-4289 3 74 - - PUNCT dpc-4289 3 75 azhar azhar PROPN dpc-4289 3 76 university university PROPN dpc-4289 3 77 , , PUNCT dpc-4289 3 78 cairo cairo PROPN dpc-4289 3 79 , , PUNCT dpc-4289 3 80 egypt egypt PROPN dpc-4289 3 81 key key PROPN dpc-4289 3 82 words word NOUN dpc-4289 3 83 : : PUNCT dpc-4289 3 84 osteopontin osteopontin ADJ dpc-4289 3 85 , , PUNCT dpc-4289 3 86 psoriasis psoriasis NOUN dpc-4289 3 87 , , PUNCT dpc-4289 3 88 ocular ocular ADJ dpc-4289 3 89 comorbidity comorbidity NOUN dpc-4289 3 90 , , PUNCT dpc-4289 3 91 blepharitis blepharitis NOUN dpc-4289 3 92 , , PUNCT dpc-4289 3 93 dry dry ADJ dpc-4289 3 94 eye eye NOUN dpc-4289 3 95 syndrome syndrome NOUN dpc-4289 3 96 citation citation NOUN dpc-4289 3 97 : : PUNCT dpc-4289 3 98 elsadek elsadek PROPN dpc-4289 3 99 hm hm PROPN dpc-4289 3 100 , , PUNCT dpc-4289 3 101 kamel kamel PROPN dpc-4289 3 102 rom rom PROPN dpc-4289 3 103 , , PUNCT dpc-4289 3 104 elsaid elsaid VERB dpc-4289 3 105 ma ma PROPN dpc-4289 3 106 , , PUNCT dpc-4289 3 107 rashed rashe VERB dpc-4289 3 108 m m PROPN dpc-4289 3 109 , , PUNCT dpc-4289 3 110 ali ali PROPN dpc-4289 3 111 ms ms PROPN dpc-4289 3 112 . . PROPN dpc-4289 3 113 elevated elevated PROPN dpc-4289 3 114 serum serum NOUN dpc-4289 3 115 levels level NOUN dpc-4289 3 116 of of ADP dpc-4289 3 117 osteopontin osteopontin NOUN dpc-4289 3 118 in in ADP dpc-4289 3 119 patients patient NOUN dpc-4289 3 120 with with ADP dpc-4289 3 121 psoriasis psoriasis NOUN dpc-4289 3 122 : : PUNCT dpc-4289 3 123 is be AUX dpc-4289 3 124 it it PRON dpc-4289 3 125 associated associate VERB dpc-4289 3 126 with with ADP dpc-4289 3 127 ocular ocular ADJ dpc-4289 3 128 comorbidities comorbiditie NOUN dpc-4289 3 129 ? ? PUNCT dpc-4289 4 1 dermatol dermatol NOUN dpc-4289 4 2 pract pract PROPN dpc-4289 4 3 concept concept NOUN dpc-4289 4 4 . . PUNCT dpc-4289 5 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 5 2 . . PUNCT dpc-4289 6 1 doi doi NOUN dpc-4289 6 2 : : PUNCT dpc-4289 6 3 https://doi.org/10.5826/dpc.1404a226 https://doi.org/10.5826/dpc.1404a226 NOUN dpc-4289 6 4 accepted accept VERB dpc-4289 6 5 : : PUNCT dpc-4289 6 6 may may AUX dpc-4289 6 7 13 13 NUM dpc-4289 6 8 , , PUNCT dpc-4289 6 9 2024 2024 NUM dpc-4289 6 10 ; ; PUNCT dpc-4289 6 11 published publish VERB dpc-4289 6 12 : : PUNCT dpc-4289 7 1 october october PROPN dpc-4289 7 2 2024 2024 NUM dpc-4289 7 3 copyright copyright NOUN dpc-4289 7 4 : : PUNCT dpc-4289 7 5 © © PROPN dpc-4289 7 6 2024 2024 NUM dpc-4289 7 7 elsadek elsadek PROPN dpc-4289 7 8 et et PROPN dpc-4289 7 9 al al PROPN dpc-4289 7 10 . . PUNCT dpc-4289 8 1 this this PRON dpc-4289 8 2 is be AUX dpc-4289 8 3 an an DET dpc-4289 8 4 open open ADJ dpc-4289 8 5 - - PUNCT dpc-4289 8 6 access access NOUN dpc-4289 8 7 article article NOUN dpc-4289 8 8 distributed distribute VERB dpc-4289 8 9 under under ADP dpc-4289 8 10 the the DET dpc-4289 8 11 terms term NOUN dpc-4289 8 12 of of ADP dpc-4289 8 13 the the DET dpc-4289 8 14 creative creative ADJ dpc-4289 8 15 commons common NOUN dpc-4289 8 16 attributionnoncommercial attributionnoncommercial ADJ dpc-4289 8 17 license license NOUN dpc-4289 8 18 ( ( PUNCT dpc-4289 8 19 by by ADP dpc-4289 8 20 - - PUNCT dpc-4289 8 21 nc-4.0 nc-4.0 NOUN dpc-4289 8 22 ) ) PUNCT dpc-4289 8 23 , , PUNCT dpc-4289 8 24 https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ PROPN dpc-4289 8 25 , , PUNCT dpc-4289 8 26 which which PRON dpc-4289 8 27 permits permit VERB dpc-4289 8 28 unrestricted unrestricted ADJ dpc-4289 8 29 noncommercial noncommercial ADJ dpc-4289 8 30 use use NOUN dpc-4289 8 31 , , PUNCT dpc-4289 8 32 distribution distribution NOUN dpc-4289 8 33 , , PUNCT dpc-4289 8 34 and and CCONJ dpc-4289 8 35 reproduction reproduction NOUN dpc-4289 8 36 in in ADP dpc-4289 8 37 any any DET dpc-4289 8 38 medium medium NOUN dpc-4289 8 39 , , PUNCT dpc-4289 8 40 provided provide VERB dpc-4289 8 41 the the DET dpc-4289 8 42 original original ADJ dpc-4289 8 43 authors author NOUN dpc-4289 8 44 and and CCONJ dpc-4289 8 45 source source NOUN dpc-4289 8 46 are be AUX dpc-4289 8 47 credited credit VERB dpc-4289 8 48 . . PUNCT dpc-4289 9 1 funding funding NOUN dpc-4289 9 2 : : PUNCT dpc-4289 9 3 none none NOUN dpc-4289 9 4 . . PUNCT dpc-4289 10 1 competing compete VERB dpc-4289 10 2 interests interest NOUN dpc-4289 10 3 : : PUNCT dpc-4289 10 4 none none NOUN dpc-4289 10 5 . . PUNCT dpc-4289 11 1 authorship authorship NOUN dpc-4289 11 2 : : PUNCT dpc-4289 11 3 all all DET dpc-4289 11 4 authors author NOUN dpc-4289 11 5 have have AUX dpc-4289 11 6 contributed contribute VERB dpc-4289 11 7 significantly significantly ADV dpc-4289 11 8 to to ADP dpc-4289 11 9 this this DET dpc-4289 11 10 publication publication NOUN dpc-4289 11 11 . . PUNCT dpc-4289 12 1 corresponding correspond VERB dpc-4289 12 2 author author NOUN dpc-4289 12 3 : : PUNCT dpc-4289 12 4 hala hala PROPN dpc-4289 12 5 m. m. PROPN dpc-4289 12 6 elsadek elsadek PROPN dpc-4289 12 7 , , PUNCT dpc-4289 12 8 department department NOUN dpc-4289 12 9 of of ADP dpc-4289 12 10 dermatology dermatology NOUN dpc-4289 12 11 and and CCONJ dpc-4289 12 12 venereology venereology NOUN dpc-4289 12 13 , , PUNCT dpc-4289 12 14 faculty faculty NOUN dpc-4289 12 15 of of ADP dpc-4289 12 16 medicine medicine NOUN dpc-4289 12 17 for for ADP dpc-4289 12 18 girls girl NOUN dpc-4289 12 19 , , PUNCT dpc-4289 12 20 al al PROPN dpc-4289 12 21 - - PUNCT dpc-4289 12 22 azhar azhar PROPN dpc-4289 12 23 university university PROPN dpc-4289 12 24 , , PUNCT dpc-4289 12 25 cairo cairo PROPN dpc-4289 12 26 , , PUNCT dpc-4289 12 27 egypt egypt PROPN dpc-4289 12 28 . . PUNCT dpc-4289 13 1 tel tel ADP dpc-4289 13 2 : : PUNCT dpc-4289 13 3 +201272243237 +201272243237 NUM dpc-4289 13 4 e e NOUN dpc-4289 13 5 - - NOUN dpc-4289 13 6 mail mail NOUN dpc-4289 13 7 : : PUNCT dpc-4289 13 8 halamohammed.5323@azhar.edu.eg halamohammed.5323@azhar.edu.eg ADJ dpc-4289 13 9 introduction introduction NOUN dpc-4289 13 10 : : PUNCT dpc-4289 13 11 psoriasis psoriasis NOUN dpc-4289 13 12 is be AUX dpc-4289 13 13 a a DET dpc-4289 13 14 chronic chronic ADJ dpc-4289 13 15 inflammatory inflammatory ADJ dpc-4289 13 16 disease disease NOUN dpc-4289 13 17 affecting affect VERB dpc-4289 13 18 2 2 NUM dpc-4289 13 19 - - SYM dpc-4289 13 20 3 3 NUM dpc-4289 13 21 % % NOUN dpc-4289 13 22 of of ADP dpc-4289 13 23 the the DET dpc-4289 13 24 global global ADJ dpc-4289 13 25 population population NOUN dpc-4289 13 26 via via ADP dpc-4289 13 27 immune immune NOUN dpc-4289 13 28 - - PUNCT dpc-4289 13 29 mediated mediate VERB dpc-4289 13 30 mechanisms mechanism NOUN dpc-4289 13 31 . . PUNCT dpc-4289 14 1 osteopontin osteopontin NOUN dpc-4289 14 2 plays play VERB dpc-4289 14 3 a a DET dpc-4289 14 4 crucial crucial ADJ dpc-4289 14 5 role role NOUN dpc-4289 14 6 in in ADP dpc-4289 14 7 t t PROPN dpc-4289 14 8 - - PUNCT dpc-4289 14 9 helper helper NOUN dpc-4289 14 10 1and 1and PROPN dpc-4289 14 11 t t PROPN dpc-4289 14 12 - - PUNCT dpc-4289 14 13 helper helper NOUN dpc-4289 14 14 17 17 NUM dpc-4289 14 15 - - PUNCT dpc-4289 14 16 mediated mediate VERB dpc-4289 14 17 illnesses illness NOUN dpc-4289 14 18 , , PUNCT dpc-4289 14 19 including include VERB dpc-4289 14 20 psoriasis psoriasis NOUN dpc-4289 14 21 . . PUNCT dpc-4289 15 1 ocular ocular ADJ dpc-4289 15 2 complications complication NOUN dpc-4289 15 3 in in ADP dpc-4289 15 4 psoriasis psoriasis NOUN dpc-4289 15 5 have have AUX dpc-4289 15 6 been be AUX dpc-4289 15 7 reported report VERB dpc-4289 15 8 , , PUNCT dpc-4289 15 9 and and CCONJ dpc-4289 15 10 their their PRON dpc-4289 15 11 assessment assessment NOUN dpc-4289 15 12 is be AUX dpc-4289 15 13 of of ADP dpc-4289 15 14 significant significant ADJ dpc-4289 15 15 importance importance NOUN dpc-4289 15 16 . . PUNCT dpc-4289 16 1 osteopontin osteopontin NOUN dpc-4289 16 2 is be AUX dpc-4289 16 3 normally normally ADV dpc-4289 16 4 expressed express VERB dpc-4289 16 5 constitutively constitutively ADV dpc-4289 16 6 in in ADP dpc-4289 16 7 ocular ocular ADJ dpc-4289 16 8 structures structure NOUN dpc-4289 16 9 and and CCONJ dpc-4289 16 10 is be AUX dpc-4289 16 11 linked link VERB dpc-4289 16 12 to to ADP dpc-4289 16 13 ocular ocular ADJ dpc-4289 16 14 homeostasis homeostasis NOUN dpc-4289 16 15 . . PUNCT dpc-4289 17 1 objectives objective NOUN dpc-4289 17 2 : : PUNCT dpc-4289 17 3 the the DET dpc-4289 17 4 study study NOUN dpc-4289 17 5 aimed aim VERB dpc-4289 17 6 to to PART dpc-4289 17 7 clarify clarify VERB dpc-4289 17 8 the the DET dpc-4289 17 9 role role NOUN dpc-4289 17 10 of of ADP dpc-4289 17 11 osteopontin osteopontin NOUN dpc-4289 17 12 ( ( PUNCT dpc-4289 17 13 opn opn PROPN dpc-4289 17 14 ) ) PUNCT dpc-4289 17 15 in in ADP dpc-4289 17 16 psoriasis psoriasis NOUN dpc-4289 17 17 ( ( PUNCT dpc-4289 17 18 ps ps NOUN dpc-4289 17 19 ) ) PUNCT dpc-4289 17 20 and and CCONJ dpc-4289 17 21 its its PRON dpc-4289 17 22 correlation correlation NOUN dpc-4289 17 23 with with ADP dpc-4289 17 24 disease disease NOUN dpc-4289 17 25 severity severity NOUN dpc-4289 17 26 and and CCONJ dpc-4289 17 27 ocular ocular ADJ dpc-4289 17 28 manifestations manifestation NOUN dpc-4289 17 29 . . PUNCT dpc-4289 18 1 methods method NOUN dpc-4289 18 2 : : PUNCT dpc-4289 18 3 a a DET dpc-4289 18 4 case case NOUN dpc-4289 18 5 - - PUNCT dpc-4289 18 6 control control NOUN dpc-4289 18 7 study study NOUN dpc-4289 18 8 involving involve VERB dpc-4289 18 9 40 40 NUM dpc-4289 18 10 psoriatic psoriatic ADJ dpc-4289 18 11 patients patient NOUN dpc-4289 18 12 and and CCONJ dpc-4289 18 13 an an DET dpc-4289 18 14 equal equal ADJ dpc-4289 18 15 number number NOUN dpc-4289 18 16 of of ADP dpc-4289 18 17 ageand ageand NOUN dpc-4289 18 18 sex sex NOUN dpc-4289 18 19 - - PUNCT dpc-4289 18 20 matched match VERB dpc-4289 18 21 healthy healthy ADJ dpc-4289 18 22 subjects subject NOUN dpc-4289 18 23 was be AUX dpc-4289 18 24 conducted conduct VERB dpc-4289 18 25 . . PUNCT dpc-4289 19 1 we we PRON dpc-4289 19 2 used use VERB dpc-4289 19 3 the the DET dpc-4289 19 4 psoriasis psoriasis NOUN dpc-4289 19 5 area area NOUN dpc-4289 19 6 severity severity NOUN dpc-4289 19 7 index index NOUN dpc-4289 19 8 ( ( PUNCT dpc-4289 19 9 pasi pasi NOUN dpc-4289 19 10 ) ) PUNCT dpc-4289 19 11 to to PART dpc-4289 19 12 assess assess VERB dpc-4289 19 13 disease disease NOUN dpc-4289 19 14 severity severity NOUN dpc-4289 19 15 and and CCONJ dpc-4289 19 16 performed perform VERB dpc-4289 19 17 a a DET dpc-4289 19 18 comprehensive comprehensive ADJ dpc-4289 19 19 ophthalmological ophthalmological ADJ dpc-4289 19 20 examination examination NOUN dpc-4289 19 21 . . PUNCT dpc-4289 20 1 additionally additionally ADV dpc-4289 20 2 , , PUNCT dpc-4289 20 3 we we PRON dpc-4289 20 4 measured measure VERB dpc-4289 20 5 serum serum NOUN dpc-4289 20 6 osteopontin osteopontin ADJ dpc-4289 20 7 levels level NOUN dpc-4289 20 8 using use VERB dpc-4289 20 9 enzyme enzyme NOUN dpc-4289 20 10 - - PUNCT dpc-4289 20 11 linked link VERB dpc-4289 20 12 immunosorbent immunosorbent NOUN dpc-4289 20 13 assay assay PROPN dpc-4289 20 14 ( ( PUNCT dpc-4289 20 15 elisa elisa NOUN dpc-4289 20 16 ) ) PUNCT dpc-4289 20 17 in in ADP dpc-4289 20 18 both both DET dpc-4289 20 19 groups group NOUN dpc-4289 20 20 . . PUNCT dpc-4289 21 1 results result NOUN dpc-4289 21 2 : : PUNCT dpc-4289 21 3 a a DET dpc-4289 21 4 significant significant ADJ dpc-4289 21 5 elevation elevation NOUN dpc-4289 21 6 in in ADP dpc-4289 21 7 serum serum PROPN dpc-4289 21 8 opn opn PROPN dpc-4289 21 9 levels level NOUN dpc-4289 21 10 in in ADP dpc-4289 21 11 psoriatic psoriatic ADJ dpc-4289 21 12 patients patient NOUN dpc-4289 21 13 compared compare VERB dpc-4289 21 14 to to ADP dpc-4289 21 15 controls control NOUN dpc-4289 21 16 was be AUX dpc-4289 21 17 found find VERB dpc-4289 21 18 ( ( PUNCT dpc-4289 21 19 p= p= NOUN dpc-4289 21 20 0.000 0.000 NUM dpc-4289 21 21 ) ) PUNCT dpc-4289 21 22 . . PUNCT dpc-4289 22 1 furthermore furthermore ADV dpc-4289 22 2 , , PUNCT dpc-4289 22 3 there there PRON dpc-4289 22 4 was be VERB dpc-4289 22 5 a a DET dpc-4289 22 6 highly highly ADV dpc-4289 22 7 significant significant ADJ dpc-4289 22 8 positive positive ADJ dpc-4289 22 9 correlation correlation NOUN dpc-4289 22 10 between between ADP dpc-4289 22 11 serum serum PROPN dpc-4289 22 12 opn opn PROPN dpc-4289 22 13 levels level NOUN dpc-4289 22 14 and and CCONJ dpc-4289 22 15 patient patient ADJ dpc-4289 22 16 age age NOUN dpc-4289 22 17 , , PUNCT dpc-4289 22 18 disease disease NOUN dpc-4289 22 19 duration duration NOUN dpc-4289 22 20 , , PUNCT dpc-4289 22 21 and and CCONJ dpc-4289 22 22 pasi pasi NOUN dpc-4289 22 23 scores score NOUN dpc-4289 22 24 . . PUNCT dpc-4289 23 1 notably notably ADV dpc-4289 23 2 , , PUNCT dpc-4289 23 3 a a DET dpc-4289 23 4 higher high ADJ dpc-4289 23 5 prevalence prevalence NOUN dpc-4289 23 6 of of ADP dpc-4289 23 7 ocular ocular ADJ dpc-4289 23 8 abstract abstract ADJ dpc-4289 23 9 2 2 NUM dpc-4289 23 10 original original ADJ dpc-4289 23 11 article article NOUN dpc-4289 23 12 | | ADV dpc-4289 23 13 dermatol dermatol ADJ dpc-4289 23 14 pract pract NOUN dpc-4289 23 15 concept concept NOUN dpc-4289 23 16 . . PUNCT dpc-4289 24 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 24 2 introduction introduction NOUN dpc-4289 24 3 psoriasis psoriasis NOUN dpc-4289 24 4 ( ( PUNCT dpc-4289 24 5 ps ps NOUN dpc-4289 24 6 ) ) PUNCT dpc-4289 24 7 is be AUX dpc-4289 24 8 an an DET dpc-4289 24 9 inflammatory inflammatory ADJ dpc-4289 24 10 disease disease NOUN dpc-4289 24 11 of of ADP dpc-4289 24 12 chronic chronic ADJ dpc-4289 24 13 nature nature NOUN dpc-4289 24 14 characterized characterize VERB dpc-4289 24 15 by by ADP dpc-4289 24 16 hyperproliferation hyperproliferation NOUN dpc-4289 24 17 of of ADP dpc-4289 24 18 keratinocytes keratinocyte NOUN dpc-4289 24 19 in in ADP dpc-4289 24 20 the the DET dpc-4289 24 21 epidermis epidermis NOUN dpc-4289 24 22 , , PUNCT dpc-4289 24 23 influenced influence VERB dpc-4289 24 24 by by ADP dpc-4289 24 25 environmental environmental ADJ dpc-4289 24 26 , , PUNCT dpc-4289 24 27 genetic genetic ADJ dpc-4289 24 28 , , PUNCT dpc-4289 24 29 and and CCONJ dpc-4289 24 30 immunologic immunologic ADJ dpc-4289 24 31 factors factor NOUN dpc-4289 24 32 . . PUNCT dpc-4289 25 1 it it PRON dpc-4289 25 2 typically typically ADV dpc-4289 25 3 affects affect VERB dpc-4289 25 4 the the DET dpc-4289 25 5 skin skin NOUN dpc-4289 25 6 of of ADP dpc-4289 25 7 the the DET dpc-4289 25 8 elbows elbow NOUN dpc-4289 25 9 , , PUNCT dpc-4289 25 10 knees knee NOUN dpc-4289 25 11 , , PUNCT dpc-4289 25 12 scalp scalp NOUN dpc-4289 25 13 , , PUNCT dpc-4289 25 14 lumbosacral lumbosacral ADJ dpc-4289 25 15 areas area NOUN dpc-4289 25 16 , , PUNCT dpc-4289 25 17 and and CCONJ dpc-4289 25 18 joints joint NOUN dpc-4289 25 19 in in ADP dpc-4289 25 20 up up ADP dpc-4289 25 21 to to PART dpc-4289 25 22 30 30 NUM dpc-4289 25 23 % % NOUN dpc-4289 25 24 of of ADP dpc-4289 25 25 patients patient NOUN dpc-4289 25 26 . . PUNCT dpc-4289 26 1 ps ps NOUN dpc-4289 26 2 affects affect VERB dpc-4289 26 3 2–3 2–3 NUM dpc-4289 26 4 % % NOUN dpc-4289 26 5 of of ADP dpc-4289 26 6 the the DET dpc-4289 26 7 worldwide worldwide ADJ dpc-4289 26 8 population population NOUN dpc-4289 26 9 due due ADP dpc-4289 26 10 to to ADP dpc-4289 26 11 immune immune NOUN dpc-4289 26 12 - - PUNCT dpc-4289 26 13 mediated mediate VERB dpc-4289 26 14 mechanisms mechanism NOUN dpc-4289 26 15 ( ( PUNCT dpc-4289 26 16 1 1 NUM dpc-4289 26 17 ) ) PUNCT dpc-4289 26 18 . . PUNCT dpc-4289 27 1 a a DET dpc-4289 27 2 variety variety NOUN dpc-4289 27 3 of of ADP dpc-4289 27 4 comorbidities comorbiditie NOUN dpc-4289 27 5 are be AUX dpc-4289 27 6 linked link VERB dpc-4289 27 7 to to ADP dpc-4289 27 8 ps ps PROPN dpc-4289 27 9 , , PUNCT dpc-4289 27 10 such such ADJ dpc-4289 27 11 as as ADP dpc-4289 27 12 psoriatic psoriatic ADJ dpc-4289 27 13 arthritis arthritis NOUN dpc-4289 27 14 , , PUNCT dpc-4289 27 15 diabetes diabetes NOUN dpc-4289 27 16 mellitus mellitus NOUN dpc-4289 27 17 , , PUNCT dpc-4289 27 18 depression depression NOUN dpc-4289 27 19 , , PUNCT dpc-4289 27 20 osteoporosis osteoporosis NOUN dpc-4289 27 21 , , PUNCT dpc-4289 27 22 cardiovascular cardiovascular ADJ dpc-4289 27 23 disease disease NOUN dpc-4289 27 24 , , PUNCT dpc-4289 27 25 autoimmune autoimmune ADJ dpc-4289 27 26 eye eye NOUN dpc-4289 27 27 disease disease NOUN dpc-4289 27 28 , , PUNCT dpc-4289 27 29 metabolic metabolic NOUN dpc-4289 27 30 syndrome syndrome NOUN dpc-4289 27 31 , , PUNCT dpc-4289 27 32 fatty fatty ADJ dpc-4289 27 33 liver liver NOUN dpc-4289 27 34 disease disease NOUN dpc-4289 27 35 , , PUNCT dpc-4289 27 36 fibromyalgia fibromyalgia NOUN dpc-4289 27 37 , , PUNCT dpc-4289 27 38 and and CCONJ dpc-4289 27 39 rheumatic rheumatic ADJ dpc-4289 27 40 disorders disorder NOUN dpc-4289 27 41 ( ( PUNCT dpc-4289 27 42 2 2 NUM dpc-4289 27 43 ) ) PUNCT dpc-4289 27 44 . . PUNCT dpc-4289 28 1 ps ps PROPN dpc-4289 28 2 is be AUX dpc-4289 28 3 associated associate VERB dpc-4289 28 4 with with ADP dpc-4289 28 5 various various ADJ dpc-4289 28 6 extracutaneous extracutaneous ADJ dpc-4289 28 7 symptoms symptom NOUN dpc-4289 28 8 , , PUNCT dpc-4289 28 9 with with ADP dpc-4289 28 10 eye eye NOUN dpc-4289 28 11 involvement involvement NOUN dpc-4289 28 12 being be AUX dpc-4289 28 13 a a DET dpc-4289 28 14 significant significant ADJ dpc-4289 28 15 aspect aspect NOUN dpc-4289 28 16 and and CCONJ dpc-4289 28 17 occurring occur VERB dpc-4289 28 18 later later ADV dpc-4289 28 19 . . PUNCT dpc-4289 29 1 ps ps NOUN dpc-4289 29 2 may may AUX dpc-4289 29 3 affect affect VERB dpc-4289 29 4 the the DET dpc-4289 29 5 eye eye NOUN dpc-4289 29 6 lid lid NOUN dpc-4289 29 7 , , PUNCT dpc-4289 29 8 cornea cornea NOUN dpc-4289 29 9 or or CCONJ dpc-4289 29 10 conjunctiva conjunctiva NOUN dpc-4289 29 11 , , PUNCT dpc-4289 29 12 or or CCONJ dpc-4289 29 13 retina retina VERB dpc-4289 29 14 leading lead VERB dpc-4289 29 15 to to ADP dpc-4289 29 16 the the DET dpc-4289 29 17 development development NOUN dpc-4289 29 18 of of ADP dpc-4289 29 19 ocular ocular ADJ dpc-4289 29 20 manifestations manifestation NOUN dpc-4289 29 21 , , PUNCT dpc-4289 29 22 including include VERB dpc-4289 29 23 dry dry ADJ dpc-4289 29 24 eyes eye NOUN dpc-4289 29 25 , , PUNCT dpc-4289 29 26 conjunctivitis conjunctivitis NOUN dpc-4289 29 27 , , PUNCT dpc-4289 29 28 blepharitis blepharitis NOUN dpc-4289 29 29 , , PUNCT dpc-4289 29 30 keratitis keratitis NOUN dpc-4289 29 31 , , PUNCT dpc-4289 29 32 trichiasis trichiasis NOUN dpc-4289 29 33 , , PUNCT dpc-4289 29 34 ectropion ectropion NOUN dpc-4289 29 35 , , PUNCT dpc-4289 29 36 and and CCONJ dpc-4289 29 37 corneal corneal ADJ dpc-4289 29 38 melting melting NOUN dpc-4289 29 39 , , PUNCT dpc-4289 29 40 uveitis uveitis NOUN dpc-4289 29 41 , , PUNCT dpc-4289 29 42 cataract cataract NOUN dpc-4289 29 43 , , PUNCT dpc-4289 29 44 glaucoma glaucoma NOUN dpc-4289 29 45 and and CCONJ dpc-4289 29 46 retinal retinal ADJ dpc-4289 29 47 micro micro ADJ dpc-4289 29 48 - - ADJ dpc-4289 29 49 vascular vascular ADJ dpc-4289 29 50 abnormalities abnormality NOUN dpc-4289 29 51 ( ( PUNCT dpc-4289 29 52 3 3 NUM dpc-4289 29 53 ) ) PUNCT dpc-4289 29 54 . . PUNCT dpc-4289 30 1 diagnosis diagnosis NOUN dpc-4289 30 2 of of ADP dpc-4289 30 3 ps ps PROPN dpc-4289 30 4 is be AUX dpc-4289 30 5 determined determine VERB dpc-4289 30 6 by by ADP dpc-4289 30 7 clinical clinical ADJ dpc-4289 30 8 features feature NOUN dpc-4289 30 9 , , PUNCT dpc-4289 30 10 dermoscopy dermoscopy NOUN dpc-4289 30 11 or or CCONJ dpc-4289 30 12 histopathology histopathology NOUN dpc-4289 30 13 in in ADP dpc-4289 30 14 uncertain uncertain ADJ dpc-4289 30 15 cases case NOUN dpc-4289 30 16 ( ( PUNCT dpc-4289 30 17 4 4 NUM dpc-4289 30 18 ) ) PUNCT dpc-4289 30 19 . . PUNCT dpc-4289 30 20     SPACE dpc-4289 31 1 recently recently ADV dpc-4289 31 2 introduced introduce VERB dpc-4289 31 3 , , PUNCT dpc-4289 31 4 line line NOUN dpc-4289 31 5 - - PUNCT dpc-4289 31 6 field field NOUN dpc-4289 31 7 confocal confocal ADJ dpc-4289 31 8 optical optical ADJ dpc-4289 31 9 coherence coherence NOUN dpc-4289 31 10 tomography tomography NOUN dpc-4289 31 11 ( ( PUNCT dpc-4289 31 12 lc lc PROPN dpc-4289 31 13 - - PUNCT dpc-4289 31 14 oct oct NOUN dpc-4289 31 15 ) ) PUNCT dpc-4289 31 16 , , PUNCT dpc-4289 31 17 a a DET dpc-4289 31 18 non non ADJ dpc-4289 31 19 - - ADJ dpc-4289 31 20 invasive invasive ADJ dpc-4289 31 21 tool tool NOUN dpc-4289 31 22 , , PUNCT dpc-4289 31 23 offers offer VERB dpc-4289 31 24 high high ADJ dpc-4289 31 25 - - PUNCT dpc-4289 31 26 resolution resolution NOUN dpc-4289 31 27 images image NOUN dpc-4289 31 28 of of ADP dpc-4289 31 29 psoriatic psoriatic ADJ dpc-4289 31 30 lesion lesion NOUN dpc-4289 31 31 in in ADP dpc-4289 31 32 vivo vivo NOUN dpc-4289 31 33 , , PUNCT dpc-4289 31 34 potentially potentially ADV dpc-4289 31 35 improving improve VERB dpc-4289 31 36 diagnosis diagnosis NOUN dpc-4289 31 37 , , PUNCT dpc-4289 31 38 biopsy biopsy NOUN dpc-4289 31 39 guidance guidance NOUN dpc-4289 31 40 , , PUNCT dpc-4289 31 41 treatment treatment NOUN dpc-4289 31 42 monitoring monitoring NOUN dpc-4289 31 43 , , PUNCT dpc-4289 31 44 and and CCONJ dpc-4289 31 45 disease disease NOUN dpc-4289 31 46 severity severity NOUN dpc-4289 31 47 evaluation evaluation NOUN dpc-4289 31 48 ( ( PUNCT dpc-4289 31 49 5 5 NUM dpc-4289 31 50 ) ) PUNCT dpc-4289 31 51 . . PUNCT dpc-4289 32 1 osteopontin osteopontin PROPN dpc-4289 32 2 ( ( PUNCT dpc-4289 32 3 opn opn PROPN dpc-4289 32 4 ) ) PUNCT dpc-4289 32 5 is be AUX dpc-4289 32 6 an an DET dpc-4289 32 7 acid acid ADJ dpc-4289 32 8 glycoprotein glycoprotein NOUN dpc-4289 32 9 that that PRON dpc-4289 32 10 is be AUX dpc-4289 32 11 expressed express VERB dpc-4289 32 12 by by ADP dpc-4289 32 13 various various ADJ dpc-4289 32 14 immune immune ADJ dpc-4289 32 15 cells cell NOUN dpc-4289 32 16 during during ADP dpc-4289 32 17 inflammation inflammation NOUN dpc-4289 32 18 , , PUNCT dpc-4289 32 19 including include VERB dpc-4289 32 20 macrophages macrophage NOUN dpc-4289 32 21 , , PUNCT dpc-4289 32 22 natural natural ADJ dpc-4289 32 23 killer killer NOUN dpc-4289 32 24 cells cell NOUN dpc-4289 32 25 , , PUNCT dpc-4289 32 26 dendritic dendritic ADJ dpc-4289 32 27 cells cell NOUN dpc-4289 32 28 , , PUNCT dpc-4289 32 29 b b NOUN dpc-4289 32 30 and and CCONJ dpc-4289 32 31 t t NOUN dpc-4289 32 32 cells cell NOUN dpc-4289 32 33 , , PUNCT dpc-4289 32 34 and and CCONJ dpc-4289 32 35 vascular vascular ADJ dpc-4289 32 36 smooth smooth ADJ dpc-4289 32 37 muscle muscle NOUN dpc-4289 32 38 cells cell NOUN dpc-4289 32 39 . . PUNCT dpc-4289 33 1 moreover moreover ADV dpc-4289 33 2 , , PUNCT dpc-4289 33 3 opn opn PROPN dpc-4289 33 4 has have AUX dpc-4289 33 5 been be AUX dpc-4289 33 6 reported report VERB dpc-4289 33 7 as as ADP dpc-4289 33 8 a a DET dpc-4289 33 9 th1 th1 NOUN dpc-4289 33 10 cytokine cytokine NOUN dpc-4289 33 11 implicated implicate VERB dpc-4289 33 12 in in ADP dpc-4289 33 13 monocyte monocyte ADJ dpc-4289 33 14 / / SYM dpc-4289 33 15 macrophage macrophage ADJ dpc-4289 33 16 activation activation NOUN dpc-4289 33 17 , , PUNCT dpc-4289 33 18 migration migration NOUN dpc-4289 33 19 , , PUNCT dpc-4289 33 20 inflammation inflammation NOUN dpc-4289 33 21 , , PUNCT dpc-4289 33 22 cell cell NOUN dpc-4289 33 23 - - PUNCT dpc-4289 33 24 mediated mediate VERB dpc-4289 33 25 immunity immunity NOUN dpc-4289 33 26 , , PUNCT dpc-4289 33 27 cell cell NOUN dpc-4289 33 28 survival survival NOUN dpc-4289 33 29 , , PUNCT dpc-4289 33 30 mediated mediate VERB dpc-4289 33 31 by by ADP dpc-4289 33 32 binding bind VERB dpc-4289 33 33 to to ADP dpc-4289 33 34 cluster cluster NOUN dpc-4289 33 35 of of ADP dpc-4289 33 36 differentiation differentiation NOUN dpc-4289 33 37 ( ( PUNCT dpc-4289 33 38 cd44 cd44 PROPN dpc-4289 33 39 ) ) PUNCT dpc-4289 33 40 , , PUNCT dpc-4289 33 41 metastases metastasis NOUN dpc-4289 33 42 , , PUNCT dpc-4289 33 43 and and CCONJ dpc-4289 33 44 tumor tumor NOUN dpc-4289 33 45 invasion invasion NOUN dpc-4289 33 46 and and CCONJ dpc-4289 33 47 plays play VERB dpc-4289 33 48 a a DET dpc-4289 33 49 crucial crucial ADJ dpc-4289 33 50 role role NOUN dpc-4289 33 51 in in ADP dpc-4289 33 52 cell cell NOUN dpc-4289 33 53 adhesion adhesion NOUN dpc-4289 33 54 ( ( PUNCT dpc-4289 33 55 6 6 NUM dpc-4289 33 56 ) ) PUNCT dpc-4289 33 57 . . PUNCT dpc-4289 34 1 it it PRON dpc-4289 34 2 has have AUX dpc-4289 34 3 been be AUX dpc-4289 34 4 shown show VERB dpc-4289 34 5 that that SCONJ dpc-4289 34 6 opn opn PROPN dpc-4289 34 7 is be AUX dpc-4289 34 8 involved involve VERB dpc-4289 34 9 in in ADP dpc-4289 34 10 both both CCONJ dpc-4289 34 11 acute acute ADJ dpc-4289 34 12 and and CCONJ dpc-4289 34 13 chronic chronic ADJ dpc-4289 34 14 inflammatory inflammatory ADJ dpc-4289 34 15 processes process NOUN dpc-4289 34 16 . . PUNCT dpc-4289 35 1 opn opn PROPN dpc-4289 35 2 is be AUX dpc-4289 35 3 mostly mostly ADV dpc-4289 35 4 released release VERB dpc-4289 35 5 at at ADP dpc-4289 35 6 the the DET dpc-4289 35 7 site site NOUN dpc-4289 35 8 of of ADP dpc-4289 35 9 inflammation inflammation NOUN dpc-4289 35 10 by by ADP dpc-4289 35 11 t t NOUN dpc-4289 35 12 cells cell NOUN dpc-4289 35 13 and and CCONJ dpc-4289 35 14 activated activate VERB dpc-4289 35 15 macrophages macrophage NOUN dpc-4289 35 16 ( ( PUNCT dpc-4289 35 17 7 7 NUM dpc-4289 35 18 ) ) PUNCT dpc-4289 35 19 . . PUNCT dpc-4289 36 1 opn opn PROPN dpc-4289 36 2 is be AUX dpc-4289 36 3 expressed express VERB dpc-4289 36 4 in in ADP dpc-4289 36 5 retinal retinal ADJ dpc-4289 36 6 ganglionic ganglionic ADJ dpc-4289 36 7 cells cell NOUN dpc-4289 36 8 ( ( PUNCT dpc-4289 36 9 rgcs rgcs NOUN dpc-4289 36 10 ) ) PUNCT dpc-4289 36 11 , , PUNCT dpc-4289 36 12 muller muller NOUN dpc-4289 36 13 cells cell NOUN dpc-4289 36 14 , , PUNCT dpc-4289 36 15 and and CCONJ dpc-4289 36 16 retinal retinal ADJ dpc-4289 36 17 pigment pigment NOUN dpc-4289 36 18 epithelium epithelium NOUN dpc-4289 36 19 . . PUNCT dpc-4289 37 1 functionally functionally ADV dpc-4289 37 2 , , PUNCT dpc-4289 37 3 opn opn PROPN dpc-4289 37 4 is be AUX dpc-4289 37 5 involved involve VERB dpc-4289 37 6 in in ADP dpc-4289 37 7 corneal corneal ADJ dpc-4289 37 8 tissue tissue NOUN dpc-4289 37 9 regeneration regeneration NOUN dpc-4289 37 10 and and CCONJ dpc-4289 37 11 persistence persistence NOUN dpc-4289 37 12 of of ADP dpc-4289 37 13 rgcs rgcs NOUN dpc-4289 37 14 against against ADP dpc-4289 37 15 ischemic ischemic ADJ dpc-4289 37 16 injury injury NOUN dpc-4289 37 17 . . PUNCT dpc-4289 38 1 opn opn PROPN dpc-4289 38 2 is be AUX dpc-4289 38 3 associated associate VERB dpc-4289 38 4 with with ADP dpc-4289 38 5 ocular ocular ADJ dpc-4289 38 6 homeostasis homeostasis NOUN dpc-4289 38 7 under under ADP dpc-4289 38 8 normal normal ADJ dpc-4289 38 9 conditions condition NOUN dpc-4289 38 10 ( ( PUNCT dpc-4289 38 11 8) 8) NUM dpc-4289 38 12 . . PUNCT dpc-4289 39 1 objectives objective NOUN dpc-4289 39 2 : : PUNCT dpc-4289 39 3 this this DET dpc-4289 39 4 study study NOUN dpc-4289 39 5 was be AUX dpc-4289 39 6 conducted conduct VERB dpc-4289 39 7 to to PART dpc-4289 39 8 measure measure VERB dpc-4289 39 9 the the DET dpc-4289 39 10 serum serum NOUN dpc-4289 39 11 levels level NOUN dpc-4289 39 12 of of ADP dpc-4289 39 13 opn opn PROPN dpc-4289 39 14 in in ADP dpc-4289 39 15 ps ps PROPN dpc-4289 39 16 patients patient NOUN dpc-4289 39 17 and and CCONJ dpc-4289 39 18 to to PART dpc-4289 39 19 correlate correlate VERB dpc-4289 39 20 it it PRON dpc-4289 39 21 with with ADP dpc-4289 39 22 disease disease NOUN dpc-4289 39 23 severity severity NOUN dpc-4289 39 24 and and CCONJ dpc-4289 39 25 ocular ocular ADJ dpc-4289 39 26 comorbidity comorbidity NOUN dpc-4289 39 27 to to PART dpc-4289 39 28 assess assess VERB dpc-4289 39 29 its its PRON dpc-4289 39 30 possible possible ADJ dpc-4289 39 31 role role NOUN dpc-4289 39 32 in in ADP dpc-4289 39 33 the the DET dpc-4289 39 34 disease disease NOUN dpc-4289 39 35 pathogenesis pathogenesis NOUN dpc-4289 39 36 . . PUNCT dpc-4289 40 1 methods method NOUN dpc-4289 40 2 study study VERB dpc-4289 40 3 design design NOUN dpc-4289 40 4 and and CCONJ dpc-4289 40 5 setting set VERB dpc-4289 40 6 this this DET dpc-4289 40 7 case case NOUN dpc-4289 40 8 - - PUNCT dpc-4289 40 9 control control NOUN dpc-4289 40 10 study study NOUN dpc-4289 40 11 was be AUX dpc-4289 40 12 conducted conduct VERB dpc-4289 40 13 at at ADP dpc-4289 40 14 xxx xxx PROPN dpc-4289 40 15 university university NOUN dpc-4289 40 16 hospital hospital NOUN dpc-4289 40 17 , , PUNCT dpc-4289 40 18 dermatology dermatology NOUN dpc-4289 40 19 and and CCONJ dpc-4289 40 20 venereology venereology NOUN dpc-4289 40 21 department department NOUN dpc-4289 40 22 , , PUNCT dpc-4289 40 23 in in ADP dpc-4289 40 24 collaboration collaboration NOUN dpc-4289 40 25 with with ADP dpc-4289 40 26 the the DET dpc-4289 40 27 ophthalmology ophthalmology NOUN dpc-4289 40 28 department department NOUN dpc-4289 40 29 affiliated affiliate VERB dpc-4289 40 30 with with ADP dpc-4289 40 31 the the DET dpc-4289 40 32 faculty faculty NOUN dpc-4289 40 33 of of ADP dpc-4289 40 34 medicine medicine PROPN dpc-4289 40 35 xxxxxx xxxxxx PROPN dpc-4289 40 36 from from ADP dpc-4289 40 37 february february PROPN dpc-4289 40 38 to to ADP dpc-4289 40 39 october october PROPN dpc-4289 40 40 2023 2023 NUM dpc-4289 40 41 . . PUNCT dpc-4289 41 1 the the DET dpc-4289 41 2 subjects subject NOUN dpc-4289 41 3 provided provide VERB dpc-4289 41 4 written write VERB dpc-4289 41 5 , , PUNCT dpc-4289 41 6 informed inform VERB dpc-4289 41 7 consent consent NOUN dpc-4289 41 8 before before ADP dpc-4289 41 9 their their PRON dpc-4289 41 10 participation participation NOUN dpc-4289 41 11 in in ADP dpc-4289 41 12 the the DET dpc-4289 41 13 study study NOUN dpc-4289 41 14 . . PUNCT dpc-4289 42 1 the the DET dpc-4289 42 2 study study NOUN dpc-4289 42 3 was be AUX dpc-4289 42 4 approved approve VERB dpc-4289 42 5 by by ADP dpc-4289 42 6 the the DET dpc-4289 42 7 research research NOUN dpc-4289 42 8 ethics ethic NOUN dpc-4289 42 9 committee committee PROPN dpc-4289 42 10 of of ADP dpc-4289 42 11 the the DET dpc-4289 42 12 faculty faculty NOUN dpc-4289 42 13 of of ADP dpc-4289 42 14 medicine medicine NOUN dpc-4289 42 15 , , PUNCT dpc-4289 42 16 al al PROPN dpc-4289 42 17 - - PUNCT dpc-4289 42 18 azhar azhar PROPN dpc-4289 42 19 university university PROPN dpc-4289 42 20 ( ( PUNCT dpc-4289 42 21 reference reference NOUN dpc-4289 42 22 number number NOUN dpc-4289 42 23 rhdirb rhdirb VERB dpc-4289 42 24 2022121668 2022121668 NUM dpc-4289 42 25 ) ) PUNCT dpc-4289 42 26 . . PUNCT dpc-4289 43 1 study study NOUN dpc-4289 43 2 size size NOUN dpc-4289 43 3 sample sample NOUN dpc-4289 43 4 size size NOUN dpc-4289 43 5 was be AUX dpc-4289 43 6 calculated calculate VERB dpc-4289 43 7 using use VERB dpc-4289 43 8 g g PROPN dpc-4289 43 9 power power NOUN dpc-4289 43 10 3.1.9.4 3.1.9.4 NUM dpc-4289 43 11 depending depend VERB dpc-4289 43 12 on on ADP dpc-4289 43 13 data datum NOUN dpc-4289 43 14 from from ADP dpc-4289 43 15 previous previous ADJ dpc-4289 43 16 studies study NOUN dpc-4289 43 17 that that PRON dpc-4289 43 18 studied study VERB dpc-4289 43 19 the the DET dpc-4289 43 20 association association NOUN dpc-4289 43 21 between between ADP dpc-4289 43 22 osteopontin osteopontin NOUN dpc-4289 43 23 and and CCONJ dpc-4289 43 24 eye eye NOUN dpc-4289 43 25 changes change NOUN dpc-4289 43 26 in in ADP dpc-4289 43 27 alopecia alopecia NOUN dpc-4289 43 28 areata areata ADJ dpc-4289 43 29 as as ADP dpc-4289 43 30 no no DET dpc-4289 43 31 previous previous ADJ dpc-4289 43 32 research research NOUN dpc-4289 43 33 on on ADP dpc-4289 43 34 the the DET dpc-4289 43 35 association association NOUN dpc-4289 43 36 between between ADP dpc-4289 43 37 osteopontin osteopontin NOUN dpc-4289 43 38 and and CCONJ dpc-4289 43 39 eye eye NOUN dpc-4289 43 40 changes change NOUN dpc-4289 43 41 in in ADP dpc-4289 43 42 psoriasis psoriasis NOUN dpc-4289 43 43 , , PUNCT dpc-4289 43 44 depending depend VERB dpc-4289 43 45 on on ADP dpc-4289 43 46 correlation correlation NOUN dpc-4289 43 47 between between ADP dpc-4289 43 48 osteopontin osteopontin NOUN dpc-4289 43 49 and and CCONJ dpc-4289 43 50 fundus fundus NOUN dpc-4289 43 51 changes change NOUN dpc-4289 43 52 = = SYM dpc-4289 43 53 0.4 0.4 NUM dpc-4289 43 54 accordingly accordingly ADV dpc-4289 43 55 the the DET dpc-4289 43 56 required require VERB dpc-4289 43 57 sample sample NOUN dpc-4289 43 58 size size NOUN dpc-4289 43 59 was be AUX dpc-4289 43 60 40 40 NUM dpc-4289 43 61 participant participant NOUN dpc-4289 43 62 in in ADP dpc-4289 43 63 each each DET dpc-4289 43 64 group group NOUN dpc-4289 43 65 . . PUNCT dpc-4289 44 1 participants participant NOUN dpc-4289 44 2 the the DET dpc-4289 44 3 study study NOUN dpc-4289 44 4 involved involve VERB dpc-4289 44 5 80 80 NUM dpc-4289 44 6 participants participant NOUN dpc-4289 44 7 attending attend VERB dpc-4289 44 8 the the DET dpc-4289 44 9 outpatient outpatient NOUN dpc-4289 44 10 clinic clinic NOUN dpc-4289 44 11 of of ADP dpc-4289 44 12 the the DET dpc-4289 44 13 dermatology dermatology NOUN dpc-4289 44 14 and and CCONJ dpc-4289 44 15 venereology venereology NOUN dpc-4289 44 16 department department NOUN dpc-4289 44 17 , , PUNCT dpc-4289 44 18 divided divide VERB dpc-4289 44 19 into into ADP dpc-4289 44 20 two two NUM dpc-4289 44 21 groups group NOUN dpc-4289 44 22 : : PUNCT dpc-4289 44 23 40 40 NUM dpc-4289 44 24 patients patient NOUN dpc-4289 44 25 with with ADP dpc-4289 44 26 ps ps PROPN dpc-4289 44 27 diagnosed diagnose VERB dpc-4289 44 28 clinically clinically ADV dpc-4289 44 29 or or CCONJ dpc-4289 44 30 histopathologically histopathologically ADV dpc-4289 44 31 , , PUNCT dpc-4289 44 32 and and CCONJ dpc-4289 44 33 40 40 NUM dpc-4289 44 34 ageand ageand NOUN dpc-4289 44 35 sex sex NOUN dpc-4289 44 36 - - PUNCT dpc-4289 44 37 matched match VERB dpc-4289 44 38 healthy healthy ADJ dpc-4289 44 39 subjects subject NOUN dpc-4289 44 40 as as ADP dpc-4289 44 41 the the DET dpc-4289 44 42 control control NOUN dpc-4289 44 43 group group NOUN dpc-4289 44 44 . . PUNCT dpc-4289 45 1 patients patient NOUN dpc-4289 45 2 of of ADP dpc-4289 45 3 both both DET dpc-4289 45 4 sexes sex NOUN dpc-4289 45 5 , , PUNCT dpc-4289 45 6 aged aged ADJ dpc-4289 45 7 20 20 NUM dpc-4289 45 8 - - SYM dpc-4289 45 9 60 60 NUM dpc-4289 45 10 years year NOUN dpc-4289 45 11 without without ADP dpc-4289 45 12 prior prior ADJ dpc-4289 45 13 systemic systemic ADJ dpc-4289 45 14 therapy therapy NOUN dpc-4289 45 15 for for ADP dpc-4289 45 16 at at ADV dpc-4289 45 17 least least ADJ dpc-4289 45 18 4 4 NUM dpc-4289 45 19 - - SYM dpc-4289 45 20 6 6 NUM dpc-4289 45 21 weeks week NOUN dpc-4289 45 22 or or CCONJ dpc-4289 45 23 prior prior ADJ dpc-4289 45 24 topical topical ADJ dpc-4289 45 25 medication medication NOUN dpc-4289 45 26 for for ADP dpc-4289 45 27 ps ps PROPN dpc-4289 45 28 for for ADP dpc-4289 45 29 at at ADV dpc-4289 45 30 least least ADV dpc-4289 45 31 two two NUM dpc-4289 45 32 complications complication NOUN dpc-4289 45 33 , , PUNCT dpc-4289 45 34 including include VERB dpc-4289 45 35 blepharitis blepharitis NOUN dpc-4289 45 36 , , PUNCT dpc-4289 45 37 corneal corneal ADJ dpc-4289 45 38 affection affection NOUN dpc-4289 45 39 , , PUNCT dpc-4289 45 40 conjunctivitis conjunctivitis NOUN dpc-4289 45 41 , , PUNCT dpc-4289 45 42 keratoconjunctivitis keratoconjunctivitis PROPN dpc-4289 45 43 sicca sicca NOUN dpc-4289 45 44 , , PUNCT dpc-4289 45 45 and and CCONJ dpc-4289 45 46 cataract cataract NOUN dpc-4289 45 47 was be AUX dpc-4289 45 48 observed observe VERB dpc-4289 45 49 in in ADP dpc-4289 45 50 psoriatic psoriatic ADJ dpc-4289 45 51 patients patient NOUN dpc-4289 45 52 compared compare VERB dpc-4289 45 53 to to ADP dpc-4289 45 54 controls control NOUN dpc-4289 45 55 . . PUNCT dpc-4289 46 1 importantly importantly ADV dpc-4289 46 2 , , PUNCT dpc-4289 46 3 significant significant ADJ dpc-4289 46 4 associations association NOUN dpc-4289 46 5 between between ADP dpc-4289 46 6 serum serum PROPN dpc-4289 46 7 opn opn PROPN dpc-4289 46 8 levels level NOUN dpc-4289 46 9 and and CCONJ dpc-4289 46 10 the the DET dpc-4289 46 11 presence presence NOUN dpc-4289 46 12 of of ADP dpc-4289 46 13 cataracts cataract NOUN dpc-4289 46 14 and and CCONJ dpc-4289 46 15 intraocular intraocular ADJ dpc-4289 46 16 pressure pressure NOUN dpc-4289 46 17 ( ( PUNCT dpc-4289 46 18 iop iop NOUN dpc-4289 46 19 ) ) PUNCT dpc-4289 46 20 were be AUX dpc-4289 46 21 identified identify VERB dpc-4289 46 22 . . PUNCT dpc-4289 47 1 additionally additionally ADV dpc-4289 47 2 , , PUNCT dpc-4289 47 3 significant significant ADJ dpc-4289 47 4 correlations correlation NOUN dpc-4289 47 5 between between ADP dpc-4289 47 6 serum serum PROPN dpc-4289 47 7 opn opn PROPN dpc-4289 47 8 levels level NOUN dpc-4289 47 9 and and CCONJ dpc-4289 47 10 measures measure NOUN dpc-4289 47 11 of of ADP dpc-4289 47 12 visual visual ADJ dpc-4289 47 13 acuity acuity NOUN dpc-4289 47 14 and and CCONJ dpc-4289 47 15 ocular ocular ADJ dpc-4289 47 16 surface surface NOUN dpc-4289 47 17 health health NOUN dpc-4289 47 18 were be AUX dpc-4289 47 19 found find VERB dpc-4289 47 20 . . PUNCT dpc-4289 48 1 conclusions conclusion NOUN dpc-4289 48 2 : : PUNCT dpc-4289 48 3 osteopontin osteopontin NOUN dpc-4289 48 4 is be AUX dpc-4289 48 5 considered consider VERB dpc-4289 48 6 a a DET dpc-4289 48 7 marker marker NOUN dpc-4289 48 8 of of ADP dpc-4289 48 9 psoriasis psoriasis NOUN dpc-4289 48 10 severity severity NOUN dpc-4289 48 11 and and CCONJ dpc-4289 48 12 is be AUX dpc-4289 48 13 associated associate VERB dpc-4289 48 14 with with ADP dpc-4289 48 15 ocular ocular ADJ dpc-4289 48 16 comorbidities comorbiditie NOUN dpc-4289 48 17 in in ADP dpc-4289 48 18 psoriasis psoriasis NOUN dpc-4289 48 19 . . PUNCT dpc-4289 49 1 original original ADJ dpc-4289 49 2 article article NOUN dpc-4289 49 3 | | ADV dpc-4289 49 4 dermatol dermatol ADJ dpc-4289 49 5 pract pract NOUN dpc-4289 49 6 concept concept NOUN dpc-4289 49 7 . . PUNCT dpc-4289 50 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 50 2 3 3 NUM dpc-4289 50 3 weeks week NOUN dpc-4289 50 4 , , PUNCT dpc-4289 50 5 were be AUX dpc-4289 50 6 included include VERB dpc-4289 50 7 . . PUNCT dpc-4289 51 1 exclusion exclusion NOUN dpc-4289 51 2 criteria criterion NOUN dpc-4289 51 3 included include VERB dpc-4289 51 4 patients patient NOUN dpc-4289 51 5 with with ADP dpc-4289 51 6 other other ADJ dpc-4289 51 7 dermatological dermatological ADJ dpc-4289 51 8 and/or and/or CCONJ dpc-4289 51 9 systemic systemic ADJ dpc-4289 51 10 autoimmune autoimmune ADJ dpc-4289 51 11 diseases disease NOUN dpc-4289 51 12 , , PUNCT dpc-4289 51 13 patients patient NOUN dpc-4289 51 14 with with ADP dpc-4289 51 15 cutaneous cutaneous ADJ dpc-4289 51 16 malignancies malignancy NOUN dpc-4289 51 17 , , PUNCT dpc-4289 51 18 and and CCONJ dpc-4289 51 19 those those PRON dpc-4289 51 20 with with ADP dpc-4289 51 21 ocular ocular ADJ dpc-4289 51 22 diseases disease NOUN dpc-4289 51 23 . . PUNCT dpc-4289 52 1 patients patient NOUN dpc-4289 52 2 diagnosed diagnose VERB dpc-4289 52 3 with with ADP dpc-4289 52 4 pneumonia pneumonia NOUN dpc-4289 52 5 , , PUNCT dpc-4289 52 6 hepatic hepatic ADJ dpc-4289 52 7 or or CCONJ dpc-4289 52 8 renal renal ADJ dpc-4289 52 9 failure failure NOUN dpc-4289 52 10 , , PUNCT dpc-4289 52 11 urinary urinary ADJ dpc-4289 52 12 tract tract NOUN dpc-4289 52 13 infection infection NOUN dpc-4289 52 14 , , PUNCT dpc-4289 52 15 and and CCONJ dpc-4289 52 16 systemic systemic ADJ dpc-4289 52 17 disorders disorder NOUN dpc-4289 52 18 likely likely ADJ dpc-4289 52 19 to to PART dpc-4289 52 20 show show VERB dpc-4289 52 21 ocular ocular ADJ dpc-4289 52 22 involvement involvement NOUN dpc-4289 52 23 such such ADJ dpc-4289 52 24 as as SCONJ dpc-4289 52 25 diabetes diabetes NOUN dpc-4289 52 26 mellitus mellitus NOUN dpc-4289 52 27 and and CCONJ dpc-4289 52 28 hypertension hypertension NOUN dpc-4289 52 29 were be AUX dpc-4289 52 30 also also ADV dpc-4289 52 31 excluded exclude VERB dpc-4289 52 32 . . PUNCT dpc-4289 53 1 data datum NOUN dpc-4289 53 2 collection collection NOUN dpc-4289 53 3 all all DET dpc-4289 53 4 participants participant NOUN dpc-4289 53 5 underwent undergo VERB dpc-4289 53 6 a a DET dpc-4289 53 7 comprehensive comprehensive ADJ dpc-4289 53 8 history history NOUN dpc-4289 53 9 taking taking NOUN dpc-4289 53 10 , , PUNCT dpc-4289 53 11 followed follow VERB dpc-4289 53 12 by by ADP dpc-4289 53 13 : : PUNCT dpc-4289 53 14 1 1 X dpc-4289 53 15 . . X dpc-4289 53 16 dermatological dermatological ADJ dpc-4289 53 17 examination examination NOUN dpc-4289 53 18 , , PUNCT dpc-4289 53 19 including include VERB dpc-4289 53 20 clinical clinical ADJ dpc-4289 53 21 evaluations evaluation NOUN dpc-4289 53 22 of of ADP dpc-4289 53 23 skin skin NOUN dpc-4289 53 24 , , PUNCT dpc-4289 53 25 nails nail NOUN dpc-4289 53 26 , , PUNCT dpc-4289 53 27 hair hair NOUN dpc-4289 53 28 , , PUNCT dpc-4289 53 29 and and CCONJ dpc-4289 53 30 mucous mucous ADJ dpc-4289 53 31 membranes membrane NOUN dpc-4289 53 32 . . PUNCT dpc-4289 54 1 the the DET dpc-4289 54 2 severity severity NOUN dpc-4289 54 3 of of ADP dpc-4289 54 4 ps ps PROPN dpc-4289 54 5 was be AUX dpc-4289 54 6 calculated calculate VERB dpc-4289 54 7 according accord VERB dpc-4289 54 8 to to ADP dpc-4289 54 9 ps ps PROPN dpc-4289 54 10 area area NOUN dpc-4289 54 11 and and CCONJ dpc-4289 54 12 severity severity NOUN dpc-4289 54 13 index index NOUN dpc-4289 54 14 ( ( PUNCT dpc-4289 54 15 pasi pasi NOUN dpc-4289 54 16 ) ) PUNCT dpc-4289 54 17 score score NOUN dpc-4289 54 18 . . PUNCT dpc-4289 55 1 accordingly accordingly ADV dpc-4289 55 2 , , PUNCT dpc-4289 55 3 patients patient NOUN dpc-4289 55 4 were be AUX dpc-4289 55 5 classified classify VERB dpc-4289 55 6 as as ADP dpc-4289 55 7 having have VERB dpc-4289 55 8 mild mild ADJ dpc-4289 55 9 ps ps NOUN dpc-4289 55 10 ( ( PUNCT dpc-4289 55 11 pasi pasi NOUN dpc-4289 55 12 < < NOUN dpc-4289 55 13 10 10 NUM dpc-4289 55 14 ) ) PUNCT dpc-4289 55 15 , , PUNCT dpc-4289 55 16 moderate moderate ADJ dpc-4289 55 17 ps ps PROPN dpc-4289 55 18 ( ( PUNCT dpc-4289 55 19 pasi pasi NOUN dpc-4289 55 20 10 10 NUM dpc-4289 55 21 - - SYM dpc-4289 55 22 20 20 NUM dpc-4289 55 23 ) ) PUNCT dpc-4289 55 24 , , PUNCT dpc-4289 55 25 or or CCONJ dpc-4289 55 26 severe severe ADJ dpc-4289 55 27 ps ps NOUN dpc-4289 55 28 ( ( PUNCT dpc-4289 55 29 pasi pasi NOUN dpc-4289 55 30 > > PROPN dpc-4289 55 31 20 20 NUM dpc-4289 55 32 ) ) PUNCT dpc-4289 55 33 ( ( PUNCT dpc-4289 55 34 9 9 NUM dpc-4289 55 35 ) ) PUNCT dpc-4289 55 36 . . PUNCT dpc-4289 56 1 2 2 X dpc-4289 56 2 . . X dpc-4289 56 3 ocular ocular ADJ dpc-4289 56 4 examinations examination NOUN dpc-4289 56 5 , , PUNCT dpc-4289 56 6 including include VERB dpc-4289 56 7 assessment assessment NOUN dpc-4289 56 8 of of ADP dpc-4289 56 9 visual visual ADJ dpc-4289 56 10 acuity acuity NOUN dpc-4289 56 11 ( ( PUNCT dpc-4289 56 12 va va NOUN dpc-4289 56 13 ) ) PUNCT dpc-4289 56 14 and and CCONJ dpc-4289 56 15 best well ADV dpc-4289 56 16 corrected correct VERB dpc-4289 56 17 visual visual ADJ dpc-4289 56 18 acuity acuity NOUN dpc-4289 56 19 ( ( PUNCT dpc-4289 56 20 bcva bcva NOUN dpc-4289 56 21 ) ) PUNCT dpc-4289 56 22 , , PUNCT dpc-4289 56 23 and and CCONJ dpc-4289 56 24 slit slit NOUN dpc-4289 56 25 lamp lamp NOUN dpc-4289 56 26 examination examination NOUN dpc-4289 56 27 of of ADP dpc-4289 56 28 anterior anterior ADJ dpc-4289 56 29 segment segment NOUN dpc-4289 56 30 ( ( PUNCT dpc-4289 56 31 lid lid NOUN dpc-4289 56 32 , , PUNCT dpc-4289 56 33 lacrimal lacrimal ADJ dpc-4289 56 34 opening opening NOUN dpc-4289 56 35 , , PUNCT dpc-4289 56 36 conjunctiva conjunctiva NOUN dpc-4289 56 37 , , PUNCT dpc-4289 56 38 cornea cornea NOUN dpc-4289 56 39 , , PUNCT dpc-4289 56 40 anterior anterior ADJ dpc-4289 56 41 chamber chamber NOUN dpc-4289 56 42 depth depth NOUN dpc-4289 56 43 and and CCONJ dpc-4289 56 44 content content NOUN dpc-4289 56 45 , , PUNCT dpc-4289 56 46 iris iris NOUN dpc-4289 56 47 and and CCONJ dpc-4289 56 48 lens len NOUN dpc-4289 56 49 ) ) PUNCT dpc-4289 56 50 using use VERB dpc-4289 56 51 topcon topcon PROPN dpc-4289 56 52 slit slit NOUN dpc-4289 56 53 lamp lamp NOUN dpc-4289 56 54 ( ( PUNCT dpc-4289 56 55 japan japan PROPN dpc-4289 56 56 ) ) PUNCT dpc-4289 56 57 . . PUNCT dpc-4289 57 1 intraocular intraocular ADJ dpc-4289 57 2 pressure pressure NOUN dpc-4289 57 3 was be AUX dpc-4289 57 4 measured measure VERB dpc-4289 57 5 using use VERB dpc-4289 57 6 goldmann goldmann NOUN dpc-4289 57 7 applanation applanation NOUN dpc-4289 57 8 tonometer tonometer NOUN dpc-4289 57 9 , , PUNCT dpc-4289 57 10 and and CCONJ dpc-4289 57 11 dilated dilate VERB dpc-4289 57 12 fundus fundus NOUN dpc-4289 57 13 examination examination NOUN dpc-4289 57 14 ( ( PUNCT dpc-4289 57 15 using use VERB dpc-4289 57 16 mydriatic mydriatic ADJ dpc-4289 57 17 eye eye NOUN dpc-4289 57 18 drops drop NOUN dpc-4289 57 19 prior prior ADV dpc-4289 57 20 to to ADP dpc-4289 57 21 the the DET dpc-4289 57 22 examination examination NOUN dpc-4289 57 23 ) ) PUNCT dpc-4289 57 24 using use VERB dpc-4289 57 25 +90 +90 PROPN dpc-4289 58 1 d d PROPN dpc-4289 58 2 volk volk PROPN dpc-4289 58 3 aspheric aspheric PROPN dpc-4289 58 4 lens len NOUN dpc-4289 58 5 . . PUNCT dpc-4289 59 1 the the DET dpc-4289 59 2 corneal corneal ADJ dpc-4289 59 3 fluorescein fluorescein NOUN dpc-4289 59 4 staining stain VERB dpc-4289 59 5 , , PUNCT dpc-4289 59 6 schirmer schirmer PROPN dpc-4289 59 7 ( ( PUNCT dpc-4289 59 8 after after ADP dpc-4289 59 9 topical topical ADJ dpc-4289 59 10 anesthesia anesthesia NOUN dpc-4289 59 11 ) ) PUNCT dpc-4289 59 12 , , PUNCT dpc-4289 59 13 and and CCONJ dpc-4289 60 1 tbut tbut CCONJ dpc-4289 60 2 tests test NOUN dpc-4289 60 3 were be AUX dpc-4289 60 4 performed perform VERB dpc-4289 60 5 . . PUNCT dpc-4289 61 1 laboratory laboratory NOUN dpc-4289 61 2 investigations investigation NOUN dpc-4289 61 3 sample sample VERB dpc-4289 61 4 collection collection NOUN dpc-4289 61 5 and and CCONJ dpc-4289 61 6 preparation preparation NOUN dpc-4289 61 7 about about ADV dpc-4289 61 8 3 3 NUM dpc-4289 61 9 ml ml NOUN dpc-4289 61 10 of of ADP dpc-4289 61 11 venous venous ADJ dpc-4289 61 12 blood blood NOUN dpc-4289 61 13 were be AUX dpc-4289 61 14 collected collect VERB dpc-4289 61 15 from from ADP dpc-4289 61 16 each each DET dpc-4289 61 17 individual individual NOUN dpc-4289 61 18 and and CCONJ dpc-4289 61 19 centrifuged centrifuge VERB dpc-4289 61 20 at at ADP dpc-4289 61 21 3000 3000 NUM dpc-4289 61 22 rpm rpm NOUN dpc-4289 61 23 for for ADP dpc-4289 61 24 20 20 NUM dpc-4289 61 25 min min NOUN dpc-4289 61 26 ; ; PUNCT dpc-4289 61 27 then then ADV dpc-4289 61 28 serum serum NOUN dpc-4289 61 29 was be AUX dpc-4289 61 30 collected collect VERB dpc-4289 61 31 and and CCONJ dpc-4289 61 32 stored store VERB dpc-4289 61 33 at at ADP dpc-4289 61 34 −60oc −60oc PROPN dpc-4289 61 35 for for ADP dpc-4289 61 36 measuring measure VERB dpc-4289 61 37 serum serum NOUN dpc-4289 61 38 opn opn PROPN dpc-4289 61 39 by by ADP dpc-4289 61 40 enzyme enzyme NOUN dpc-4289 61 41 - - PUNCT dpc-4289 61 42 linked link VERB dpc-4289 61 43 immunosorbent immunosorbent NOUN dpc-4289 61 44 assay assay PROPN dpc-4289 61 45 ( ( PUNCT dpc-4289 61 46 elisa elisa NOUN dpc-4289 61 47 ) ) PUNCT dpc-4289 61 48 . . PUNCT dpc-4289 62 1 measurement measurement NOUN dpc-4289 62 2 of of ADP dpc-4289 62 3 opn opn PROPN dpc-4289 62 4 serum serum PROPN dpc-4289 62 5 levels level NOUN dpc-4289 62 6 the the DET dpc-4289 62 7 concentration concentration NOUN dpc-4289 62 8 of of ADP dpc-4289 62 9 opn opn PROPN dpc-4289 62 10 level level NOUN dpc-4289 62 11 in in ADP dpc-4289 62 12 serum serum NOUN dpc-4289 62 13 was be AUX dpc-4289 62 14 analyzed analyze VERB dpc-4289 62 15 following follow VERB dpc-4289 62 16 the the DET dpc-4289 62 17 manufacturer manufacturer NOUN dpc-4289 62 18 ’s ’s PART dpc-4289 62 19 instructions instruction NOUN dpc-4289 62 20 . . PUNCT dpc-4289 63 1 measurements measurement NOUN dpc-4289 63 2 were be AUX dpc-4289 63 3 done do VERB dpc-4289 63 4 by by ADP dpc-4289 63 5 quantitative quantitative ADJ dpc-4289 63 6 sandwich sandwich NOUN dpc-4289 63 7 elisa elisa NOUN dpc-4289 63 8 technique technique NOUN dpc-4289 63 9 using use VERB dpc-4289 63 10 an an DET dpc-4289 63 11 elisa elisa NOUN dpc-4289 63 12 reader reader NOUN dpc-4289 63 13 ( ( PUNCT dpc-4289 63 14 das das PROPN dpc-4289 63 15 1851 1851 NUM dpc-4289 63 16 ) ) PUNCT dpc-4289 63 17 and and CCONJ dpc-4289 63 18 human human PROPN dpc-4289 63 19 opn opn PROPN dpc-4289 63 20 elisa elisa PROPN dpc-4289 63 21 kit kit PROPN dpc-4289 63 22 ( ( PUNCT dpc-4289 63 23 catalog catalog NOUN dpc-4289 63 24 number number NOUN dpc-4289 63 25 : : PUNCT dpc-4289 63 26 e1525hu e1525hu NUM dpc-4289 63 27 ) ) PUNCT dpc-4289 63 28 ( ( PUNCT dpc-4289 63 29 bioassay bioassay NOUN dpc-4289 63 30 technology technology PROPN dpc-4289 63 31 laboratory laboratory PROPN dpc-4289 63 32 , , PUNCT dpc-4289 63 33 china china PROPN dpc-4289 63 34 ) ) PUNCT dpc-4289 63 35 . . PUNCT dpc-4289 64 1 statistical statistical ADJ dpc-4289 64 2 analysis analysis NOUN dpc-4289 64 3 data datum NOUN dpc-4289 64 4 were be AUX dpc-4289 64 5 analyzed analyze VERB dpc-4289 64 6 by by ADP dpc-4289 64 7 the the DET dpc-4289 64 8 statistical statistical ADJ dpc-4289 64 9 package package NOUN dpc-4289 64 10 for for ADP dpc-4289 64 11 social social ADJ dpc-4289 64 12 science science NOUN dpc-4289 64 13 ( ( PUNCT dpc-4289 64 14 ibm ibm PROPN dpc-4289 64 15 spss spss PROPN dpc-4289 64 16 ) ) PUNCT dpc-4289 64 17 version version NOUN dpc-4289 64 18 23 23 NUM dpc-4289 64 19 . . PUNCT dpc-4289 65 1 the the DET dpc-4289 65 2 quantitative quantitative ADJ dpc-4289 65 3 data datum NOUN dpc-4289 65 4 are be AUX dpc-4289 65 5 presented present VERB dpc-4289 65 6 as as ADP dpc-4289 65 7 mean mean ADJ dpc-4289 65 8 , , PUNCT dpc-4289 65 9 standard standard ADJ dpc-4289 65 10 deviations deviation NOUN dpc-4289 65 11 ( ( PUNCT dpc-4289 65 12 sd sd NOUN dpc-4289 65 13 ) ) PUNCT dpc-4289 65 14 , , PUNCT dpc-4289 65 15 and and CCONJ dpc-4289 65 16 ranges range VERB dpc-4289 65 17 in in ADP dpc-4289 65 18 case case NOUN dpc-4289 65 19 of of ADP dpc-4289 65 20 parametric parametric ADJ dpc-4289 65 21 data datum NOUN dpc-4289 65 22 and and CCONJ dpc-4289 65 23 median median ADJ dpc-4289 65 24 , , PUNCT dpc-4289 65 25 inter inter ADJ dpc-4289 65 26 - - ADJ dpc-4289 65 27 quartile quartile ADJ dpc-4289 65 28 range range NOUN dpc-4289 65 29 ( ( PUNCT dpc-4289 65 30 iqr iqr NOUN dpc-4289 65 31 ) ) PUNCT dpc-4289 65 32 when when SCONJ dpc-4289 65 33 data datum NOUN dpc-4289 65 34 were be AUX dpc-4289 65 35 non non ADJ dpc-4289 65 36 - - ADJ dpc-4289 65 37 parametric parametric ADJ dpc-4289 65 38 . . PUNCT dpc-4289 66 1 instead instead ADV dpc-4289 66 2 , , PUNCT dpc-4289 66 3 qualitative qualitative ADJ dpc-4289 66 4 variables variable NOUN dpc-4289 66 5 are be AUX dpc-4289 66 6 presented present VERB dpc-4289 66 7 as as ADP dpc-4289 66 8 numbers number NOUN dpc-4289 66 9 and and CCONJ dpc-4289 66 10 percentages percentage NOUN dpc-4289 66 11 : : PUNCT dpc-4289 66 12 chi chi ADJ dpc-4289 66 13 - - PUNCT dpc-4289 66 14 square square ADJ dpc-4289 66 15 test test NOUN dpc-4289 66 16 was be AUX dpc-4289 66 17 used use VERB dpc-4289 66 18 to to PART dpc-4289 66 19 compare compare VERB dpc-4289 66 20 qualitative qualitative ADJ dpc-4289 66 21 data datum NOUN dpc-4289 66 22 between between ADP dpc-4289 66 23 groups group NOUN dpc-4289 66 24 . . PUNCT dpc-4289 67 1 comparing compare VERB dpc-4289 67 2 two two NUM dpc-4289 67 3 independent independent ADJ dpc-4289 67 4 groups group NOUN dpc-4289 67 5 with with ADP dpc-4289 67 6 quantitative quantitative ADJ dpc-4289 67 7 data datum NOUN dpc-4289 67 8 and and CCONJ dpc-4289 67 9 parametric parametric ADJ dpc-4289 67 10 distribution distribution NOUN dpc-4289 67 11 was be AUX dpc-4289 67 12 performed perform VERB dpc-4289 67 13 by by ADP dpc-4289 67 14 using use VERB dpc-4289 67 15 independent independent ADJ dpc-4289 67 16 t t NOUN dpc-4289 67 17 - - PUNCT dpc-4289 67 18 test test NOUN dpc-4289 67 19 , , PUNCT dpc-4289 67 20 while while SCONJ dpc-4289 67 21 data datum NOUN dpc-4289 67 22 with with ADP dpc-4289 67 23 non non ADJ dpc-4289 67 24 - - ADJ dpc-4289 67 25 parametric parametric ADJ dpc-4289 67 26 distribution distribution NOUN dpc-4289 67 27 was be AUX dpc-4289 67 28 compared compare VERB dpc-4289 67 29 using use VERB dpc-4289 67 30 mann mann PROPN dpc-4289 67 31 - - PUNCT dpc-4289 67 32 whitney whitney PROPN dpc-4289 67 33 test test NOUN dpc-4289 67 34 . . PUNCT dpc-4289 68 1 the the DET dpc-4289 68 2 correlation correlation NOUN dpc-4289 68 3 between between ADP dpc-4289 68 4 two two NUM dpc-4289 68 5 quantitative quantitative ADJ dpc-4289 68 6 variables variable NOUN dpc-4289 68 7 in in ADP dpc-4289 68 8 the the DET dpc-4289 68 9 same same ADJ dpc-4289 68 10 group group NOUN dpc-4289 68 11 was be AUX dpc-4289 68 12 assessed assess VERB dpc-4289 68 13 by by ADP dpc-4289 68 14 spearman spearman NOUN dpc-4289 68 15 ’s ’s PART dpc-4289 68 16 correlation correlation NOUN dpc-4289 68 17 coefficient coefficient NOUN dpc-4289 68 18 . . PUNCT dpc-4289 69 1 receiver receiver ADJ dpc-4289 69 2 operating operate VERB dpc-4289 69 3 characteristic characteristic ADJ dpc-4289 69 4 curve curve NOUN dpc-4289 69 5 ( ( PUNCT dpc-4289 69 6 roc roc PROPN dpc-4289 69 7 ) ) PUNCT dpc-4289 69 8 was be AUX dpc-4289 69 9 used use VERB dpc-4289 69 10 to to PART dpc-4289 69 11 determine determine VERB dpc-4289 69 12 the the DET dpc-4289 69 13 best good ADJ dpc-4289 69 14 cutoff cutoff NOUN dpc-4289 69 15 point point NOUN dpc-4289 69 16 with with ADP dpc-4289 69 17 its its PRON dpc-4289 69 18 specificity specificity NOUN dpc-4289 69 19 , , PUNCT dpc-4289 69 20 sensitivity sensitivity NOUN dpc-4289 69 21 , , PUNCT dpc-4289 69 22 positive positive ADJ dpc-4289 69 23 predictive predictive ADJ dpc-4289 69 24 value value NOUN dpc-4289 69 25 ( ( PUNCT dpc-4289 69 26 ppv ppv NOUN dpc-4289 69 27 ) ) PUNCT dpc-4289 69 28 , , PUNCT dpc-4289 69 29 negative negative ADJ dpc-4289 69 30 predictive predictive ADJ dpc-4289 69 31 value value NOUN dpc-4289 69 32 ( ( PUNCT dpc-4289 69 33 npv npv NOUN dpc-4289 69 34 ) ) PUNCT dpc-4289 69 35 , , PUNCT dpc-4289 69 36 and and CCONJ dpc-4289 69 37 area area NOUN dpc-4289 69 38 under under ADP dpc-4289 69 39 curve curve NOUN dpc-4289 69 40 ( ( PUNCT dpc-4289 69 41 auc auc NOUN dpc-4289 69 42 ) ) PUNCT dpc-4289 69 43 of of ADP dpc-4289 69 44 opn opn PROPN dpc-4289 69 45 level level NOUN dpc-4289 69 46 to to PART dpc-4289 69 47 differentiate differentiate VERB dpc-4289 69 48 between between ADP dpc-4289 69 49 the the DET dpc-4289 69 50 two two NUM dpc-4289 69 51 studied studied ADJ dpc-4289 69 52 groups group NOUN dpc-4289 69 53 . . PUNCT dpc-4289 70 1 the the DET dpc-4289 70 2 p p PROPN dpc-4289 70 3 value value NOUN dpc-4289 70 4 was be AUX dpc-4289 70 5 considered consider VERB dpc-4289 70 6 significant significant ADJ dpc-4289 70 7 when when SCONJ dpc-4289 70 8 the the DET dpc-4289 70 9 value value NOUN dpc-4289 70 10 is be AUX dpc-4289 70 11 less less ADJ dpc-4289 70 12 than than ADP dpc-4289 70 13 0.05 0.05 NUM dpc-4289 70 14 . . PUNCT dpc-4289 71 1 results result VERB dpc-4289 71 2 a a DET dpc-4289 71 3 total total NOUN dpc-4289 71 4 of of ADP dpc-4289 71 5 40 40 NUM dpc-4289 71 6 psoriatic psoriatic ADJ dpc-4289 71 7 patients patient NOUN dpc-4289 71 8 included include VERB dpc-4289 71 9 23 23 NUM dpc-4289 71 10 ( ( PUNCT dpc-4289 71 11 57.5 57.5 NUM dpc-4289 71 12 % % NOUN dpc-4289 71 13 ) ) PUNCT dpc-4289 71 14 females female NOUN dpc-4289 71 15 and and CCONJ dpc-4289 71 16 17 17 NUM dpc-4289 71 17 ( ( PUNCT dpc-4289 71 18 42.5 42.5 NUM dpc-4289 71 19 % % NOUN dpc-4289 71 20 ) ) PUNCT dpc-4289 71 21 males male NOUN dpc-4289 71 22 . . PUNCT dpc-4289 72 1 their their PRON dpc-4289 72 2 ages age NOUN dpc-4289 72 3 ranged range VERB dpc-4289 72 4 from from ADP dpc-4289 72 5 22 22 NUM dpc-4289 72 6 to to PART dpc-4289 72 7 60 60 NUM dpc-4289 72 8 years year NOUN dpc-4289 72 9 , , PUNCT dpc-4289 72 10 with with ADP dpc-4289 72 11 a a DET dpc-4289 72 12 mean mean NOUN dpc-4289 72 13 of of ADP dpc-4289 72 14 40.15 40.15 NUM dpc-4289 72 15 ± ± NUM dpc-4289 72 16 9.26 9.26 NUM dpc-4289 72 17 . . PUNCT dpc-4289 73 1 a a DET dpc-4289 73 2 similar similar ADJ dpc-4289 73 3 number number NOUN dpc-4289 73 4 of of ADP dpc-4289 73 5 healthy healthy ADJ dpc-4289 73 6 individuals individual NOUN dpc-4289 73 7 as as ADP dpc-4289 73 8 controls control NOUN dpc-4289 73 9 included include VERB dpc-4289 73 10 28 28 NUM dpc-4289 73 11 ( ( PUNCT dpc-4289 73 12 70 70 NUM dpc-4289 73 13 % % NOUN dpc-4289 73 14 ) ) PUNCT dpc-4289 73 15 females female NOUN dpc-4289 73 16 and and CCONJ dpc-4289 73 17 12 12 NUM dpc-4289 73 18 ( ( PUNCT dpc-4289 73 19 30 30 NUM dpc-4289 73 20 % % NOUN dpc-4289 73 21 ) ) PUNCT dpc-4289 73 22     SPACE dpc-4289 73 23 males male NOUN dpc-4289 73 24 , , PUNCT dpc-4289 73 25 age age NOUN dpc-4289 73 26 range range NOUN dpc-4289 73 27 20–60 20–60 NUM dpc-4289 73 28     SPACE dpc-4289 73 29 years year NOUN dpc-4289 73 30 , , PUNCT dpc-4289 73 31 with with ADP dpc-4289 73 32 a a DET dpc-4289 73 33 mean mean NOUN dpc-4289 73 34 of of ADP dpc-4289 73 35 40.25 40.25 NUM dpc-4289 73 36 ± ± NUM dpc-4289 73 37 12.16 12.16 NUM dpc-4289 73 38 years year NOUN dpc-4289 73 39 without without ADP dpc-4289 73 40 a a DET dpc-4289 73 41 statistically statistically ADV dpc-4289 73 42 significant significant ADJ dpc-4289 73 43 difference difference NOUN dpc-4289 73 44 . . PUNCT dpc-4289 74 1 the the DET dpc-4289 74 2 ps ps PROPN dpc-4289 74 3 duration duration NOUN dpc-4289 74 4 ranged range VERB dpc-4289 74 5 from from ADP dpc-4289 74 6 2 2 NUM dpc-4289 74 7 to to ADP dpc-4289 74 8 23 23 NUM dpc-4289 74 9 years year NOUN dpc-4289 74 10 , , PUNCT dpc-4289 74 11 with with ADP dpc-4289 74 12 a a DET dpc-4289 74 13 mean mean NOUN dpc-4289 74 14 of of ADP dpc-4289 74 15 11.18 11.18 NUM dpc-4289 74 16 ± ± NUM dpc-4289 74 17 6.29 6.29 NUM dpc-4289 74 18 . . PUNCT dpc-4289 75 1 ps ps NOUN dpc-4289 75 2 severity severity NOUN dpc-4289 75 3 was be AUX dpc-4289 75 4 assessed assess VERB dpc-4289 75 5 by by ADP dpc-4289 75 6 pasi pasi NOUN dpc-4289 75 7 score score NOUN dpc-4289 75 8 ranging range VERB dpc-4289 75 9 from from ADP dpc-4289 75 10 9 9 NUM dpc-4289 75 11 to to ADP dpc-4289 75 12 26 26 NUM dpc-4289 75 13 , , PUNCT dpc-4289 75 14 with with ADP dpc-4289 75 15 mild mild ADJ dpc-4289 75 16 - - PUNCT dpc-4289 75 17 to to ADP dpc-4289 75 18 - - PUNCT dpc-4289 75 19 moderate moderate ADJ dpc-4289 75 20 disease disease NOUN dpc-4289 75 21 in in ADP dpc-4289 75 22 28 28 NUM dpc-4289 75 23 cases case NOUN dpc-4289 75 24 ( ( PUNCT dpc-4289 75 25 70.0 70.0 NUM dpc-4289 75 26 % % NOUN dpc-4289 75 27 ) ) PUNCT dpc-4289 75 28 and and CCONJ dpc-4289 75 29 severe severe ADJ dpc-4289 75 30 disease disease NOUN dpc-4289 75 31 in in ADP dpc-4289 75 32 12 12 NUM dpc-4289 75 33 cases case NOUN dpc-4289 75 34 ( ( PUNCT dpc-4289 75 35 30.0 30.0 NUM dpc-4289 75 36 % % NOUN dpc-4289 75 37 ) ) PUNCT dpc-4289 75 38 , , PUNCT dpc-4289 75 39 as as SCONJ dpc-4289 75 40 shown show VERB dpc-4289 75 41 in in ADP dpc-4289 75 42 table table NOUN dpc-4289 75 43 1 1 NUM dpc-4289 75 44 . . PUNCT dpc-4289 76 1 regarding regard VERB dpc-4289 76 2 serum serum PROPN dpc-4289 76 3 opn opn PROPN dpc-4289 76 4 , , PUNCT dpc-4289 76 5 psoriatic psoriatic ADJ dpc-4289 76 6 cases case NOUN dpc-4289 76 7 showed show VERB dpc-4289 76 8 a a DET dpc-4289 76 9 statistically statistically ADV dpc-4289 76 10 significantly significantly ADV dpc-4289 76 11 higher high ADJ dpc-4289 76 12 level level NOUN dpc-4289 76 13 compared compare VERB dpc-4289 76 14 to to ADP dpc-4289 76 15 controls control NOUN dpc-4289 76 16 ( ( PUNCT dpc-4289 76 17 p p X dpc-4289 76 18 = = NOUN dpc-4289 76 19 0.000 0.000 NUM dpc-4289 76 20 ) ) PUNCT dpc-4289 76 21 . . PUNCT dpc-4289 77 1 based base VERB dpc-4289 77 2 on on ADP dpc-4289 77 3 the the DET dpc-4289 77 4 ocular ocular ADJ dpc-4289 77 5 findings finding NOUN dpc-4289 77 6 of of ADP dpc-4289 77 7 both both DET dpc-4289 77 8 eyes eye NOUN dpc-4289 77 9 in in ADP dpc-4289 77 10 the the DET dpc-4289 77 11 studied studied ADJ dpc-4289 77 12 groups group NOUN dpc-4289 77 13 , , PUNCT dpc-4289 77 14 anterior anterior ADJ dpc-4289 77 15 and and CCONJ dpc-4289 77 16 posterior posterior ADJ dpc-4289 77 17 blepharitis blepharitis NOUN dpc-4289 77 18 , , PUNCT dpc-4289 77 19 corneal corneal ADJ dpc-4289 77 20 affection affection NOUN dpc-4289 77 21 , , PUNCT dpc-4289 77 22 conjunctivitis conjunctivitis NOUN dpc-4289 77 23 , , PUNCT dpc-4289 77 24 keratoconjunctivitis keratoconjunctivitis PROPN dpc-4289 77 25 sicca sicca NOUN dpc-4289 77 26 , , PUNCT dpc-4289 77 27 and and CCONJ dpc-4289 77 28 cataract cataract NOUN dpc-4289 77 29 were be AUX dpc-4289 77 30 significantly significantly ADV dpc-4289 77 31 more more ADV dpc-4289 77 32 frequent frequent ADJ dpc-4289 77 33 among among ADP dpc-4289 77 34 patients patient NOUN dpc-4289 77 35 than than ADP dpc-4289 77 36 controls control NOUN dpc-4289 77 37 ( ( PUNCT dpc-4289 77 38 p<0.05 p<0.05 NOUN dpc-4289 77 39 ) ) PUNCT dpc-4289 77 40 . . PUNCT dpc-4289 78 1 neither neither DET dpc-4289 78 2 group group NOUN dpc-4289 78 3 showed show VERB dpc-4289 78 4 uveitis uveitis NOUN dpc-4289 78 5 or or CCONJ dpc-4289 78 6 fundus fundus NOUN dpc-4289 78 7 abnormalities abnormality NOUN dpc-4289 78 8 ( ( PUNCT dpc-4289 78 9 table table NOUN dpc-4289 78 10 2 2 NUM dpc-4289 78 11 ) ) PUNCT dpc-4289 78 12 . . PUNCT dpc-4289 79 1 a a DET dpc-4289 79 2 receiver receiver ADV dpc-4289 79 3 operating operate VERB dpc-4289 79 4 characteristic characteristic NOUN dpc-4289 79 5 ( ( PUNCT dpc-4289 79 6 roc roc PROPN dpc-4289 79 7 ) ) PUNCT dpc-4289 79 8 curve curve NOUN dpc-4289 79 9 was be AUX dpc-4289 79 10 conducted conduct VERB dpc-4289 79 11 for for ADP dpc-4289 79 12 serum serum NOUN dpc-4289 79 13 levels level NOUN dpc-4289 79 14 of of ADP dpc-4289 79 15 opn opn PROPN dpc-4289 79 16 to to PART dpc-4289 79 17 discriminate discriminate VERB dpc-4289 79 18 between between ADP dpc-4289 79 19 patients patient NOUN dpc-4289 79 20 and and CCONJ dpc-4289 79 21 controls control NOUN dpc-4289 79 22 . . PUNCT dpc-4289 80 1 at at ADP dpc-4289 80 2 a a DET dpc-4289 80 3 cutoff cutoff NOUN dpc-4289 80 4 value value NOUN dpc-4289 80 5 > > PUNCT dpc-4289 80 6 20.7 20.7 NUM dpc-4289 80 7 , , PUNCT dpc-4289 80 8 the the DET dpc-4289 80 9 opn opn PROPN dpc-4289 80 10 level level NOUN dpc-4289 80 11 showed show VERB dpc-4289 80 12 100 100 NUM dpc-4289 80 13 % % NOUN dpc-4289 80 14 sensitivity sensitivity NOUN dpc-4289 80 15 and and CCONJ dpc-4289 80 16 specificity specificity NOUN dpc-4289 80 17 ( ( PUNCT dpc-4289 80 18 figure figure NOUN dpc-4289 80 19 1 1 NUM dpc-4289 80 20 ) ) PUNCT dpc-4289 80 21 . . PUNCT dpc-4289 81 1 there there PRON dpc-4289 81 2 was be VERB dpc-4289 81 3 a a DET dpc-4289 81 4 highly highly ADV dpc-4289 81 5 statistically statistically ADV dpc-4289 81 6 significant significant ADJ dpc-4289 81 7 positive positive ADJ dpc-4289 81 8 correlation correlation NOUN dpc-4289 81 9 between between ADP dpc-4289 81 10 serum serum PROPN dpc-4289 81 11 opn opn PROPN dpc-4289 81 12 levels level NOUN dpc-4289 81 13 in in ADP dpc-4289 81 14 patients patient NOUN dpc-4289 81 15 and and CCONJ dpc-4289 81 16 their their PRON dpc-4289 81 17 ages age NOUN dpc-4289 81 18 , , PUNCT dpc-4289 81 19 disease disease NOUN dpc-4289 81 20 duration duration NOUN dpc-4289 81 21 , , PUNCT dpc-4289 81 22 and and CCONJ dpc-4289 81 23 pasi pasi NOUN dpc-4289 81 24 score score NOUN dpc-4289 81 25 ( ( PUNCT dpc-4289 81 26 r= r= NOUN dpc-4289 81 27 0.467 0.467 NUM dpc-4289 81 28 , , PUNCT dpc-4289 81 29 0.773 0.773 NUM dpc-4289 81 30 and and CCONJ dpc-4289 81 31 0.966 0.966 NUM dpc-4289 81 32 , , PUNCT dpc-4289 81 33 p=0.002 p=0.002 NOUN dpc-4289 81 34 and and CCONJ dpc-4289 81 35 p=0.000 p=0.000 NUM dpc-4289 81 36 , , PUNCT dpc-4289 81 37 respectively respectively ADV dpc-4289 81 38 ) ) PUNCT dpc-4289 81 39 ( ( PUNCT dpc-4289 81 40 figure figure NOUN dpc-4289 81 41 2 2 NUM dpc-4289 81 42 a a PRON dpc-4289 81 43 , , PUNCT dpc-4289 81 44 b b NOUN dpc-4289 81 45 and and CCONJ dpc-4289 81 46 c c NOUN dpc-4289 81 47 ) ) PUNCT dpc-4289 81 48 . . PUNCT dpc-4289 82 1 concerning concern VERB dpc-4289 82 2 ocular ocular ADJ dpc-4289 82 3 surface surface NOUN dpc-4289 82 4 tests test NOUN dpc-4289 82 5 , , PUNCT dpc-4289 82 6 the the DET dpc-4289 82 7 mean mean ADJ dpc-4289 82 8 bcva bcva NOUN dpc-4289 82 9 , , PUNCT dpc-4289 82 10 but but CCONJ dpc-4289 82 11 , , PUNCT dpc-4289 82 12 and and CCONJ dpc-4289 82 13 schirmer schirmer PROPN dpc-4289 82 14 tests test NOUN dpc-4289 82 15 were be AUX dpc-4289 82 16 statistically statistically ADV dpc-4289 82 17 significantly significantly ADV dpc-4289 82 18 lower low ADJ dpc-4289 82 19 in in ADP dpc-4289 82 20 cases case NOUN dpc-4289 82 21 compared compare VERB dpc-4289 82 22 to to ADP dpc-4289 82 23 controls control NOUN dpc-4289 82 24 . . PUNCT dpc-4289 83 1 the the DET dpc-4289 83 2 mean mean ADJ dpc-4289 83 3 iop iop NOUN dpc-4289 83 4 value value NOUN dpc-4289 83 5 showed show VERB dpc-4289 83 6 no no DET dpc-4289 83 7 significant significant ADJ dpc-4289 83 8 differences difference NOUN dpc-4289 83 9 in in ADP dpc-4289 83 10 cases case NOUN dpc-4289 83 11 and and CCONJ dpc-4289 83 12 controls control NOUN dpc-4289 83 13 and and CCONJ dpc-4289 83 14 was be AUX dpc-4289 83 15 within within ADP dpc-4289 83 16 the the DET dpc-4289 83 17 normal normal ADJ dpc-4289 83 18 range range NOUN dpc-4289 83 19 ( ( PUNCT dpc-4289 83 20 table table NOUN dpc-4289 83 21 3 3 NUM dpc-4289 83 22 ) ) PUNCT dpc-4289 83 23 . . PUNCT dpc-4289 84 1 regarding regard VERB dpc-4289 84 2 the the DET dpc-4289 84 3 relationship relationship NOUN dpc-4289 84 4 between between ADP dpc-4289 84 5 opn opn PROPN dpc-4289 84 6 levels level NOUN dpc-4289 84 7 and and CCONJ dpc-4289 84 8 disease disease NOUN dpc-4289 84 9 severity severity NOUN dpc-4289 84 10 as as ADV dpc-4289 84 11 well well ADV dpc-4289 84 12 as as ADP dpc-4289 84 13 ocular ocular ADJ dpc-4289 84 14 changes change NOUN dpc-4289 84 15 in in ADP dpc-4289 84 16 psoriatic psoriatic ADJ dpc-4289 84 17 patients patient NOUN dpc-4289 84 18 , , PUNCT dpc-4289 84 19 4 4 NUM dpc-4289 84 20 original original ADJ dpc-4289 84 21 article article NOUN dpc-4289 84 22 | | ADV dpc-4289 84 23 dermatol dermatol ADJ dpc-4289 84 24 pract pract NOUN dpc-4289 84 25 concept concept NOUN dpc-4289 84 26 . . PUNCT dpc-4289 85 1 2024;14(4):e2024226 2024;14(4):e2024226 PRON dpc-4289 85 2 table table VERB dpc-4289 85 3 1 1 NUM dpc-4289 85 4 . . PUNCT dpc-4289 86 1 demographic demographic ADJ dpc-4289 86 2 data datum NOUN dpc-4289 86 3 of of ADP dpc-4289 86 4 the the DET dpc-4289 86 5 study study NOUN dpc-4289 86 6 groups group NOUN dpc-4289 86 7 and and CCONJ dpc-4289 86 8 clinical clinical ADJ dpc-4289 86 9 characteristics characteristic NOUN dpc-4289 86 10 of of ADP dpc-4289 86 11 the the DET dpc-4289 86 12 patient patient NOUN dpc-4289 86 13 group group NOUN dpc-4289 86 14 . . PUNCT dpc-4289 87 1 items item NOUN dpc-4289 87 2 patients patient NOUN dpc-4289 87 3 group group NOUN dpc-4289 87 4 ( ( PUNCT dpc-4289 87 5 n= n= ADJ dpc-4289 87 6 40 40 NUM dpc-4289 87 7 ) ) PUNCT dpc-4289 87 8 controls control NOUN dpc-4289 87 9 group group NOUN dpc-4289 87 10 ( ( PUNCT dpc-4289 87 11 n= n= ADJ dpc-4289 87 12 40 40 NUM dpc-4289 87 13 ) ) PUNCT dpc-4289 87 14 test test NOUN dpc-4289 87 15 value value NOUN dpc-4289 87 16 p p NOUN dpc-4289 87 17 - - PUNCT dpc-4289 87 18 value value NOUN dpc-4289 87 19 sig sig NOUN dpc-4289 87 20 . . PUNCT dpc-4289 88 1 age age NOUN dpc-4289 88 2 mean mean VERB dpc-4289 88 3 ± ± PROPN dpc-4289 88 4 sd sd ADP dpc-4289 88 5 40.15 40.15 NUM dpc-4289 88 6 ± ± NUM dpc-4289 88 7 9.26 9.26 NUM dpc-4289 88 8 40.25 40.25 NUM dpc-4289 88 9 ± ± NUM dpc-4289 88 10 12.16 12.16 NUM dpc-4289 88 11 0.041 0.041 NUM dpc-4289 88 12 ● ● NUM dpc-4289 88 13 0.967 0.967 NUM dpc-4289 88 14 ns ns NUM dpc-4289 88 15 range range NOUN dpc-4289 88 16 22 22 NUM dpc-4289 88 17 – – PUNCT dpc-4289 88 18 60 60 NUM dpc-4289 88 19 20 20 NUM dpc-4289 88 20 – – PUNCT dpc-4289 88 21 60 60 NUM dpc-4289 88 22 sex sex NOUN dpc-4289 88 23 females female NOUN dpc-4289 88 24 23 23 NUM dpc-4289 88 25 ( ( PUNCT dpc-4289 88 26 57.5 57.5 NUM dpc-4289 88 27 % % NOUN dpc-4289 88 28 ) ) PUNCT dpc-4289 88 29 28 28 NUM dpc-4289 88 30 ( ( PUNCT dpc-4289 88 31 70.0 70.0 NUM dpc-4289 88 32 % % NOUN dpc-4289 88 33 ) ) PUNCT dpc-4289 88 34 1.352 1.352 NUM dpc-4289 88 35 * * SYM dpc-4289 88 36 0.245 0.245 NUM dpc-4289 88 37 ns ns NUM dpc-4289 88 38 males male NOUN dpc-4289 88 39 17 17 NUM dpc-4289 88 40 ( ( PUNCT dpc-4289 88 41 42.5 42.5 NUM dpc-4289 88 42 % % NOUN dpc-4289 88 43 ) ) PUNCT dpc-4289 88 44 12 12 NUM dpc-4289 88 45 ( ( PUNCT dpc-4289 88 46 30.0 30.0 NUM dpc-4289 88 47 % % NOUN dpc-4289 88 48 ) ) PUNCT dpc-4289 88 49 duration duration NOUN dpc-4289 88 50 of of ADP dpc-4289 88 51 disease disease NOUN dpc-4289 88 52 ( ( PUNCT dpc-4289 88 53 years year NOUN dpc-4289 88 54 ) ) PUNCT dpc-4289 88 55 mean mean VERB dpc-4289 89 1 ± ± NUM dpc-4289 89 2 sd sd ADP dpc-4289 89 3 11.18 11.18 NUM dpc-4289 89 4 ± ± NUM dpc-4289 89 5 6.29 6.29 NUM dpc-4289 89 6 na na PART dpc-4289 89 7 na na PART dpc-4289 89 8 na na PART dpc-4289 89 9 range range VERB dpc-4289 89 10 2 2 NUM dpc-4289 89 11 – – PUNCT dpc-4289 89 12 23 23 NUM dpc-4289 89 13 pasi pasi NOUN dpc-4289 89 14 median median PROPN dpc-4289 89 15 ( ( PUNCT dpc-4289 89 16 iqr iqr PROPN dpc-4289 89 17 ) ) PUNCT dpc-4289 89 18 19 19 NUM dpc-4289 89 19 ( ( PUNCT dpc-4289 89 20 16–22 16–22 NUM dpc-4289 89 21 ) ) PUNCT dpc-4289 89 22 na na PART dpc-4289 89 23 na na PART dpc-4289 89 24 na na PART dpc-4289 89 25 range range VERB dpc-4289 89 26 9 9 NUM dpc-4289 89 27 – – SYM dpc-4289 89 28 26 26 NUM dpc-4289 89 29 mild mild ADJ dpc-4289 89 30 / / SYM dpc-4289 89 31 moderate moderate ADJ dpc-4289 89 32 28 28 NUM dpc-4289 89 33 ( ( PUNCT dpc-4289 89 34 70.0 70.0 NUM dpc-4289 89 35 % % NOUN dpc-4289 89 36 ) ) PUNCT dpc-4289 89 37 severe severe ADJ dpc-4289 89 38 12 12 NUM dpc-4289 89 39 ( ( PUNCT dpc-4289 89 40 30.0 30.0 NUM dpc-4289 89 41 % % NOUN dpc-4289 89 42 ) ) PUNCT dpc-4289 89 43 abbreviations abbreviation NOUN dpc-4289 89 44 : : PUNCT dpc-4289 89 45 ns ns NUM dpc-4289 89 46 : : PUNCT dpc-4289 89 47 non non ADJ dpc-4289 89 48 - - ADJ dpc-4289 89 49 significant significant ADJ dpc-4289 89 50 ; ; PUNCT dpc-4289 89 51 s s X dpc-4289 89 52 : : PUNCT dpc-4289 89 53 significant significant ADJ dpc-4289 89 54 , , PUNCT dpc-4289 89 55 hs hs ADJ dpc-4289 89 56 : : PUNCT dpc-4289 89 57 highly highly ADV dpc-4289 89 58 significant significant ADJ dpc-4289 89 59 . . PUNCT dpc-4289 90 1 * * PUNCT dpc-4289 90 2 : : PUNCT dpc-4289 90 3 chi chi ADJ dpc-4289 90 4 - - PUNCT dpc-4289 90 5 square square ADJ dpc-4289 90 6 test test NOUN dpc-4289 90 7 ; ; PUNCT dpc-4289 91 1 ● ● X dpc-4289 91 2 : : PUNCT dpc-4289 91 3 independent independent ADJ dpc-4289 91 4 t t PROPN dpc-4289 91 5 - - PUNCT dpc-4289 91 6 test test NOUN dpc-4289 91 7 , , PUNCT dpc-4289 91 8 pasi pasi NOUN dpc-4289 91 9 : : PUNCT dpc-4289 91 10 psoriasis psoriasis NOUN dpc-4289 91 11 area area NOUN dpc-4289 91 12 severity severity PROPN dpc-4289 91 13 index index PROPN dpc-4289 91 14 , , PUNCT dpc-4289 91 15 iqr iqr PROPN dpc-4289 91 16 : : PUNCT dpc-4289 91 17 interquartile interquartile NOUN dpc-4289 91 18 . . PUNCT dpc-4289 92 1 table table NOUN dpc-4289 92 2 2 2 NUM dpc-4289 92 3 . . PUNCT dpc-4289 92 4 comparison comparison NOUN dpc-4289 92 5 of of ADP dpc-4289 92 6 serum serum NOUN dpc-4289 92 7 levels level NOUN dpc-4289 92 8 of of ADP dpc-4289 92 9 osteopontin osteopontin ADJ dpc-4289 92 10 and and CCONJ dpc-4289 92 11 ocular ocular ADJ dpc-4289 92 12 comorbidities comorbiditie NOUN dpc-4289 92 13 between between ADP dpc-4289 92 14 the the DET dpc-4289 92 15 two two NUM dpc-4289 92 16 study study NOUN dpc-4289 92 17 groups group NOUN dpc-4289 92 18 . . PUNCT dpc-4289 93 1 items item NOUN dpc-4289 93 2 patient patient PROPN dpc-4289 93 3 group group NOUN dpc-4289 93 4 ( ( PUNCT dpc-4289 93 5 n= n= ADJ dpc-4289 93 6 40 40 NUM dpc-4289 93 7 ) ) PUNCT dpc-4289 93 8 control control NOUN dpc-4289 93 9 group group NOUN dpc-4289 93 10 ( ( PUNCT dpc-4289 93 11 n= n= ADJ dpc-4289 93 12 40 40 NUM dpc-4289 93 13 ) ) PUNCT dpc-4289 93 14 test test NOUN dpc-4289 93 15 value value NOUN dpc-4289 93 16 p p NOUN dpc-4289 93 17 - - PUNCT dpc-4289 93 18 value value NOUN dpc-4289 93 19 sig sig NOUN dpc-4289 93 20 . . PUNCT dpc-4289 94 1 opn opn PROPN dpc-4289 94 2 level level PROPN dpc-4289 94 3 opn opn PROPN dpc-4289 94 4 mean±sd mean±sd ADP dpc-4289 94 5 80.2 80.2 NUM dpc-4289 94 6 ± ± NUM dpc-4289 94 7 40.54 40.54 NUM dpc-4289 94 8 8.38 8.38 NUM dpc-4289 94 9 ± ± NUM dpc-4289 94 10 6.63 6.63 NUM dpc-4289 94 11 -11.058 -11.058 NOUN dpc-4289 94 12 ● ● NUM dpc-4289 94 13 0.000 0.000 NUM dpc-4289 94 14 hs hs NOUN dpc-4289 94 15 range range PROPN dpc-4289 94 16 26.5 26.5 NUM dpc-4289 94 17 – – PUNCT dpc-4289 94 18 182.3 182.3 NUM dpc-4289 94 19 0 0 NUM dpc-4289 94 20 – – PUNCT dpc-4289 94 21 20.7 20.7 NUM dpc-4289 94 22 opn opn PROPN dpc-4289 94 23 classification classification NOUN dpc-4289 94 24 normal normal ADJ dpc-4289 94 25 high high ADJ dpc-4289 94 26 0 0 NUM dpc-4289 95 1 ( ( PUNCT dpc-4289 95 2 0.0 0.0 NUM dpc-4289 95 3 % % NOUN dpc-4289 95 4 ) ) PUNCT dpc-4289 95 5 40 40 NUM dpc-4289 95 6 ( ( PUNCT dpc-4289 95 7 100.0 100.0 NUM dpc-4289 95 8 % % NOUN dpc-4289 95 9 ) ) PUNCT dpc-4289 95 10 38 38 NUM dpc-4289 95 11 ( ( PUNCT dpc-4289 95 12 95.0 95.0 NUM dpc-4289 95 13 % % NOUN dpc-4289 95 14 ) ) PUNCT dpc-4289 95 15 2 2 NUM dpc-4289 95 16 ( ( PUNCT dpc-4289 95 17 5.0 5.0 NUM dpc-4289 95 18 % % NOUN dpc-4289 95 19 ) ) PUNCT dpc-4289 96 1 72.381 72.381 NUM dpc-4289 96 2 * * SYM dpc-4289 96 3 0.000 0.000 NUM dpc-4289 96 4 hs hs PROPN dpc-4289 96 5 ocular ocular ADJ dpc-4289 96 6 comorbidities comorbiditie NOUN dpc-4289 96 7 posterior posterior ADJ dpc-4289 96 8 blepharitis blepharitis NOUN dpc-4289 96 9 no no DET dpc-4289 96 10 13 13 NUM dpc-4289 96 11 ( ( PUNCT dpc-4289 96 12 32.5 32.5 NUM dpc-4289 96 13 % % NOUN dpc-4289 96 14 ) ) PUNCT dpc-4289 96 15 28 28 NUM dpc-4289 96 16 ( ( PUNCT dpc-4289 96 17 70.0 70.0 NUM dpc-4289 96 18 % % NOUN dpc-4289 96 19 ) ) PUNCT dpc-4289 97 1 11.257 11.257 NUM dpc-4289 97 2 * * SYM dpc-4289 97 3 0.001 0.001 NUM dpc-4289 97 4 yes yes NUM dpc-4289 97 5 27 27 NUM dpc-4289 97 6 ( ( PUNCT dpc-4289 97 7 67.5 67.5 NUM dpc-4289 97 8 % % NOUN dpc-4289 97 9 ) ) PUNCT dpc-4289 97 10 12 12 NUM dpc-4289 97 11 ( ( PUNCT dpc-4289 97 12 30.0 30.0 NUM dpc-4289 97 13 % % NOUN dpc-4289 97 14 ) ) PUNCT dpc-4289 97 15 unilateral unilateral ADJ dpc-4289 97 16 6 6 NUM dpc-4289 97 17 ( ( PUNCT dpc-4289 97 18 22.2 22.2 NUM dpc-4289 97 19 % % NOUN dpc-4289 97 20 ) ) PUNCT dpc-4289 97 21 6 6 NUM dpc-4289 97 22 ( ( PUNCT dpc-4289 97 23 50.0 50.0 NUM dpc-4289 97 24 % % NOUN dpc-4289 97 25 ) ) PUNCT dpc-4289 97 26 3.009 3.009 NUM dpc-4289 97 27 0.083 0.083 NUM dpc-4289 97 28 bilateral bilateral ADJ dpc-4289 97 29 21 21 NUM dpc-4289 97 30 ( ( PUNCT dpc-4289 97 31 77.8 77.8 NUM dpc-4289 97 32 % % NOUN dpc-4289 97 33 ) ) PUNCT dpc-4289 97 34 6 6 NUM dpc-4289 97 35 ( ( PUNCT dpc-4289 97 36 50.0 50.0 NUM dpc-4289 97 37 % % NOUN dpc-4289 97 38 ) ) PUNCT dpc-4289 97 39 anterior anterior ADJ dpc-4289 97 40 blepharitis blepharitis NOUN dpc-4289 97 41 no no DET dpc-4289 97 42 21 21 NUM dpc-4289 97 43 ( ( PUNCT dpc-4289 97 44 52.5 52.5 NUM dpc-4289 97 45 % % NOUN dpc-4289 97 46 ) ) PUNCT dpc-4289 97 47 32 32 NUM dpc-4289 97 48 ( ( PUNCT dpc-4289 97 49 80.0 80.0 NUM dpc-4289 97 50 % % NOUN dpc-4289 97 51 ) ) PUNCT dpc-4289 98 1 6.765 6.765 NUM dpc-4289 98 2 * * NOUN dpc-4289 98 3 0.009 0.009 NUM dpc-4289 98 4 yes yes NUM dpc-4289 98 5 19 19 NUM dpc-4289 98 6 ( ( PUNCT dpc-4289 98 7 47.5 47.5 NUM dpc-4289 98 8 % % NOUN dpc-4289 98 9 ) ) PUNCT dpc-4289 98 10 8 8 NUM dpc-4289 98 11 ( ( PUNCT dpc-4289 98 12 20.0 20.0 NUM dpc-4289 98 13 % % NOUN dpc-4289 98 14 ) ) PUNCT dpc-4289 98 15 unilateral unilateral ADJ dpc-4289 98 16 7 7 NUM dpc-4289 98 17 ( ( PUNCT dpc-4289 98 18 36.8 36.8 NUM dpc-4289 98 19 % % NOUN dpc-4289 98 20 ) ) PUNCT dpc-4289 98 21 3 3 NUM dpc-4289 98 22 ( ( PUNCT dpc-4289 98 23 37.5 37.5 NUM dpc-4289 98 24 % % NOUN dpc-4289 98 25 ) ) PUNCT dpc-4289 98 26 0.001 0.001 NUM dpc-4289 98 27 0.974 0.974 NUM dpc-4289 98 28 bilateral bilateral ADJ dpc-4289 98 29 12 12 NUM dpc-4289 98 30 ( ( PUNCT dpc-4289 98 31 63.2 63.2 NUM dpc-4289 98 32 % % NOUN dpc-4289 98 33 ) ) PUNCT dpc-4289 98 34 5 5 NUM dpc-4289 98 35 ( ( PUNCT dpc-4289 98 36 62.5 62.5 NUM dpc-4289 98 37 % % NOUN dpc-4289 98 38 ) ) PUNCT dpc-4289 98 39 cornea cornea NOUN dpc-4289 98 40 affections affection NOUN dpc-4289 98 41 no no DET dpc-4289 98 42 30 30 NUM dpc-4289 98 43 ( ( PUNCT dpc-4289 98 44 75.0 75.0 NUM dpc-4289 98 45 % % NOUN dpc-4289 98 46 ) ) PUNCT dpc-4289 98 47 40 40 NUM dpc-4289 98 48 ( ( PUNCT dpc-4289 98 49 100.0 100.0 NUM dpc-4289 98 50 % % NOUN dpc-4289 98 51 ) ) PUNCT dpc-4289 98 52 11.429 11.429 NUM dpc-4289 98 53 * * SYM dpc-4289 98 54 0.001 0.001 NUM dpc-4289 98 55 p.e.e p.e.e NOUN dpc-4289 98 56 . . PUNCT dpc-4289 99 1 10 10 NUM dpc-4289 99 2 ( ( PUNCT dpc-4289 99 3 25.0 25.0 NUM dpc-4289 99 4 % % NOUN dpc-4289 99 5 ) ) PUNCT dpc-4289 99 6 0 0 NUM dpc-4289 100 1 ( ( PUNCT dpc-4289 100 2 0.0 0.0 NUM dpc-4289 100 3 % % NOUN dpc-4289 100 4 ) ) PUNCT dpc-4289 100 5 conjunctivitis conjunctivitis NOUN dpc-4289 100 6 no no DET dpc-4289 100 7 13 13 NUM dpc-4289 100 8 ( ( PUNCT dpc-4289 100 9 32.5 32.5 NUM dpc-4289 100 10 % % NOUN dpc-4289 100 11 ) ) PUNCT dpc-4289 100 12 34 34 NUM dpc-4289 100 13 ( ( PUNCT dpc-4289 100 14 85.0 85.0 NUM dpc-4289 100 15 % % NOUN dpc-4289 100 16 ) ) PUNCT dpc-4289 101 1 24.590 24.590 NUM dpc-4289 101 2 * * SYM dpc-4289 101 3 0.000 0.000 NUM dpc-4289 101 4 hyperemic hyperemic ADJ dpc-4289 101 5 25 25 NUM dpc-4289 101 6 ( ( PUNCT dpc-4289 101 7 62.5 62.5 NUM dpc-4289 101 8 % % NOUN dpc-4289 101 9 ) ) PUNCT dpc-4289 101 10 4 4 NUM dpc-4289 101 11 ( ( PUNCT dpc-4289 101 12 10.0 10.0 NUM dpc-4289 101 13 % % NOUN dpc-4289 101 14 ) ) PUNCT dpc-4289 101 15 pinguecula pinguecula NOUN dpc-4289 101 16 2 2 NUM dpc-4289 101 17 ( ( PUNCT dpc-4289 101 18 5.0 5.0 NUM dpc-4289 101 19 % % NOUN dpc-4289 101 20 ) ) PUNCT dpc-4289 101 21 2 2 NUM dpc-4289 101 22 ( ( PUNCT dpc-4289 101 23 5.0 5.0 NUM dpc-4289 101 24 % % NOUN dpc-4289 101 25 ) ) PUNCT dpc-4289 101 26 keratoconjunctivitis keratoconjunctivitis PROPN dpc-4289 101 27 sicca sicca VERB dpc-4289 101 28 no no DET dpc-4289 101 29 5 5 NUM dpc-4289 101 30 ( ( PUNCT dpc-4289 101 31 12.5 12.5 NUM dpc-4289 101 32 % % NOUN dpc-4289 101 33 ) ) PUNCT dpc-4289 101 34 37 37 NUM dpc-4289 101 35 ( ( PUNCT dpc-4289 101 36 92.5 92.5 NUM dpc-4289 101 37 % % NOUN dpc-4289 101 38 ) ) PUNCT dpc-4289 102 1 51.328 51.328 NUM dpc-4289 102 2 * * SYM dpc-4289 103 1 0.000 0.000 NUM dpc-4289 103 2 yes yes INTJ dpc-4289 103 3 35 35 NUM dpc-4289 103 4 ( ( PUNCT dpc-4289 103 5 87.5 87.5 NUM dpc-4289 103 6 % % NOUN dpc-4289 103 7 ) ) PUNCT dpc-4289 103 8 3 3 NUM dpc-4289 103 9 ( ( PUNCT dpc-4289 103 10 7.5 7.5 NUM dpc-4289 103 11 % % NOUN dpc-4289 103 12 ) ) PUNCT dpc-4289 103 13 unilateral unilateral ADJ dpc-4289 103 14 16 16 NUM dpc-4289 103 15 ( ( PUNCT dpc-4289 103 16 45.7 45.7 NUM dpc-4289 103 17 % % NOUN dpc-4289 103 18 ) ) PUNCT dpc-4289 103 19 0 0 NUM dpc-4289 104 1 ( ( PUNCT dpc-4289 104 2 0.0 0.0 NUM dpc-4289 104 3 % % NOUN dpc-4289 104 4 ) ) PUNCT dpc-4289 104 5 2.369 2.369 NUM dpc-4289 104 6 0.124 0.124 NUM dpc-4289 104 7 bilateral bilateral ADJ dpc-4289 104 8 19 19 NUM dpc-4289 104 9 ( ( PUNCT dpc-4289 104 10 54.3 54.3 NUM dpc-4289 104 11 % % NOUN dpc-4289 104 12 ) ) PUNCT dpc-4289 104 13 3 3 NUM dpc-4289 104 14 ( ( PUNCT dpc-4289 104 15 100.0 100.0 NUM dpc-4289 104 16 % % NOUN dpc-4289 104 17 ) ) PUNCT dpc-4289 104 18 cataract cataract NOUN dpc-4289 104 19 no no DET dpc-4289 104 20 16 16 NUM dpc-4289 104 21 ( ( PUNCT dpc-4289 104 22 40.0 40.0 NUM dpc-4289 104 23 % % NOUN dpc-4289 104 24 ) ) PUNCT dpc-4289 104 25 28 28 NUM dpc-4289 104 26 ( ( PUNCT dpc-4289 104 27 70.0 70.0 NUM dpc-4289 104 28 % % NOUN dpc-4289 104 29 ) ) PUNCT dpc-4289 104 30 7.273 7.273 NUM dpc-4289 104 31 0.007 0.007 NUM dpc-4289 104 32 present present ADJ dpc-4289 104 33 24 24 NUM dpc-4289 104 34 ( ( PUNCT dpc-4289 104 35 60.0 60.0 NUM dpc-4289 104 36 % % NOUN dpc-4289 104 37 ) ) PUNCT dpc-4289 104 38 12 12 NUM dpc-4289 104 39 ( ( PUNCT dpc-4289 104 40 30.0 30.0 NUM dpc-4289 104 41 % % NOUN dpc-4289 104 42 ) ) PUNCT dpc-4289 104 43 unilateral unilateral ADJ dpc-4289 104 44 3 3 NUM dpc-4289 104 45 ( ( PUNCT dpc-4289 104 46 12.5 12.5 NUM dpc-4289 104 47 % % NOUN dpc-4289 104 48 ) ) PUNCT dpc-4289 104 49 4 4 NUM dpc-4289 104 50 ( ( PUNCT dpc-4289 104 51 33.3 33.3 NUM dpc-4289 104 52 % % NOUN dpc-4289 104 53 ) ) PUNCT dpc-4289 104 54 2.217 2.217 NUM dpc-4289 104 55 0.137 0.137 NUM dpc-4289 104 56 bilateral bilateral ADJ dpc-4289 104 57 21 21 NUM dpc-4289 104 58 ( ( PUNCT dpc-4289 104 59 87.5 87.5 NUM dpc-4289 104 60 % % NOUN dpc-4289 104 61 ) ) PUNCT dpc-4289 104 62 8 8 NUM dpc-4289 104 63 ( ( PUNCT dpc-4289 104 64 66.7 66.7 NUM dpc-4289 104 65 % % NOUN dpc-4289 104 66 ) ) PUNCT dpc-4289 104 67 abbreviations abbreviation NOUN dpc-4289 104 68 : : PUNCT dpc-4289 104 69 hs hs NUM dpc-4289 104 70 : : PUNCT dpc-4289 104 71 highly highly ADV dpc-4289 104 72 significant significant ADJ dpc-4289 104 73 , , PUNCT dpc-4289 104 74 opn opn PROPN dpc-4289 104 75 : : PUNCT dpc-4289 104 76 osteopontin osteopontin ADJ dpc-4289 104 77 ; ; PUNCT dpc-4289 104 78 * * PUNCT dpc-4289 104 79 : : PUNCT dpc-4289 104 80 chi chi ADJ dpc-4289 104 81 - - PUNCT dpc-4289 104 82 square square ADJ dpc-4289 104 83 test test NOUN dpc-4289 104 84 ; ; PUNCT dpc-4289 104 85 ● ● X dpc-4289 104 86 : : PUNCT dpc-4289 104 87 independent independent ADJ dpc-4289 104 88 t t NOUN dpc-4289 104 89 - - PUNCT dpc-4289 104 90 test test NOUN dpc-4289 104 91 . . PUNCT dpc-4289 105 1 original original ADJ dpc-4289 105 2 article article NOUN dpc-4289 105 3 | | ADV dpc-4289 105 4 dermatol dermatol ADJ dpc-4289 105 5 pract pract NOUN dpc-4289 105 6 concept concept NOUN dpc-4289 105 7 . . PUNCT dpc-4289 106 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 106 2 5 5 NUM dpc-4289 106 3 figure figure NOUN dpc-4289 106 4 1 1 NUM dpc-4289 106 5 . . PUNCT dpc-4289 107 1 roc roc PROPN dpc-4289 107 2 curve curve NOUN dpc-4289 107 3 for for ADP dpc-4289 107 4 opn opn PROPN dpc-4289 107 5 level level NOUN dpc-4289 107 6 to to PART dpc-4289 107 7 differentiate differentiate VERB dpc-4289 107 8 between between ADP dpc-4289 107 9 the the DET dpc-4289 107 10 two two NUM dpc-4289 107 11 study study NOUN dpc-4289 107 12 groups group NOUN dpc-4289 107 13 . . PUNCT dpc-4289 108 1 figure figure NOUN dpc-4289 108 2 2 2 NUM dpc-4289 108 3 . . PUNCT dpc-4289 108 4 correlation correlation NOUN dpc-4289 108 5 between between ADP dpc-4289 108 6 osteopontin osteopontin ADJ dpc-4289 108 7 level level NOUN dpc-4289 108 8 and and CCONJ dpc-4289 108 9 pasi pasi NOUN dpc-4289 108 10 ( ( PUNCT dpc-4289 108 11 a a NOUN dpc-4289 108 12 ) ) PUNCT dpc-4289 108 13 , , PUNCT dpc-4289 108 14 age age NOUN dpc-4289 108 15 of of ADP dpc-4289 108 16 patients patient NOUN dpc-4289 108 17 ( ( PUNCT dpc-4289 108 18 b b NOUN dpc-4289 108 19 ) ) PUNCT dpc-4289 108 20 , , PUNCT dpc-4289 108 21 and and CCONJ dpc-4289 108 22 duration duration NOUN dpc-4289 108 23 of of ADP dpc-4289 108 24 disease disease NOUN dpc-4289 108 25 ( ( PUNCT dpc-4289 108 26 c c NOUN dpc-4289 108 27 ) ) PUNCT dpc-4289 108 28 . . PUNCT dpc-4289 109 1 6 6 NUM dpc-4289 109 2 original original ADJ dpc-4289 109 3 article article NOUN dpc-4289 109 4 | | ADV dpc-4289 109 5 dermatol dermatol ADJ dpc-4289 109 6 pract pract NOUN dpc-4289 109 7 concept concept NOUN dpc-4289 109 8 . . PUNCT dpc-4289 110 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 110 2 concomitant concomitant ADJ dpc-4289 110 3 conditions condition NOUN dpc-4289 110 4 , , PUNCT dpc-4289 110 5 including include VERB dpc-4289 110 6 ocular ocular ADJ dpc-4289 110 7 comorbidities comorbiditie NOUN dpc-4289 110 8 ( ( PUNCT dpc-4289 110 9 11 11 NUM dpc-4289 110 10 ) ) PUNCT dpc-4289 110 11 . . PUNCT dpc-4289 111 1 opn opn PROPN dpc-4289 111 2 is be AUX dpc-4289 111 3 linked link VERB dpc-4289 111 4 to to ADP dpc-4289 111 5 severity severity NOUN dpc-4289 111 6 of of ADP dpc-4289 111 7 psoriasis psoriasis NOUN dpc-4289 111 8 and and CCONJ dpc-4289 111 9 is be AUX dpc-4289 111 10 regulated regulate VERB dpc-4289 111 11 by by ADP dpc-4289 111 12 its its PRON dpc-4289 111 13 expression expression NOUN dpc-4289 111 14 by by ADP dpc-4289 111 15 lesional lesional ADJ dpc-4289 111 16 keratinocytes keratinocyte NOUN dpc-4289 111 17 , , PUNCT dpc-4289 111 18 inflammatory inflammatory ADJ dpc-4289 111 19 cells cell NOUN dpc-4289 111 20 , , PUNCT dpc-4289 111 21 and and CCONJ dpc-4289 111 22 endothelial endothelial ADJ dpc-4289 111 23 cells cell NOUN dpc-4289 111 24 ( ( PUNCT dpc-4289 111 25 12 12 NUM dpc-4289 111 26 ) ) PUNCT dpc-4289 111 27 . . PUNCT dpc-4289 112 1 serum serum PROPN dpc-4289 112 2 osteopontin osteopontin NOUN dpc-4289 112 3 in in ADP dpc-4289 112 4 psoriasis psoriasis NOUN dpc-4289 112 5 patients patient NOUN dpc-4289 112 6 in in ADP dpc-4289 112 7 this this DET dpc-4289 112 8 study study NOUN dpc-4289 112 9 , , PUNCT dpc-4289 112 10 we we PRON dpc-4289 112 11 observed observe VERB dpc-4289 112 12 a a DET dpc-4289 112 13 statistically statistically ADV dpc-4289 112 14 significantly significantly ADV dpc-4289 112 15 higher high ADJ dpc-4289 112 16 level level NOUN dpc-4289 112 17 of of ADP dpc-4289 112 18 opn opn PROPN dpc-4289 112 19 in in ADP dpc-4289 112 20 psoriatic psoriatic ADJ dpc-4289 112 21 patients patient NOUN dpc-4289 112 22 compared compare VERB dpc-4289 112 23 to to ADP dpc-4289 112 24 healthy healthy ADJ dpc-4289 112 25 controls control NOUN dpc-4289 112 26 . . PUNCT dpc-4289 113 1 in in ADP dpc-4289 113 2 addition addition NOUN dpc-4289 113 3 , , PUNCT dpc-4289 113 4 the the DET dpc-4289 113 5 roc roc PROPN dpc-4289 113 6 curve curve NOUN dpc-4289 113 7 showed show VERB dpc-4289 113 8 that that SCONJ dpc-4289 113 9 opn opn PROPN dpc-4289 113 10 level level NOUN dpc-4289 113 11 can can AUX dpc-4289 113 12 be be AUX dpc-4289 113 13 used use VERB dpc-4289 113 14 to to PART dpc-4289 113 15 differentiate differentiate VERB dpc-4289 113 16 between between ADP dpc-4289 113 17 patients patient NOUN dpc-4289 113 18 and and CCONJ dpc-4289 113 19 healthy healthy ADJ dpc-4289 113 20 controls control NOUN dpc-4289 113 21 with with ADP dpc-4289 113 22 high high ADJ dpc-4289 113 23 specificity specificity NOUN dpc-4289 113 24 and and CCONJ dpc-4289 113 25 sensitivity sensitivity NOUN dpc-4289 113 26 . . PUNCT dpc-4289 114 1 these these DET dpc-4289 114 2 findings finding NOUN dpc-4289 114 3 were be AUX dpc-4289 114 4 consistent consistent ADJ dpc-4289 114 5 with with ADP dpc-4289 114 6 earlier early ADJ dpc-4289 114 7 research research NOUN dpc-4289 114 8 studies study NOUN dpc-4289 114 9 ( ( PUNCT dpc-4289 114 10 10 10 NUM dpc-4289 114 11 , , PUNCT dpc-4289 114 12 13 13 NUM dpc-4289 114 13 ) ) PUNCT dpc-4289 114 14 that that PRON dpc-4289 114 15 found find VERB dpc-4289 114 16 significantly significantly ADV dpc-4289 114 17 higher high ADJ dpc-4289 114 18 levels level NOUN dpc-4289 114 19 of of ADP dpc-4289 114 20 opn opn PROPN dpc-4289 114 21 in in ADP dpc-4289 114 22 psoriasis psoriasis NOUN dpc-4289 114 23 patients patient NOUN dpc-4289 114 24 ’ ' PUNCT dpc-4289 114 25 serum serum NOUN dpc-4289 114 26 and/or and/or CCONJ dpc-4289 114 27 skin skin NOUN dpc-4289 114 28 lesions lesion NOUN dpc-4289 114 29 . . PUNCT dpc-4289 115 1 additionally additionally ADV dpc-4289 115 2 , , PUNCT dpc-4289 115 3 przepiórka przepiórka PROPN dpc-4289 115 4 - - PUNCT dpc-4289 115 5 kosińska kosińska PROPN dpc-4289 115 6 et et PROPN dpc-4289 115 7 al al PROPN dpc-4289 115 8 . . PUNCT dpc-4289 116 1 ( ( PUNCT dpc-4289 116 2 11 11 NUM dpc-4289 116 3 ) ) PUNCT dpc-4289 116 4 found find VERB dpc-4289 116 5 that that SCONJ dpc-4289 116 6 opn opn PROPN dpc-4289 116 7 concentrations concentration NOUN dpc-4289 116 8 in in ADP dpc-4289 116 9 psoriatic psoriatic ADJ dpc-4289 116 10 patients patient NOUN dpc-4289 116 11 were be AUX dpc-4289 116 12 substantially substantially ADV dpc-4289 116 13 higher high ADJ dpc-4289 116 14 than than ADP dpc-4289 116 15 in in ADP dpc-4289 116 16 healthy healthy ADJ dpc-4289 116 17 volunteers volunteer NOUN dpc-4289 116 18 . . PUNCT dpc-4289 117 1 this this PRON dpc-4289 117 2 can can AUX dpc-4289 117 3 be be AUX dpc-4289 117 4 explained explain VERB dpc-4289 117 5 by by ADP dpc-4289 117 6 the the DET dpc-4289 117 7 notion notion NOUN dpc-4289 117 8 that that SCONJ dpc-4289 117 9 opn opn PROPN dpc-4289 117 10 promotes promote VERB dpc-4289 117 11 epidermal epidermal ADJ dpc-4289 117 12 proliferation proliferation NOUN dpc-4289 117 13 by by ADP dpc-4289 117 14 blocking block VERB dpc-4289 117 15 keratinocyte keratinocyte NOUN dpc-4289 117 16 death death NOUN dpc-4289 117 17 and and CCONJ dpc-4289 117 18 stimulates stimulate VERB dpc-4289 117 19 vascular vascular ADJ dpc-4289 117 20 formation formation NOUN dpc-4289 117 21 , , PUNCT dpc-4289 117 22 which which PRON dpc-4289 117 23 in in ADP dpc-4289 117 24 turn turn NOUN dpc-4289 117 25 facilitates facilitate VERB dpc-4289 117 26 the the DET dpc-4289 117 27 influx influx NOUN dpc-4289 117 28 of of ADP dpc-4289 117 29 inflammatory inflammatory ADJ dpc-4289 117 30 cells cell NOUN dpc-4289 117 31 into into ADP dpc-4289 117 32 the the DET dpc-4289 117 33 skin skin NOUN dpc-4289 117 34 ( ( PUNCT dpc-4289 117 35 14 14 NUM dpc-4289 117 36 ) ) PUNCT dpc-4289 117 37 . . PUNCT dpc-4289 118 1 the the DET dpc-4289 118 2 pathophysiology pathophysiology NOUN dpc-4289 118 3 of of ADP dpc-4289 118 4 psoriatic psoriatic ADJ dpc-4289 118 5 lesions lesion NOUN dpc-4289 118 6 also also ADV dpc-4289 118 7 exhibits exhibit VERB dpc-4289 118 8 similar similar ADJ dpc-4289 118 9 immunological immunological ADJ dpc-4289 118 10 processes process NOUN dpc-4289 118 11 , , PUNCT dpc-4289 118 12 which which PRON dpc-4289 118 13 raises raise VERB dpc-4289 118 14 the the DET dpc-4289 118 15 possibility possibility NOUN dpc-4289 118 16 that that SCONJ dpc-4289 118 17 opn opn PROPN dpc-4289 118 18 plays play VERB dpc-4289 118 19 a a DET dpc-4289 118 20 role role NOUN dpc-4289 118 21 in in ADP dpc-4289 118 22 the the DET dpc-4289 118 23 emergence emergence NOUN dpc-4289 118 24 of of ADP dpc-4289 118 25 systemic systemic ADJ dpc-4289 118 26 and and CCONJ dpc-4289 118 27 local local ADJ dpc-4289 118 28 inflammation inflammation NOUN dpc-4289 118 29 in in ADP dpc-4289 118 30 ps ps PROPN dpc-4289 118 31 ( ( PUNCT dpc-4289 118 32 11 11 NUM dpc-4289 118 33 ) ) PUNCT dpc-4289 118 34 . . PUNCT dpc-4289 119 1 cases case NOUN dpc-4289 119 2 with with ADP dpc-4289 119 3 severe severe ADJ dpc-4289 119 4 psoriasis psoriasis NOUN dpc-4289 119 5 showed show VERB dpc-4289 119 6 significantly significantly ADV dpc-4289 119 7 higher high ADJ dpc-4289 119 8 opn opn PROPN dpc-4289 119 9 levels level NOUN dpc-4289 119 10 compared compare VERB dpc-4289 119 11 to to ADP dpc-4289 119 12 mild mild ADJ dpc-4289 119 13 and and CCONJ dpc-4289 119 14 moderate moderate ADJ dpc-4289 119 15 cases case NOUN dpc-4289 119 16 . . PUNCT dpc-4289 120 1 also also ADV dpc-4289 120 2 , , PUNCT dpc-4289 120 3 cases case NOUN dpc-4289 120 4 affected affect VERB dpc-4289 120 5 with with ADP dpc-4289 120 6 cataract cataract NOUN dpc-4289 120 7 and and CCONJ dpc-4289 120 8 those those PRON dpc-4289 120 9 with with ADP dpc-4289 120 10 high high ADJ dpc-4289 120 11 iop iop NOUN dpc-4289 120 12 showed show VERB dpc-4289 120 13 a a DET dpc-4289 120 14 significantly significantly ADV dpc-4289 120 15 higher high ADJ dpc-4289 120 16 opn opn PROPN dpc-4289 120 17 level level NOUN dpc-4289 120 18 compared compare VERB dpc-4289 120 19 to to ADP dpc-4289 120 20 cases case NOUN dpc-4289 120 21 without without ADP dpc-4289 120 22 these these DET dpc-4289 120 23 findings finding NOUN dpc-4289 120 24 ( ( PUNCT dpc-4289 120 25 p=0.018 p=0.018 NOUN dpc-4289 120 26 and and CCONJ dpc-4289 120 27 0.013 0.013 NUM dpc-4289 120 28 , , PUNCT dpc-4289 120 29 respectively respectively ADV dpc-4289 120 30 ) ) PUNCT dpc-4289 120 31 , , PUNCT dpc-4289 120 32 but but CCONJ dpc-4289 120 33 no no DET dpc-4289 120 34 statistically statistically ADV dpc-4289 120 35 significant significant ADJ dpc-4289 120 36 relations relation NOUN dpc-4289 120 37 were be AUX dpc-4289 120 38 found find VERB dpc-4289 120 39 with with ADP dpc-4289 120 40 other other ADJ dpc-4289 120 41 ocular ocular ADJ dpc-4289 120 42 findings finding NOUN dpc-4289 120 43 ( ( PUNCT dpc-4289 120 44 p>0.05 p>0.05 PROPN dpc-4289 120 45 ) ) PUNCT dpc-4289 120 46 . . PUNCT dpc-4289 121 1 also also ADV dpc-4289 121 2 , , PUNCT dpc-4289 121 3 higher high ADJ dpc-4289 121 4 opn opn PROPN dpc-4289 121 5 levels level NOUN dpc-4289 121 6 were be AUX dpc-4289 121 7 associated associate VERB dpc-4289 121 8 significantly significantly ADV dpc-4289 121 9 with with ADP dpc-4289 121 10 lower low ADJ dpc-4289 121 11 values value NOUN dpc-4289 121 12 of of ADP dpc-4289 121 13 both both CCONJ dpc-4289 121 14 schirmer schirmer PROPN dpc-4289 121 15 and and CCONJ dpc-4289 121 16 tbut tbut ADV dpc-4289 121 17 tests test NOUN dpc-4289 121 18 ( ( PUNCT dpc-4289 121 19 p=0.001 p=0.001 NUM dpc-4289 121 20 and and CCONJ dpc-4289 121 21 p=0.003 p=0.003 NOUN dpc-4289 121 22 , , PUNCT dpc-4289 121 23 respectively respectively ADV dpc-4289 121 24 ) ) PUNCT dpc-4289 121 25 ( ( PUNCT dpc-4289 121 26 table table NOUN dpc-4289 121 27 4 4 NUM dpc-4289 121 28 ) ) PUNCT dpc-4289 121 29 . . PUNCT dpc-4289 122 1 there there PRON dpc-4289 122 2 was be VERB dpc-4289 122 3 a a DET dpc-4289 122 4 significant significant ADJ dpc-4289 122 5 negative negative ADJ dpc-4289 122 6 correlation correlation NOUN dpc-4289 122 7 between between ADP dpc-4289 122 8 serum serum PROPN dpc-4289 122 9 opn opn PROPN dpc-4289 122 10 levels level NOUN dpc-4289 122 11 and and CCONJ dpc-4289 122 12 bcva bcva NOUN dpc-4289 122 13 , , PUNCT dpc-4289 122 14 schirmer schirmer PROPN dpc-4289 122 15 , , PUNCT dpc-4289 122 16 and and CCONJ dpc-4289 122 17 but but CCONJ dpc-4289 122 18 tests test NOUN dpc-4289 122 19 ( ( PUNCT dpc-4289 122 20 r=-0.521 r=-0.521 NOUN dpc-4289 122 21 , , PUNCT dpc-4289 122 22 p=0.000 p=0.000 NOUN dpc-4289 122 23 , , PUNCT dpc-4289 122 24 r=-0.359 r=-0.359 NOUN dpc-4289 122 25 , , PUNCT dpc-4289 122 26 p=0.001 p=0.001 NUM dpc-4289 122 27 , , PUNCT dpc-4289 122 28 and and CCONJ dpc-4289 122 29 r=-0.737 r=-0.737 PROPN dpc-4289 122 30 , , PUNCT dpc-4289 122 31 p=0.000 p=0.000 NOUN dpc-4289 122 32 , , PUNCT dpc-4289 122 33 respectively respectively ADV dpc-4289 122 34 ) ) PUNCT dpc-4289 122 35 , , PUNCT dpc-4289 122 36 while while SCONJ dpc-4289 122 37 a a DET dpc-4289 122 38 significant significant ADJ dpc-4289 122 39 positive positive ADJ dpc-4289 122 40 correlation correlation NOUN dpc-4289 122 41 was be AUX dpc-4289 122 42 present present ADJ dpc-4289 122 43 between between ADP dpc-4289 122 44 serum serum NOUN dpc-4289 122 45 opn opn PROPN dpc-4289 122 46 level level PROPN dpc-4289 122 47 and and CCONJ dpc-4289 122 48 iop iop PROPN dpc-4289 122 49 ( ( PUNCT dpc-4289 122 50 r=0.281 r=0.281 ADV dpc-4289 122 51 , , PUNCT dpc-4289 122 52 p=0.012 p=0.012 NUM dpc-4289 122 53 ) ) PUNCT dpc-4289 122 54 ( ( PUNCT dpc-4289 122 55 table table NOUN dpc-4289 122 56 5 5 NUM dpc-4289 122 57 ) ) PUNCT dpc-4289 122 58 . . PUNCT dpc-4289 123 1 conclusions conclusion NOUN dpc-4289 123 2 psoriasis psoriasis NOUN dpc-4289 123 3 may may AUX dpc-4289 123 4 be be AUX dpc-4289 123 5 linked link VERB dpc-4289 123 6 to to ADP dpc-4289 123 7 an an DET dpc-4289 123 8 inflammatory inflammatory ADJ dpc-4289 123 9 response response NOUN dpc-4289 123 10 in in ADP dpc-4289 123 11 the the DET dpc-4289 123 12 eyes eye NOUN dpc-4289 123 13 . . PUNCT dpc-4289 124 1 these these DET dpc-4289 124 2 conditions condition NOUN dpc-4289 124 3 include include VERB dpc-4289 124 4 defects defect NOUN dpc-4289 124 5 of of ADP dpc-4289 124 6 the the DET dpc-4289 124 7 lens len NOUN dpc-4289 124 8 , , PUNCT dpc-4289 124 9 uvea uvea NOUN dpc-4289 124 10 , , PUNCT dpc-4289 124 11 sclera sclera NOUN dpc-4289 124 12 , , PUNCT dpc-4289 124 13 cornea cornea PROPN dpc-4289 124 14 , , PUNCT dpc-4289 124 15 and and CCONJ dpc-4289 124 16 conjunctiva conjunctiva NOUN dpc-4289 124 17 ( ( PUNCT dpc-4289 124 18 10 10 NUM dpc-4289 124 19 ) ) PUNCT dpc-4289 124 20 . . PUNCT dpc-4289 125 1 opn opn PROPN dpc-4289 125 2 , , PUNCT dpc-4289 125 3 through through ADP dpc-4289 125 4 its its PRON dpc-4289 125 5 pro pro ADJ dpc-4289 125 6 - - ADJ dpc-4289 125 7 inflammatory inflammatory ADJ dpc-4289 125 8 and and CCONJ dpc-4289 125 9 angiogenic angiogenic ADJ dpc-4289 125 10 effects effect NOUN dpc-4289 125 11 , , PUNCT dpc-4289 125 12 may may AUX dpc-4289 125 13 play play VERB dpc-4289 125 14 a a DET dpc-4289 125 15 key key ADJ dpc-4289 125 16 role role NOUN dpc-4289 125 17 in in ADP dpc-4289 125 18 the the DET dpc-4289 125 19 pathophysiology pathophysiology NOUN dpc-4289 125 20 of of ADP dpc-4289 125 21 ps ps NOUN dpc-4289 125 22 by by ADP dpc-4289 125 23 helping help VERB dpc-4289 125 24 to to PART dpc-4289 125 25 cause cause VERB dpc-4289 125 26 chronic chronic ADJ dpc-4289 125 27 inflammation inflammation NOUN dpc-4289 125 28 and and CCONJ dpc-4289 125 29 consequently consequently ADV dpc-4289 125 30 the the DET dpc-4289 125 31 emergence emergence NOUN dpc-4289 125 32 of of ADP dpc-4289 125 33 table table NOUN dpc-4289 125 34 3 3 NUM dpc-4289 125 35 . . PUNCT dpc-4289 125 36 comparison comparison NOUN dpc-4289 125 37 of of ADP dpc-4289 125 38 ocular ocular ADJ dpc-4289 125 39 surface surface NOUN dpc-4289 125 40 tests test NOUN dpc-4289 125 41 and and CCONJ dpc-4289 125 42 iop iop NOUN dpc-4289 125 43 between between ADP dpc-4289 125 44 the the DET dpc-4289 125 45 two two NUM dpc-4289 125 46 study study NOUN dpc-4289 125 47 groups group NOUN dpc-4289 125 48 . . PUNCT dpc-4289 126 1 patient patient ADJ dpc-4289 126 2 group group NOUN dpc-4289 126 3 ( ( PUNCT dpc-4289 126 4 n=40 n=40 ADJ dpc-4289 126 5 ) ) PUNCT dpc-4289 126 6 control control NOUN dpc-4289 126 7 group group NOUN dpc-4289 126 8 ( ( PUNCT dpc-4289 126 9 n=40 n=40 ADJ dpc-4289 126 10 ) ) PUNCT dpc-4289 126 11 test test NOUN dpc-4289 126 12 value value NOUN dpc-4289 126 13 p p NOUN dpc-4289 126 14 - - PUNCT dpc-4289 126 15 value value NOUN dpc-4289 126 16 bcva bcva NOUN dpc-4289 126 17 right right PROPN dpc-4289 126 18 eye eye NOUN dpc-4289 126 19 mean mean VERB dpc-4289 126 20 ± ± NUM dpc-4289 126 21 sd sd ADP dpc-4289 126 22 0.62 0.62 NUM dpc-4289 126 23 ± ± NUM dpc-4289 126 24 0.20 0.20 NUM dpc-4289 126 25 0.91 0.91 NUM dpc-4289 126 26 ± ± NUM dpc-4289 126 27 0.14 0.14 NUM dpc-4289 126 28 7.220• 7.220• NUM dpc-4289 126 29 0.000 0.000 NUM dpc-4289 126 30 range range NOUN dpc-4289 126 31 0.32 0.32 NUM dpc-4289 126 32 – – PUNCT dpc-4289 126 33 1 1 NUM dpc-4289 126 34 0.5 0.5 NUM dpc-4289 126 35 – – PUNCT dpc-4289 126 36 1 1 NUM dpc-4289 126 37 left leave VERB dpc-4289 126 38 eye eye NOUN dpc-4289 126 39 mean mean NOUN dpc-4289 126 40 ± ± NUM dpc-4289 126 41 sd sd ADP dpc-4289 126 42 0.70 0.70 NUM dpc-4289 126 43 ± ± NOUN dpc-4289 126 44 0.22 0.22 NUM dpc-4289 126 45 0.85 0.85 NUM dpc-4289 126 46 ± ± NUM dpc-4289 126 47 0.21 0.21 NUM dpc-4289 126 48 3.106• 3.106• NUM dpc-4289 126 49 0.003 0.003 NUM dpc-4289 126 50 range range NOUN dpc-4289 126 51 0.32 0.32 NUM dpc-4289 126 52 – – PUNCT dpc-4289 126 53 1 1 NUM dpc-4289 126 54 0.32 0.32 NUM dpc-4289 126 55 – – PUNCT dpc-4289 126 56 1 1 NUM dpc-4289 126 57 tbut tbut CCONJ dpc-4289 126 58 right right ADJ dpc-4289 126 59 eye eye NOUN dpc-4289 126 60 mean mean VERB dpc-4289 126 61 ± ± NUM dpc-4289 126 62 sd sd ADP dpc-4289 126 63 8.43 8.43 NUM dpc-4289 126 64 ± ± NUM dpc-4289 126 65 1.68 1.68 NUM dpc-4289 126 66 12.80 12.80 NUM dpc-4289 126 67 ± ± NUM dpc-4289 126 68 2.57 2.57 NUM dpc-4289 126 69 9.006• 9.006• NOUN dpc-4289 126 70 0.000 0.000 NUM dpc-4289 126 71 range range NOUN dpc-4289 126 72 5 5 NUM dpc-4289 126 73 – – PUNCT dpc-4289 126 74 11 11 NUM dpc-4289 126 75 9 9 NUM dpc-4289 126 76 – – PUNCT dpc-4289 126 77 18 18 NUM dpc-4289 126 78 left leave VERB dpc-4289 126 79 eye eye NOUN dpc-4289 126 80 mean mean NOUN dpc-4289 126 81 ± ± NUM dpc-4289 126 82 sd sd ADP dpc-4289 126 83 8.60 8.60 NUM dpc-4289 126 84 ± ± NUM dpc-4289 126 85 1.57 1.57 NUM dpc-4289 126 86 10.10 10.10 NUM dpc-4289 126 87 ± ± NUM dpc-4289 126 88 1.60 1.60 NUM dpc-4289 126 89 4.240• 4.240• NUM dpc-4289 126 90 0.000 0.000 NUM dpc-4289 126 91 range range NOUN dpc-4289 126 92 5 5 NUM dpc-4289 126 93 – – PUNCT dpc-4289 126 94 11 11 NUM dpc-4289 126 95 6 6 NUM dpc-4289 126 96 – – SYM dpc-4289 126 97 13 13 NUM dpc-4289 126 98 schirmer schirmer PROPN dpc-4289 126 99 test test NOUN dpc-4289 126 100 right right ADJ dpc-4289 126 101 eye eye NOUN dpc-4289 126 102 mean mean VERB dpc-4289 126 103 ± ± NUM dpc-4289 126 104 sd sd ADP dpc-4289 126 105 10.60 10.60 NUM dpc-4289 126 106 ± ± NUM dpc-4289 126 107 2.58 2.58 NUM dpc-4289 126 108 12.30 12.30 NUM dpc-4289 126 109 ± ± NUM dpc-4289 126 110 1.90 1.90 NUM dpc-4289 126 111 3.357• 3.357• NUM dpc-4289 126 112 0.001 0.001 NUM dpc-4289 126 113 range range NOUN dpc-4289 126 114 5 5 NUM dpc-4289 126 115 – – PUNCT dpc-4289 126 116 15 15 NUM dpc-4289 126 117 9 9 NUM dpc-4289 126 118 – – PUNCT dpc-4289 126 119 15 15 NUM dpc-4289 126 120 left leave VERB dpc-4289 126 121 eye eye NOUN dpc-4289 126 122 mean mean NOUN dpc-4289 126 123 ± ± NUM dpc-4289 126 124 sd sd ADP dpc-4289 126 125 10.00 10.00 NUM dpc-4289 126 126 ± ± NUM dpc-4289 126 127 2.71 2.71 NUM dpc-4289 126 128 12.00 12.00 NUM dpc-4289 126 129 ± ± NUM dpc-4289 126 130 1.87 1.87 NUM dpc-4289 126 131 3.845• 3.845• NUM dpc-4289 126 132 0.000 0.000 NUM dpc-4289 126 133 range range NOUN dpc-4289 126 134 4 4 NUM dpc-4289 126 135 – – SYM dpc-4289 126 136 14 14 NUM dpc-4289 126 137 8 8 NUM dpc-4289 126 138 – – PUNCT dpc-4289 126 139 15 15 NUM dpc-4289 126 140 iop iop NOUN dpc-4289 126 141 right right ADJ dpc-4289 126 142 eye eye NOUN dpc-4289 126 143 mean mean VERB dpc-4289 126 144 ± ± NUM dpc-4289 126 145 sd sd ADP dpc-4289 126 146 15.40 15.40 NUM dpc-4289 126 147 ± ± NUM dpc-4289 126 148 3.33 3.33 NUM dpc-4289 126 149 14.90 14.90 NUM dpc-4289 126 150 ± ± NUM dpc-4289 126 151 1.46 1.46 NUM dpc-4289 126 152 -0.868• -0.868• SYM dpc-4289 126 153 0.388 0.388 NUM dpc-4289 126 154 range range NOUN dpc-4289 126 155 12 12 NUM dpc-4289 126 156 – – PUNCT dpc-4289 126 157 25 25 NUM dpc-4289 126 158 12 12 NUM dpc-4289 126 159 – – PUNCT dpc-4289 126 160 18 18 NUM dpc-4289 126 161 left leave VERB dpc-4289 126 162 eye eye NOUN dpc-4289 126 163 mean mean NOUN dpc-4289 126 164 ± ± NUM dpc-4289 126 165 sd sd ADP dpc-4289 126 166 15.55 15.55 NUM dpc-4289 126 167 ± ± NUM dpc-4289 126 168 2.62 2.62 NUM dpc-4289 126 169 15.00 15.00 NUM dpc-4289 126 170 ± ± NUM dpc-4289 126 171 1.50 1.50 NUM dpc-4289 126 172 -1.151• -1.151• PUNCT dpc-4289 126 173 0.253 0.253 NUM dpc-4289 126 174 range range NOUN dpc-4289 126 175 12 12 NUM dpc-4289 126 176 – – PUNCT dpc-4289 126 177 23 23 NUM dpc-4289 126 178 12 12 NUM dpc-4289 126 179 – – SYM dpc-4289 126 180 18 18 NUM dpc-4289 126 181 chi chi ADJ dpc-4289 126 182 - - PUNCT dpc-4289 126 183 square square NOUN dpc-4289 126 184 test test NOUN dpc-4289 126 185 ; ; PUNCT dpc-4289 126 186 * * PUNCT dpc-4289 126 187 p p X dpc-4289 126 188 - - PUNCT dpc-4289 126 189 value value NOUN dpc-4289 126 190 < < X dpc-4289 126 191 0.05 0.05 NUM dpc-4289 126 192 ; ; PUNCT dpc-4289 126 193 * * PUNCT dpc-4289 126 194 * * PUNCT dpc-4289 126 195 p p NOUN dpc-4289 126 196 - - PUNCT dpc-4289 126 197 value value NOUN dpc-4289 126 198 < < X dpc-4289 126 199 0.01 0.01 NUM dpc-4289 126 200 . . PUNCT dpc-4289 127 1 abbreviations abbreviation NOUN dpc-4289 127 2 : : PUNCT dpc-4289 127 3 p.e.e p.e.e VERB dpc-4289 127 4 : : PUNCT dpc-4289 127 5 punctate punctate VERB dpc-4289 127 6 epithelial epithelial ADJ dpc-4289 127 7 erosions erosion NOUN dpc-4289 127 8 ; ; PUNCT dpc-4289 127 9 bcva bcva NOUN dpc-4289 127 10 : : PUNCT dpc-4289 127 11 best good ADJ dpc-4289 127 12 corrected correct VERB dpc-4289 127 13 visual visual ADJ dpc-4289 127 14 acuity acuity NOUN dpc-4289 127 15 , , PUNCT dpc-4289 127 16 sd sd ADP dpc-4289 127 17 : : PUNCT dpc-4289 127 18 standard standard ADJ dpc-4289 127 19 deviation deviation NOUN dpc-4289 127 20 , , PUNCT dpc-4289 127 21 but but CCONJ dpc-4289 127 22 : : PUNCT dpc-4289 127 23 tear tear ADJ dpc-4289 127 24 break break NOUN dpc-4289 127 25 - - PUNCT dpc-4289 127 26 up up ADP dpc-4289 127 27 time time NOUN dpc-4289 127 28 ; ; PUNCT dpc-4289 127 29 iop iop NOUN dpc-4289 127 30 : : PUNCT dpc-4289 127 31 intraocular intraocular ADJ dpc-4289 127 32 pressure pressure NOUN dpc-4289 127 33 ; ; PUNCT dpc-4289 127 34 • • NUM dpc-4289 127 35 : : PUNCT dpc-4289 127 36 independent independent ADJ dpc-4289 127 37 t t NOUN dpc-4289 127 38 - - PUNCT dpc-4289 127 39 test test NOUN dpc-4289 127 40 . . PUNCT dpc-4289 128 1 original original ADJ dpc-4289 128 2 article article NOUN dpc-4289 128 3 | | ADV dpc-4289 128 4 dermatol dermatol ADJ dpc-4289 128 5 pract pract NOUN dpc-4289 128 6 concept concept NOUN dpc-4289 128 7 . . PUNCT dpc-4289 129 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 129 2 7 7 NUM dpc-4289 129 3 table table NOUN dpc-4289 129 4 4 4 NUM dpc-4289 129 5 . . PUNCT dpc-4289 129 6 relation relation NOUN dpc-4289 129 7 between between ADP dpc-4289 129 8 opn opn PROPN dpc-4289 129 9 levels level NOUN dpc-4289 129 10 and and CCONJ dpc-4289 129 11 sex sex NOUN dpc-4289 129 12 , , PUNCT dpc-4289 129 13 disease disease NOUN dpc-4289 129 14 severity severity NOUN dpc-4289 129 15 , , PUNCT dpc-4289 129 16 and and CCONJ dpc-4289 129 17 ocular ocular ADJ dpc-4289 129 18 changes change NOUN dpc-4289 129 19 in in ADP dpc-4289 129 20 psoriatic psoriatic ADJ dpc-4289 129 21 patients patient NOUN dpc-4289 129 22 . . PUNCT dpc-4289 130 1 opn opn PROPN dpc-4289 130 2 test test PROPN dpc-4289 130 3 value value NOUN dpc-4289 130 4 p p NOUN dpc-4289 130 5 - - PUNCT dpc-4289 130 6 value value NOUN dpc-4289 130 7 sig.mean sig.mean NOUN dpc-4289 130 8 ± ± NUM dpc-4289 130 9 sd sd ADP dpc-4289 130 10 range range NOUN dpc-4289 130 11 sex sex NOUN dpc-4289 130 12 females female NOUN dpc-4289 130 13 74.8 74.8 NUM dpc-4289 130 14 ± ± NUM dpc-4289 130 15 33.36 33.36 NUM dpc-4289 130 16 26.5 26.5 NUM dpc-4289 130 17 – – PUNCT dpc-4289 130 18 149.1 149.1 NUM dpc-4289 130 19 0.979• 0.979• NOUN dpc-4289 130 20 0.334 0.334 NUM dpc-4289 130 21 ns ns NUM dpc-4289 130 22 males male NOUN dpc-4289 130 23 87.5 87.5 NUM dpc-4289 130 24 ± ± NUM dpc-4289 130 25 48.75 48.75 NUM dpc-4289 130 26 34.1 34.1 NUM dpc-4289 130 27 – – PUNCT dpc-4289 130 28 182.3 182.3 NUM dpc-4289 130 29 severity severity NOUN dpc-4289 130 30 of of ADP dpc-4289 130 31 disease disease NOUN dpc-4289 130 32 mild mild ADJ dpc-4289 130 33 / / SYM dpc-4289 130 34 moderate moderate ADJ dpc-4289 130 35 58.86 58.86 NUM dpc-4289 130 36 ± ± NUM dpc-4289 130 37 22.29 22.29 NUM dpc-4289 130 38 26.5 26.5 NUM dpc-4289 130 39 – – PUNCT dpc-4289 130 40 99.7 99.7 NUM dpc-4289 130 41 42.737• 42.737• PROPN dpc-4289 130 42 < < X dpc-4289 130 43 0.001 0.001 NUM dpc-4289 130 44 hs hs NOUN dpc-4289 130 45 severe severe ADJ dpc-4289 130 46 129.98 129.98 NUM dpc-4289 130 47 ± ± NUM dpc-4289 130 48 27.29 27.29 NUM dpc-4289 130 49 102 102 NUM dpc-4289 130 50 – – PUNCT dpc-4289 130 51 182.3 182.3 NUM dpc-4289 130 52 posterior posterior ADJ dpc-4289 130 53 blepharitis blepharitis NOUN dpc-4289 131 1 no no PROPN dpc-4289 131 2 90.63 90.63 NUM dpc-4289 131 3 ± ± NUM dpc-4289 131 4 42.83 42.83 NUM dpc-4289 131 5 34.2 34.2 NUM dpc-4289 131 6 – – PUNCT dpc-4289 131 7 149.1 149.1 NUM dpc-4289 131 8 1.134• 1.134• NUM dpc-4289 131 9 0.264 0.264 NUM dpc-4289 131 10 ns ns INTJ dpc-4289 132 1 yes yes INTJ dpc-4289 132 2 75.17 75.17 NUM dpc-4289 132 3 ± ± NUM dpc-4289 132 4 39.21 39.21 NUM dpc-4289 132 5 26.5 26.5 NUM dpc-4289 132 6 – – PUNCT dpc-4289 132 7 182.3 182.3 NUM dpc-4289 132 8 anterior anterior NOUN dpc-4289 132 9 blepharitis blepharitis NOUN dpc-4289 133 1 no no DET dpc-4289 133 2 78.82 78.82 NUM dpc-4289 133 3 ± ± NUM dpc-4289 133 4 42.05 42.05 NUM dpc-4289 133 5 26.5 26.5 NUM dpc-4289 133 6 – – PUNCT dpc-4289 133 7 182.3 182.3 NUM dpc-4289 133 8 -0.223• -0.223• SYM dpc-4289 133 9 0.825 0.825 NUM dpc-4289 133 10 ns ns NUM dpc-4289 134 1 yes yes INTJ dpc-4289 134 2 81.72 81.72 NUM dpc-4289 134 3 ± ± NUM dpc-4289 134 4 39.89 39.89 NUM dpc-4289 134 5 34.1 34.1 NUM dpc-4289 134 6 – – PUNCT dpc-4289 134 7 149.1 149.1 NUM dpc-4289 134 8 corneal corneal ADJ dpc-4289 134 9 affection affection NOUN dpc-4289 134 10 no no DET dpc-4289 134 11 76.69 76.69 NUM dpc-4289 134 12 ± ± NUM dpc-4289 134 13 39.35 39.35 NUM dpc-4289 134 14 26.5 26.5 NUM dpc-4289 134 15 – – PUNCT dpc-4289 134 16 182.3 182.3 NUM dpc-4289 134 17 -0.947• -0.947• SYM dpc-4289 134 18 0.35 0.35 NUM dpc-4289 134 19 ns ns NUM dpc-4289 134 20 p.e.e p.e.e NOUN dpc-4289 134 21 . . PUNCT dpc-4289 135 1 90.72 90.72 NUM dpc-4289 135 2 ± ± NUM dpc-4289 135 3 44.35 44.35 NUM dpc-4289 135 4 34.7 34.7 NUM dpc-4289 135 5 – – PUNCT dpc-4289 135 6 149.1 149.1 NUM dpc-4289 135 7 keratoconjunctivitis keratoconjunctivitis PROPN dpc-4289 135 8 sicca sicca VERB dpc-4289 135 9 no no DET dpc-4289 135 10 77.64 77.64 NUM dpc-4289 135 11 ± ± NUM dpc-4289 135 12 52.07 52.07 NUM dpc-4289 135 13 26.5 26.5 NUM dpc-4289 135 14 – – PUNCT dpc-4289 135 15 148.1 148.1 NUM dpc-4289 135 16 -0.149• -0.149• NUM dpc-4289 135 17 0.882 0.882 NUM dpc-4289 135 18 ns ns NUM dpc-4289 135 19 yes yes NOUN dpc-4289 135 20 80.56 80.56 NUM dpc-4289 135 21 ± ± NUM dpc-4289 135 22 39.56 39.56 NUM dpc-4289 135 23 34.1 34.1 NUM dpc-4289 135 24 – – PUNCT dpc-4289 135 25 182.3 182.3 NUM dpc-4289 135 26 cataract cataract NOUN dpc-4289 135 27 no no DET dpc-4289 135 28 61.97 61.97 NUM dpc-4289 135 29 ± ± NUM dpc-4289 135 30 32.98 32.98 NUM dpc-4289 135 31 26.5 26.5 NUM dpc-4289 135 32 – – PUNCT dpc-4289 135 33 149.1 149.1 NUM dpc-4289 135 34 2.469 2.469 NUM dpc-4289 135 35 0.018 0.018 NUM dpc-4289 135 36 s s VERB dpc-4289 135 37 yes yes INTJ dpc-4289 135 38 92.35 92.35 NUM dpc-4289 135 39 ± ± NOUN dpc-4289 135 40 41.13 41.13 NUM dpc-4289 135 41 34.1 34.1 NUM dpc-4289 135 42 – – PUNCT dpc-4289 135 43 182.3 182.3 NUM dpc-4289 135 44 iop iop NOUN dpc-4289 135 45 normal normal ADJ dpc-4289 135 46 74.99 74.99 NUM dpc-4289 135 47 ± ± NUM dpc-4289 135 48 38.71 38.71 NUM dpc-4289 135 49 26.5 26.5 NUM dpc-4289 135 50 – – PUNCT dpc-4289 135 51 182.3 182.3 NUM dpc-4289 135 52 2.616• 2.616• NUM dpc-4289 135 53 0.013 0.013 NUM dpc-4289 135 54 s s VERB dpc-4289 135 55 high high ADJ dpc-4289 135 56 127.1 127.1 NUM dpc-4289 135 57 ± ± NUM dpc-4289 135 58 24.97 24.97 NUM dpc-4289 135 59 102.4 102.4 NUM dpc-4289 135 60 – – PUNCT dpc-4289 135 61 149.1 149.1 NUM dpc-4289 135 62 schirmer schirmer PROPN dpc-4289 135 63 test test NOUN dpc-4289 135 64 < < X dpc-4289 135 65 15(dryness 15(dryness NUM dpc-4289 135 66 ) ) PUNCT dpc-4289 135 67 165.7 165.7 NUM dpc-4289 135 68 ± ± NUM dpc-4289 135 69 23.48 23.48 NUM dpc-4289 135 70 149.1 149.1 NUM dpc-4289 135 71 – – PUNCT dpc-4289 135 72 182.3 182.3 NUM dpc-4289 135 73 3.466• 3.466• NUM dpc-4289 135 74 0.001 0.001 NUM dpc-4289 135 75 hs hs PROPN dpc-4289 135 76 > > PROPN dpc-4289 135 77 15(normal 15(normal NUM dpc-4289 135 78 ) ) PUNCT dpc-4289 135 79 75.7 75.7 NUM dpc-4289 135 80 ± ± NUM dpc-4289 135 81 36.07 36.07 NUM dpc-4289 135 82 26.5 26.5 NUM dpc-4289 135 83 – – PUNCT dpc-4289 135 84 149.1 149.1 NUM dpc-4289 135 85 tbut tbut ADP dpc-4289 135 86 < < X dpc-4289 135 87 10 10 NUM dpc-4289 135 88 107.98 107.98 NUM dpc-4289 135 89 ± ± NUM dpc-4289 135 90 43.93 43.93 NUM dpc-4289 135 91 26.6 26.6 NUM dpc-4289 135 92 – – PUNCT dpc-4289 135 93 182.3 182.3 NUM dpc-4289 135 94 3.145• 3.145• NUM dpc-4289 135 95 0.003 0.003 NUM dpc-4289 135 96 hs hs PROPN dpc-4289 135 97 > > PROPN dpc-4289 135 98 10 10 NUM dpc-4289 135 99 68.29 68.29 NUM dpc-4289 135 100 ± ± NUM dpc-4289 135 101 33.13 33.13 NUM dpc-4289 135 102 26.5 26.5 NUM dpc-4289 135 103 – – PUNCT dpc-4289 135 104 149.1 149.1 NUM dpc-4289 135 105 abbreviations abbreviation NOUN dpc-4289 135 106 : : PUNCT dpc-4289 135 107 ns ns NUM dpc-4289 135 108 : : PUNCT dpc-4289 135 109 non non ADJ dpc-4289 135 110 - - ADJ dpc-4289 135 111 significant significant ADJ dpc-4289 135 112 ; ; PUNCT dpc-4289 135 113 s s X dpc-4289 135 114 : : PUNCT dpc-4289 135 115 significant significant ADJ dpc-4289 135 116 ; ; PUNCT dpc-4289 135 117 hs hs ADJ dpc-4289 135 118 : : PUNCT dpc-4289 135 119 highly highly ADV dpc-4289 135 120 significant significant ADJ dpc-4289 135 121 ; ; PUNCT dpc-4289 135 122 opn= opn= PROPN dpc-4289 135 123 osteopontin osteopontin NOUN dpc-4289 135 124 ; ; PUNCT dpc-4289 135 125 p.e.e p.e.e NOUN dpc-4289 135 126 : : PUNCT dpc-4289 135 127 punctate punctate VERB dpc-4289 135 128 epithelial epithelial ADJ dpc-4289 135 129 erosions erosion NOUN dpc-4289 135 130 ; ; PUNCT dpc-4289 135 131 bcva bcva NOUN dpc-4289 135 132 : : PUNCT dpc-4289 135 133 best good ADJ dpc-4289 135 134 corrected correct VERB dpc-4289 135 135 visual visual ADJ dpc-4289 135 136 acuity acuity NOUN dpc-4289 135 137 , , PUNCT dpc-4289 135 138 sd sd ADP dpc-4289 135 139 : : PUNCT dpc-4289 135 140 standard standard ADJ dpc-4289 135 141 deviation deviation NOUN dpc-4289 135 142 , , PUNCT dpc-4289 135 143 tbut tbut ADV dpc-4289 135 144 : : PUNCT dpc-4289 135 145 tear tear ADJ dpc-4289 135 146 break break NOUN dpc-4289 135 147 - - PUNCT dpc-4289 135 148 up up ADP dpc-4289 135 149 time time NOUN dpc-4289 135 150 ; ; PUNCT dpc-4289 135 151 iop iop NOUN dpc-4289 135 152 : : PUNCT dpc-4289 135 153 intraocular intraocular ADJ dpc-4289 135 154 pressure pressure NOUN dpc-4289 135 155 . . PUNCT dpc-4289 136 1 • • NUM dpc-4289 136 2 : : PUNCT dpc-4289 136 3 independent independent ADJ dpc-4289 136 4 t t PROPN dpc-4289 136 5 - - PUNCT dpc-4289 136 6 test test NOUN dpc-4289 136 7 ; ; PUNCT dpc-4289 136 8 ≠ ≠ PROPN dpc-4289 136 9 : : PUNCT dpc-4289 136 10 one one NUM dpc-4289 136 11 way way NOUN dpc-4289 136 12 anova anova PROPN dpc-4289 136 13 test test PROPN dpc-4289 136 14 . . PUNCT dpc-4289 137 1 table table NOUN dpc-4289 137 2 5 5 NUM dpc-4289 137 3 . . PUNCT dpc-4289 137 4 correlation correlation NOUN dpc-4289 137 5 of of ADP dpc-4289 137 6 opn opn PROPN dpc-4289 137 7 level level NOUN dpc-4289 137 8 with with ADP dpc-4289 137 9 bcva bcva NOUN dpc-4289 137 10 , , PUNCT dpc-4289 137 11 iop iop PROPN dpc-4289 137 12 , , PUNCT dpc-4289 137 13 schirmer schirmer PROPN dpc-4289 137 14 , , PUNCT dpc-4289 137 15 and and CCONJ dpc-4289 137 16 but but CCONJ dpc-4289 137 17 tests test NOUN dpc-4289 137 18 in in ADP dpc-4289 137 19 patients patient NOUN dpc-4289 137 20 with with ADP dpc-4289 137 21 ps ps PROPN dpc-4289 137 22 . . PROPN dpc-4289 137 23 patient patient PROPN dpc-4289 137 24 group group NOUN dpc-4289 137 25 opn opn PROPN dpc-4289 137 26 r r PROPN dpc-4289 137 27 p p ADJ dpc-4289 137 28 - - PUNCT dpc-4289 137 29 value value NOUN dpc-4289 137 30 bcva bcva NOUN dpc-4289 137 31 -0.521 -0.521 NOUN dpc-4289 137 32 * * X dpc-4289 137 33 * * PUNCT dpc-4289 137 34 0.000 0.000 NUM dpc-4289 137 35 iop iop NOUN dpc-4289 137 36 0.281 0.281 NUM dpc-4289 137 37 * * PUNCT dpc-4289 137 38 0.012 0.012 NUM dpc-4289 137 39 schirmer schirmer PROPN dpc-4289 137 40 test test NOUN dpc-4289 137 41 -0.359 -0.359 PROPN dpc-4289 137 42 * * PUNCT dpc-4289 138 1 * * NOUN dpc-4289 138 2 0.001 0.001 NUM dpc-4289 138 3 but but CCONJ dpc-4289 138 4 -0.737 -0.737 NOUN dpc-4289 138 5 * * NOUN dpc-4289 138 6 * * NOUN dpc-4289 138 7 0.000 0.000 NUM dpc-4289 138 8 abbreviations abbreviation NOUN dpc-4289 138 9 : : PUNCT dpc-4289 138 10 bcva bcva NOUN dpc-4289 138 11 : : PUNCT dpc-4289 138 12 best good ADJ dpc-4289 138 13 corrected correct VERB dpc-4289 138 14 visual visual ADJ dpc-4289 138 15 acuity acuity NOUN dpc-4289 138 16 ; ; PUNCT dpc-4289 138 17 iop iop NOUN dpc-4289 138 18 : : PUNCT dpc-4289 138 19 intraocular intraocular ADJ dpc-4289 138 20 pressure pressure NOUN dpc-4289 138 21 ; ; PUNCT dpc-4289 138 22 but but CCONJ dpc-4289 138 23 : : PUNCT dpc-4289 138 24 tear tear ADJ dpc-4289 138 25 break break NOUN dpc-4289 138 26 - - PUNCT dpc-4289 138 27 up up ADP dpc-4289 138 28 time time NOUN dpc-4289 138 29 . . PUNCT dpc-4289 139 1 in in ADP dpc-4289 139 2 contrast contrast NOUN dpc-4289 139 3 to to ADP dpc-4289 139 4 our our PRON dpc-4289 139 5 study study NOUN dpc-4289 139 6 , , PUNCT dpc-4289 139 7 kılınç kılınç VERB dpc-4289 139 8 et et PROPN dpc-4289 139 9 al al PROPN dpc-4289 139 10 . . PROPN dpc-4289 140 1 ( ( PUNCT dpc-4289 140 2 15 15 NUM dpc-4289 140 3 ) ) PUNCT dpc-4289 140 4 reported report VERB dpc-4289 140 5 no no DET dpc-4289 140 6 significant significant ADJ dpc-4289 140 7 variations variation NOUN dpc-4289 140 8 in in ADP dpc-4289 140 9 opn opn PROPN dpc-4289 140 10 level level NOUN dpc-4289 140 11 between between ADP dpc-4289 140 12 the the DET dpc-4289 140 13 control control NOUN dpc-4289 140 14 and and CCONJ dpc-4289 140 15 ps ps PROPN dpc-4289 140 16 groups group NOUN dpc-4289 140 17 . . PUNCT dpc-4289 141 1 correlations correlation NOUN dpc-4289 141 2 between between ADP dpc-4289 141 3 serum serum PROPN dpc-4289 141 4 opn opn PROPN dpc-4289 141 5 and and CCONJ dpc-4289 141 6 disease disease NOUN dpc-4289 141 7 severity severity NOUN dpc-4289 141 8 and and CCONJ dpc-4289 141 9 demographic demographic ADJ dpc-4289 141 10 factors factor NOUN dpc-4289 141 11 the the DET dpc-4289 141 12 current current ADJ dpc-4289 141 13 study study NOUN dpc-4289 141 14 revealed reveal VERB dpc-4289 141 15 a a DET dpc-4289 141 16 significant significant ADJ dpc-4289 141 17 positive positive ADJ dpc-4289 141 18 correlation correlation NOUN dpc-4289 141 19 between between ADP dpc-4289 141 20 opn opn PROPN dpc-4289 141 21 serum serum PROPN dpc-4289 141 22 levels level NOUN dpc-4289 141 23 and and CCONJ dpc-4289 141 24 pasi pasi NOUN dpc-4289 141 25 score score NOUN dpc-4289 141 26 in in ADP dpc-4289 141 27 patients patient NOUN dpc-4289 141 28 , , PUNCT dpc-4289 141 29 with with ADP dpc-4289 141 30 severe severe ADJ dpc-4289 141 31 cases case NOUN dpc-4289 141 32 exhibiting exhibit VERB dpc-4289 141 33 higher high ADJ dpc-4289 141 34 levels level NOUN dpc-4289 141 35 compared compare VERB dpc-4289 141 36 to to ADP dpc-4289 141 37 mild mild ADJ dpc-4289 141 38 and and CCONJ dpc-4289 141 39 moderate moderate ADJ dpc-4289 141 40 cases case NOUN dpc-4289 141 41 . . PUNCT dpc-4289 142 1 our our PRON dpc-4289 142 2 findings finding NOUN dpc-4289 142 3 are be AUX dpc-4289 142 4 consistent consistent ADJ dpc-4289 142 5 with with ADP dpc-4289 142 6 those those PRON dpc-4289 142 7 of of ADP dpc-4289 142 8 kadry kadry PROPN dpc-4289 142 9 et et PROPN dpc-4289 142 10     SPACE dpc-4289 142 11 al al PROPN dpc-4289 142 12 . . PUNCT dpc-4289 143 1 ( ( PUNCT dpc-4289 143 2 16 16 NUM dpc-4289 143 3 ) ) PUNCT dpc-4289 143 4 , , PUNCT dpc-4289 143 5 who who PRON dpc-4289 143 6 reported report VERB dpc-4289 143 7 a a DET dpc-4289 143 8 favorable favorable ADJ dpc-4289 143 9 relationship relationship NOUN dpc-4289 143 10 between between ADP dpc-4289 143 11 the the DET dpc-4289 143 12 clinical clinical ADJ dpc-4289 143 13 severity severity NOUN dpc-4289 143 14 of of ADP dpc-4289 143 15 ps ps PROPN dpc-4289 143 16 and and CCONJ dpc-4289 143 17 plasma plasma NOUN dpc-4289 143 18 opn opn PROPN dpc-4289 143 19 level level NOUN dpc-4289 143 20 , , PUNCT dpc-4289 143 21 and and CCONJ dpc-4289 143 22 abdel abdel NOUN dpc-4289 143 23 - - PUNCT dpc-4289 143 24 mawla mawla PROPN dpc-4289 143 25 et et PROPN dpc-4289 143 26 al al PROPN dpc-4289 143 27 . . PUNCT dpc-4289 144 1 ( ( PUNCT dpc-4289 144 2 17 17 NUM dpc-4289 144 3 ) ) PUNCT dpc-4289 144 4 , , PUNCT dpc-4289 144 5 who who PRON dpc-4289 144 6 reported report VERB dpc-4289 144 7 a a DET dpc-4289 144 8 significant significant ADJ dpc-4289 144 9 correlation correlation NOUN dpc-4289 144 10 between between ADP dpc-4289 144 11 opn opn PROPN dpc-4289 144 12 expression expression NOUN dpc-4289 144 13 in in ADP dpc-4289 144 14 the the DET dpc-4289 144 15 epidermis epidermis NOUN dpc-4289 144 16 , , PUNCT dpc-4289 144 17 dermal dermal VERB dpc-4289 144 18 inflammatory inflammatory ADJ dpc-4289 144 19 infiltrate infiltrate NOUN dpc-4289 144 20 of of ADP dpc-4289 144 21 lesional lesional ADJ dpc-4289 144 22 psoriatic psoriatic ADJ dpc-4289 144 23 skin skin NOUN dpc-4289 144 24 , , PUNCT dpc-4289 144 25 and and CCONJ dpc-4289 144 26 pasi pasi NOUN dpc-4289 144 27 score score NOUN dpc-4289 144 28 . . PUNCT dpc-4289 145 1 this this PRON dpc-4289 145 2 can can AUX dpc-4289 145 3 be be AUX dpc-4289 145 4 explained explain VERB dpc-4289 145 5 by by ADP dpc-4289 145 6 opn opn PROPN dpc-4289 145 7 ’s ’s PART dpc-4289 145 8 role role NOUN dpc-4289 145 9 in in ADP dpc-4289 145 10 several several ADJ dpc-4289 145 11 th1and th1and NOUN dpc-4289 145 12 th th CCONJ dpc-4289 145 13 17 17 NUM dpc-4289 145 14 - - PUNCT dpc-4289 145 15 mediated mediate VERB dpc-4289 145 16 diseases disease NOUN dpc-4289 145 17 including include VERB dpc-4289 145 18 ps ps PROPN dpc-4289 145 19 , , PUNCT dpc-4289 145 20 via via ADP dpc-4289 145 21 several several ADJ dpc-4289 145 22 mechanisms mechanism NOUN dpc-4289 145 23 that that PRON dpc-4289 145 24 share share VERB dpc-4289 145 25 in in ADP dpc-4289 145 26 ps ps NOUN dpc-4289 145 27 onset onset NOUN dpc-4289 145 28 and and CCONJ dpc-4289 145 29 worsening worsening NOUN dpc-4289 145 30 . . PUNCT dpc-4289 146 1 conversely conversely ADV dpc-4289 146 2 , , PUNCT dpc-4289 146 3 it it PRON dpc-4289 146 4 has have AUX dpc-4289 146 5 been be AUX dpc-4289 146 6 shown show VERB dpc-4289 146 7 that that SCONJ dpc-4289 146 8 there there PRON dpc-4289 146 9 is be VERB dpc-4289 146 10 no no DET dpc-4289 146 11 correlation correlation NOUN dpc-4289 146 12 between between ADP dpc-4289 146 13 the the DET dpc-4289 146 14 existence existence NOUN dpc-4289 146 15 of of ADP dpc-4289 146 16 opn opn PROPN dpc-4289 146 17 and and CCONJ dpc-4289 146 18 psoriatic psoriatic ADJ dpc-4289 146 19 arthritis arthritis NOUN dpc-4289 146 20 and and CCONJ dpc-4289 146 21 pasi pasi NOUN dpc-4289 146 22 score score NOUN dpc-4289 146 23 in in ADP dpc-4289 146 24 psoriatic psoriatic ADJ dpc-4289 146 25 patients patient NOUN dpc-4289 146 26 ( ( PUNCT dpc-4289 146 27 13 13 NUM dpc-4289 146 28 , , PUNCT dpc-4289 146 29 18 18 NUM dpc-4289 146 30 ) ) PUNCT dpc-4289 146 31 . . PUNCT dpc-4289 147 1 furthermore furthermore ADV dpc-4289 147 2 , , PUNCT dpc-4289 147 3 a a DET dpc-4289 147 4 highly highly ADV dpc-4289 147 5 significant significant ADJ dpc-4289 147 6 positive positive ADJ dpc-4289 147 7 correlation correlation NOUN dpc-4289 147 8 was be AUX dpc-4289 147 9 observed observe VERB dpc-4289 147 10 between between ADP dpc-4289 147 11 the the DET dpc-4289 147 12 serum serum NOUN dpc-4289 147 13 level level NOUN dpc-4289 147 14 of of ADP dpc-4289 147 15 opn opn PROPN dpc-4289 147 16 and and CCONJ dpc-4289 147 17 both both DET dpc-4289 147 18 the the DET dpc-4289 147 19 duration duration NOUN dpc-4289 147 20 of of ADP dpc-4289 147 21 the the DET dpc-4289 147 22 disease disease NOUN dpc-4289 147 23 and and CCONJ dpc-4289 147 24 the the DET dpc-4289 147 25 age age NOUN dpc-4289 147 26 of of ADP dpc-4289 147 27 patients patient NOUN dpc-4289 147 28 . . PUNCT dpc-4289 148 1 this this DET dpc-4289 148 2 result result NOUN dpc-4289 148 3 is be AUX dpc-4289 148 4 consistent consistent ADJ dpc-4289 148 5 with with ADP dpc-4289 148 6 the the DET dpc-4289 148 7 findings finding NOUN dpc-4289 148 8 of of ADP dpc-4289 148 9 abdel abdel NOUN dpc-4289 148 10 - - PUNCT dpc-4289 148 11 mawla mawla PROPN dpc-4289 148 12 et et PROPN dpc-4289 148 13 al al PROPN dpc-4289 148 14 . . PUNCT dpc-4289 149 1 ( ( PUNCT dpc-4289 149 2 17 17 NUM dpc-4289 149 3 ) ) PUNCT dpc-4289 149 4 , , PUNCT dpc-4289 149 5 who who PRON dpc-4289 149 6 found find VERB dpc-4289 149 7 a a DET dpc-4289 149 8 significant significant ADJ dpc-4289 149 9 association association NOUN dpc-4289 149 10 between between ADP dpc-4289 149 11 the the DET dpc-4289 149 12 duration duration NOUN dpc-4289 149 13 of of ADP dpc-4289 149 14 the the DET dpc-4289 149 15 disease disease NOUN dpc-4289 149 16 and and CCONJ dpc-4289 149 17 opn opn PROPN dpc-4289 149 18 tissue tissue NOUN dpc-4289 149 19 expression expression NOUN dpc-4289 149 20 . . PUNCT dpc-4289 150 1 in in ADP dpc-4289 150 2 contrast contrast NOUN dpc-4289 150 3 , , PUNCT dpc-4289 150 4 the the DET dpc-4289 150 5 serum serum NOUN dpc-4289 150 6 level level NOUN dpc-4289 150 7 of of ADP dpc-4289 150 8 opn opn PROPN dpc-4289 150 9 is be AUX dpc-4289 150 10 not not PART dpc-4289 150 11 related relate VERB dpc-4289 150 12 to to ADP dpc-4289 150 13 disease disease NOUN dpc-4289 150 14 duration duration NOUN dpc-4289 150 15 ( ( PUNCT dpc-4289 150 16 18 18 NUM dpc-4289 150 17 ) ) PUNCT dpc-4289 150 18 . . PUNCT dpc-4289 151 1 the the DET dpc-4289 151 2 ocular ocular ADJ dpc-4289 151 3 findings finding NOUN dpc-4289 151 4 of of ADP dpc-4289 151 5 both both DET dpc-4289 151 6 studied study VERB dpc-4289 151 7 groups group NOUN dpc-4289 151 8 a a DET dpc-4289 151 9 previous previous ADJ dpc-4289 151 10 study study NOUN dpc-4289 151 11 ( ( PUNCT dpc-4289 151 12 19 19 NUM dpc-4289 151 13 ) ) PUNCT dpc-4289 151 14 reported report VERB dpc-4289 151 15 an an DET dpc-4289 151 16 association association NOUN dpc-4289 151 17 of of ADP dpc-4289 151 18 ocular ocular ADJ dpc-4289 151 19 findings finding NOUN dpc-4289 151 20 with with ADP dpc-4289 151 21 ps ps PROPN dpc-4289 151 22 . . PROPN dpc-4289 152 1 in in ADP dpc-4289 152 2 the the DET dpc-4289 152 3 present present ADJ dpc-4289 152 4 study study NOUN dpc-4289 152 5 , , PUNCT dpc-4289 152 6 patients patient NOUN dpc-4289 152 7 with with ADP dpc-4289 152 8 ps ps PROPN dpc-4289 152 9 showed show VERB dpc-4289 152 10 8 8 NUM dpc-4289 152 11 original original ADJ dpc-4289 152 12 article article NOUN dpc-4289 152 13 | | ADV dpc-4289 152 14 dermatol dermatol ADJ dpc-4289 152 15 pract pract NOUN dpc-4289 152 16 concept concept NOUN dpc-4289 152 17 . . PUNCT dpc-4289 153 1 2024;14(4):e2024226 2024;14(4):e2024226 PRON dpc-4289 153 2 significant significant ADJ dpc-4289 153 3 ocular ocular ADJ dpc-4289 153 4 changes change NOUN dpc-4289 153 5 compared compare VERB dpc-4289 153 6 to to ADP dpc-4289 153 7 controls control NOUN dpc-4289 153 8 . . PUNCT dpc-4289 154 1 ocular ocular ADJ dpc-4289 154 2 affections affection NOUN dpc-4289 154 3 in in ADP dpc-4289 154 4 the the DET dpc-4289 154 5 patient patient NOUN dpc-4289 154 6 group group NOUN dpc-4289 154 7 included include VERB dpc-4289 154 8 anterior anterior ADJ dpc-4289 154 9 blepharitis blepharitis NOUN dpc-4289 154 10 ( ( PUNCT dpc-4289 154 11 47.5 47.5 NUM dpc-4289 154 12 % % NOUN dpc-4289 154 13 ) ) PUNCT dpc-4289 154 14 , , PUNCT dpc-4289 154 15 posterior posterior ADJ dpc-4289 154 16 blepharitis blepharitis NOUN dpc-4289 154 17 ( ( PUNCT dpc-4289 154 18 67.5 67.5 NUM dpc-4289 154 19 % % NOUN dpc-4289 154 20 ) ) PUNCT dpc-4289 154 21 , , PUNCT dpc-4289 154 22 punctate punctate VERB dpc-4289 154 23 epithelial epithelial ADJ dpc-4289 154 24 erosions erosion NOUN dpc-4289 154 25 ( ( PUNCT dpc-4289 154 26 25.0 25.0 NUM dpc-4289 154 27 % % NOUN dpc-4289 154 28 ) ) PUNCT dpc-4289 154 29 , , PUNCT dpc-4289 154 30 conjunctivitis conjunctivitis NOUN dpc-4289 154 31 ( ( PUNCT dpc-4289 154 32 67.5 67.5 NUM dpc-4289 154 33 % % NOUN dpc-4289 154 34 ) ) PUNCT dpc-4289 154 35 , , PUNCT dpc-4289 154 36 keratoconjunctivitis keratoconjunctivitis PROPN dpc-4289 154 37 sicca sicca PROPN dpc-4289 154 38 ( ( PUNCT dpc-4289 154 39 87.5 87.5 NUM dpc-4289 154 40 % % NOUN dpc-4289 154 41 ) ) PUNCT dpc-4289 154 42 , , PUNCT dpc-4289 154 43 and and CCONJ dpc-4289 154 44 cataract cataract NOUN dpc-4289 154 45 ( ( PUNCT dpc-4289 154 46 60.0 60.0 NUM dpc-4289 154 47 % % NOUN dpc-4289 154 48 ) ) PUNCT dpc-4289 154 49 . . PUNCT dpc-4289 155 1 our our PRON dpc-4289 155 2 findings finding NOUN dpc-4289 155 3 are be AUX dpc-4289 155 4 consistent consistent ADJ dpc-4289 155 5 with with ADP dpc-4289 155 6 those those PRON dpc-4289 155 7 reported report VERB dpc-4289 155 8 in in ADP dpc-4289 155 9 previous previous ADJ dpc-4289 155 10 case case NOUN dpc-4289 155 11 - - PUNCT dpc-4289 155 12 control control NOUN dpc-4289 155 13 studies study NOUN dpc-4289 155 14 ( ( PUNCT dpc-4289 155 15 20 20 NUM dpc-4289 155 16 - - SYM dpc-4289 155 17 22 22 NUM dpc-4289 155 18 ) ) PUNCT dpc-4289 155 19 , , PUNCT dpc-4289 155 20 which which PRON dpc-4289 155 21 reported report VERB dpc-4289 155 22 a a DET dpc-4289 155 23 higher high ADJ dpc-4289 155 24 prevalence prevalence NOUN dpc-4289 155 25 of of ADP dpc-4289 155 26 ocular ocular ADJ dpc-4289 155 27 changes change NOUN dpc-4289 155 28 in in ADP dpc-4289 155 29 psoriatic psoriatic ADJ dpc-4289 155 30 patients patient NOUN dpc-4289 155 31 compared compare VERB dpc-4289 155 32 to to ADP dpc-4289 155 33 healthy healthy ADJ dpc-4289 155 34 individuals individual NOUN dpc-4289 155 35 . . PUNCT dpc-4289 156 1 ocular ocular ADJ dpc-4289 156 2 comorbidities comorbiditie NOUN dpc-4289 156 3 in in ADP dpc-4289 156 4 ps ps PROPN dpc-4289 156 5 may may AUX dpc-4289 156 6 be be AUX dpc-4289 156 7 influenced influence VERB dpc-4289 156 8 by by ADP dpc-4289 156 9 various various ADJ dpc-4289 156 10 etiopathogenetic etiopathogenetic ADJ dpc-4289 156 11 mechanisms mechanism NOUN dpc-4289 156 12 , , PUNCT dpc-4289 156 13 including include VERB dpc-4289 156 14 direct direct ADJ dpc-4289 156 15 ocular ocular ADJ dpc-4289 156 16 involvement involvement NOUN dpc-4289 156 17 with with ADP dpc-4289 156 18 psoriatic psoriatic ADJ dpc-4289 156 19 plaques plaque NOUN dpc-4289 156 20 , , PUNCT dpc-4289 156 21 immune immune NOUN dpc-4289 156 22 - - PUNCT dpc-4289 156 23 mediated mediate VERB dpc-4289 156 24 inflammatory inflammatory ADJ dpc-4289 156 25 conditions condition NOUN dpc-4289 156 26 , , PUNCT dpc-4289 156 27 and and CCONJ dpc-4289 156 28 side side NOUN dpc-4289 156 29 effects effect NOUN dpc-4289 156 30 of of ADP dpc-4289 156 31 treatments treatment NOUN dpc-4289 156 32 such such ADJ dpc-4289 156 33 as as ADP dpc-4289 156 34 phototherapy phototherapy NOUN dpc-4289 156 35 , , PUNCT dpc-4289 156 36 methotrexate methotrexate NOUN dpc-4289 156 37 , , PUNCT dpc-4289 156 38 biologics biologic NOUN dpc-4289 156 39 , , PUNCT dpc-4289 156 40 and and CCONJ dpc-4289 156 41 oral oral ADJ dpc-4289 156 42 retinoids retinoid NOUN dpc-4289 156 43 ( ( PUNCT dpc-4289 156 44 21 21 NUM dpc-4289 156 45 , , PUNCT dpc-4289 156 46 23 23 NUM dpc-4289 156 47 ) ) PUNCT dpc-4289 156 48 . . PUNCT dpc-4289 157 1 furthermore furthermore ADV dpc-4289 157 2 , , PUNCT dpc-4289 157 3 due due ADP dpc-4289 157 4 to to ADP dpc-4289 157 5 similar similar ADJ dpc-4289 157 6 immune immune ADJ dpc-4289 157 7 system system NOUN dpc-4289 157 8 dysregulation dysregulation NOUN dpc-4289 157 9 and and CCONJ dpc-4289 157 10 inflammation inflammation NOUN dpc-4289 157 11 , , PUNCT dpc-4289 157 12 psoriasis psoriasis NOUN dpc-4289 157 13 is be AUX dpc-4289 157 14 more more ADV dpc-4289 157 15 likely likely ADV dpc-4289 157 16 associated associate VERB dpc-4289 157 17 with with ADP dpc-4289 157 18 diabetes diabetes NOUN dpc-4289 157 19 and and CCONJ dpc-4289 157 20 hypertension hypertension NOUN dpc-4289 157 21 , , PUNCT dpc-4289 157 22 which which PRON dpc-4289 157 23 may may AUX dpc-4289 157 24 contribute contribute VERB dpc-4289 157 25 to to ADP dpc-4289 157 26 ocular ocular ADJ dpc-4289 157 27 abnormalities abnormality NOUN dpc-4289 157 28 ( ( PUNCT dpc-4289 157 29 24 24 NUM dpc-4289 157 30 ) ) PUNCT dpc-4289 157 31 . . PUNCT dpc-4289 158 1 nevertheless nevertheless ADV dpc-4289 158 2 , , PUNCT dpc-4289 158 3 none none NOUN dpc-4289 158 4 of of ADP dpc-4289 158 5 these these DET dpc-4289 158 6 explanations explanation NOUN dpc-4289 158 7 was be AUX dpc-4289 158 8 included include VERB dpc-4289 158 9 in in ADP dpc-4289 158 10 our our PRON dpc-4289 158 11 analysis analysis NOUN dpc-4289 158 12 . . PUNCT dpc-4289 159 1 keratoconjunctivitis keratoconjunctivitis PROPN dpc-4289 159 2 sicca sicca PROPN dpc-4289 159 3 ( ( PUNCT dpc-4289 159 4 dry dry ADJ dpc-4289 159 5 eye eye NOUN dpc-4289 159 6 syndrome syndrome NOUN dpc-4289 159 7 ) ) PUNCT dpc-4289 159 8 , , PUNCT dpc-4289 159 9 blepharitis blepharitis NOUN dpc-4289 159 10 , , PUNCT dpc-4289 159 11 and and CCONJ dpc-4289 159 12 conjunctivitis conjunctivitis NOUN dpc-4289 159 13 were be AUX dpc-4289 159 14 the the DET dpc-4289 159 15 most most ADV dpc-4289 159 16 common common ADJ dpc-4289 159 17 ocular ocular ADJ dpc-4289 159 18 affections affection NOUN dpc-4289 159 19 in in ADP dpc-4289 159 20 psoriatic psoriatic ADJ dpc-4289 159 21 patients patient NOUN dpc-4289 159 22 in in ADP dpc-4289 159 23 our our PRON dpc-4289 159 24 study study NOUN dpc-4289 159 25 . . PUNCT dpc-4289 160 1 this this PRON dpc-4289 160 2 is be AUX dpc-4289 160 3 in in ADP dpc-4289 160 4 line line NOUN dpc-4289 160 5 with with ADP dpc-4289 160 6 the the DET dpc-4289 160 7 earlier early ADJ dpc-4289 160 8 research research NOUN dpc-4289 160 9 ( ( PUNCT dpc-4289 160 10 20 20 NUM dpc-4289 160 11 ) ) PUNCT dpc-4289 160 12 findings finding NOUN dpc-4289 160 13 , , PUNCT dpc-4289 160 14 where where SCONJ dpc-4289 160 15 the the DET dpc-4289 160 16 most most ADV dpc-4289 160 17 common common ADJ dpc-4289 160 18 ocular ocular ADJ dpc-4289 160 19 abnormalities abnormality NOUN dpc-4289 160 20 in in ADP dpc-4289 160 21 psoriatic psoriatic ADJ dpc-4289 160 22 patients patient NOUN dpc-4289 160 23 were be AUX dpc-4289 160 24 dry dry ADJ dpc-4289 160 25 eye eye NOUN dpc-4289 160 26 and and CCONJ dpc-4289 160 27 blepharitis blepharitis NOUN dpc-4289 160 28 . . PUNCT dpc-4289 161 1 psoriatic psoriatic ADJ dpc-4289 161 2 patients patient NOUN dpc-4289 161 3 experience experience VERB dpc-4289 161 4 dry dry ADJ dpc-4289 161 5 eye eye NOUN dpc-4289 161 6 syndrome syndrome NOUN dpc-4289 161 7 as as ADP dpc-4289 161 8 a a DET dpc-4289 161 9 result result NOUN dpc-4289 161 10 of of ADP dpc-4289 161 11 meibomian meibomian ADJ dpc-4289 161 12 gland gland NOUN dpc-4289 161 13 dysfunction dysfunction NOUN dpc-4289 161 14 . . PUNCT dpc-4289 162 1 the the DET dpc-4289 162 2 glandular glandular ADJ dpc-4289 162 3 ducts duct NOUN dpc-4289 162 4 ’ ' PUNCT dpc-4289 162 5 epithelial epithelial ADJ dpc-4289 162 6 keratinization keratinization NOUN dpc-4289 162 7 is be AUX dpc-4289 162 8 the the DET dpc-4289 162 9 cause cause NOUN dpc-4289 162 10 of of ADP dpc-4289 162 11 the the DET dpc-4289 162 12 malfunction malfunction NOUN dpc-4289 162 13 ( ( PUNCT dpc-4289 162 14 21 21 NUM dpc-4289 162 15 ) ) PUNCT dpc-4289 162 16 . . PUNCT dpc-4289 163 1 the the DET dpc-4289 163 2 tbut tbut NOUN dpc-4289 163 3 and and CCONJ dpc-4289 163 4 schirmer schirmer PROPN dpc-4289 163 5 tests test NOUN dpc-4289 163 6 are be AUX dpc-4289 163 7 two two NUM dpc-4289 163 8 commonly commonly ADV dpc-4289 163 9 used use VERB dpc-4289 163 10 diagnostic diagnostic ADJ dpc-4289 163 11 procedures procedure NOUN dpc-4289 163 12 for for ADP dpc-4289 163 13 dry dry ADJ dpc-4289 163 14 eye eye NOUN dpc-4289 163 15 disease disease NOUN dpc-4289 163 16 ( ( PUNCT dpc-4289 163 17 ded de VERB dpc-4289 163 18 ) ) PUNCT dpc-4289 163 19 . . PUNCT dpc-4289 164 1 in in ADP dpc-4289 164 2 the the DET dpc-4289 164 3 present present ADJ dpc-4289 164 4 study study NOUN dpc-4289 164 5 , , PUNCT dpc-4289 164 6 the the DET dpc-4289 164 7 mean mean ADJ dpc-4289 164 8 values value NOUN dpc-4289 164 9 of of ADP dpc-4289 164 10 both both DET dpc-4289 164 11 tests test NOUN dpc-4289 164 12 in in ADP dpc-4289 164 13 both both DET dpc-4289 164 14 eyes eye NOUN dpc-4289 164 15 were be AUX dpc-4289 164 16 significantly significantly ADV dpc-4289 164 17 lower low ADJ dpc-4289 164 18 than than ADP dpc-4289 164 19 values value NOUN dpc-4289 164 20 in in ADP dpc-4289 164 21 controls control NOUN dpc-4289 164 22 . . PUNCT dpc-4289 165 1 similarly similarly ADV dpc-4289 165 2 , , PUNCT dpc-4289 165 3 previous previous ADJ dpc-4289 165 4 studies study NOUN dpc-4289 165 5 ( ( PUNCT dpc-4289 165 6 20 20 NUM dpc-4289 165 7 , , PUNCT dpc-4289 165 8 22 22 NUM dpc-4289 165 9 ) ) PUNCT dpc-4289 165 10 detected detect VERB dpc-4289 165 11 a a DET dpc-4289 165 12 decrease decrease NOUN dpc-4289 165 13 in in ADP dpc-4289 165 14 the the DET dpc-4289 165 15 mean mean ADJ dpc-4289 165 16 values value NOUN dpc-4289 165 17 of of ADP dpc-4289 165 18 tbut tbut NOUN dpc-4289 165 19 and and CCONJ dpc-4289 165 20 schirmer schirmer PROPN dpc-4289 165 21 tests test NOUN dpc-4289 165 22 in in ADP dpc-4289 165 23 psoriatic psoriatic ADJ dpc-4289 165 24 patients patient NOUN dpc-4289 165 25 , , PUNCT dpc-4289 165 26 denoting denote VERB dpc-4289 165 27 tear tear ADJ dpc-4289 165 28 film film NOUN dpc-4289 165 29 instability instability NOUN dpc-4289 165 30 and and CCONJ dpc-4289 165 31 eye eye NOUN dpc-4289 165 32 dryness dryness NOUN dpc-4289 165 33 . . PUNCT dpc-4289 166 1 the the DET dpc-4289 166 2 meibomian meibomian PROPN dpc-4289 166 3 glands gland NOUN dpc-4289 166 4 provide provide VERB dpc-4289 166 5 a a DET dpc-4289 166 6 lipid lipid NOUN dpc-4289 166 7 component component NOUN dpc-4289 166 8 that that PRON dpc-4289 166 9 is be AUX dpc-4289 166 10 crucial crucial ADJ dpc-4289 166 11 to to ADP dpc-4289 166 12 the the DET dpc-4289 166 13 integrity integrity NOUN dpc-4289 166 14 of of ADP dpc-4289 166 15 the the DET dpc-4289 166 16 tear tear ADJ dpc-4289 166 17 film film NOUN dpc-4289 166 18 . . PUNCT dpc-4289 167 1 ded ded PROPN dpc-4289 167 2 may may AUX dpc-4289 167 3 have have AUX dpc-4289 167 4 occurred occur VERB dpc-4289 167 5 due due ADP dpc-4289 167 6 to to PART dpc-4289 167 7 ps ps VERB dpc-4289 167 8 - - PUNCT dpc-4289 167 9 related relate VERB dpc-4289 167 10 meibomian meibomian ADJ dpc-4289 167 11 gland gland NOUN dpc-4289 167 12 dysfunction dysfunction NOUN dpc-4289 167 13 , , PUNCT dpc-4289 167 14 resulting result VERB dpc-4289 167 15 in in ADP dpc-4289 167 16 tear tear ADJ dpc-4289 167 17 evaporation evaporation NOUN dpc-4289 167 18 , , PUNCT dpc-4289 167 19 or or CCONJ dpc-4289 167 20 due due ADP dpc-4289 167 21 to to PART dpc-4289 167 22 increase increase VERB dpc-4289 167 23 tear tear ADJ dpc-4289 167 24 osmolarity osmolarity NOUN dpc-4289 167 25 from from ADP dpc-4289 167 26 inflammation inflammation NOUN dpc-4289 167 27 in in ADP dpc-4289 167 28 psoriasis psoriasis NOUN dpc-4289 167 29 or or CCONJ dpc-4289 167 30 lacrimal lacrimal ADJ dpc-4289 167 31 duct duct NOUN dpc-4289 167 32 blockage blockage NOUN dpc-4289 167 33 ( ( PUNCT dpc-4289 167 34 20 20 NUM dpc-4289 167 35 ) ) PUNCT dpc-4289 167 36 . . PUNCT dpc-4289 168 1 since since SCONJ dpc-4289 168 2 ps ps PROPN dpc-4289 168 3 is be AUX dpc-4289 168 4 primarily primarily ADV dpc-4289 168 5 an an DET dpc-4289 168 6 epithelial epithelial ADJ dpc-4289 168 7 disease disease NOUN dpc-4289 168 8 , , PUNCT dpc-4289 168 9 one one NUM dpc-4289 168 10 of of ADP dpc-4289 168 11 the the DET dpc-4289 168 12 main main ADJ dpc-4289 168 13 sites site NOUN dpc-4289 168 14 of of ADP dpc-4289 168 15 ocular ocular ADJ dpc-4289 168 16 involvement involvement NOUN dpc-4289 168 17 is be AUX dpc-4289 168 18 the the DET dpc-4289 168 19 eyelids eyelid NOUN dpc-4289 168 20 ( ( PUNCT dpc-4289 168 21 25 25 NUM dpc-4289 168 22 ) ) PUNCT dpc-4289 168 23 . . PUNCT dpc-4289 169 1 we we PRON dpc-4289 169 2 reported report VERB dpc-4289 169 3 anterior anterior ADJ dpc-4289 169 4 and and CCONJ dpc-4289 169 5 posterior posterior ADJ dpc-4289 169 6 blepharitis blepharitis NOUN dpc-4289 169 7 in in ADP dpc-4289 169 8 47.5 47.5 NUM dpc-4289 169 9 % % NOUN dpc-4289 169 10 and and CCONJ dpc-4289 169 11 67.5 67.5 NUM dpc-4289 169 12 % % NOUN dpc-4289 169 13 of of ADP dpc-4289 169 14 psoriatic psoriatic ADJ dpc-4289 169 15 patients patient NOUN dpc-4289 169 16 , , PUNCT dpc-4289 169 17 respectively respectively ADV dpc-4289 169 18 . . PUNCT dpc-4289 170 1 like like ADP dpc-4289 170 2 our our PRON dpc-4289 170 3 results result NOUN dpc-4289 170 4 , , PUNCT dpc-4289 170 5 erbagci erbagci NOUN dpc-4289 170 6 et et NOUN dpc-4289 170 7 al al PROPN dpc-4289 170 8 . . PUNCT dpc-4289 171 1 ( ( PUNCT dpc-4289 171 2 26 26 NUM dpc-4289 171 3 ) ) PUNCT dpc-4289 171 4 showed show VERB dpc-4289 171 5 a a DET dpc-4289 171 6 65 65 NUM dpc-4289 171 7 % % NOUN dpc-4289 171 8 prevalence prevalence NOUN dpc-4289 171 9 of of ADP dpc-4289 171 10 blepharitis blepharitis NOUN dpc-4289 171 11 in in ADP dpc-4289 171 12 ps ps NOUN dpc-4289 171 13 patients patient NOUN dpc-4289 171 14 . . PUNCT dpc-4289 172 1 blepharitis blepharitis NOUN dpc-4289 172 2 is be AUX dpc-4289 172 3 a a DET dpc-4289 172 4 common common ADJ dpc-4289 172 5 prevalent prevalent ADJ dpc-4289 172 6 ocular ocular ADJ dpc-4289 172 7 finding finding NOUN dpc-4289 172 8 in in ADP dpc-4289 172 9 psoriatic psoriatic ADJ dpc-4289 172 10 patients patient NOUN dpc-4289 172 11 ( ( PUNCT dpc-4289 172 12 22 22 NUM dpc-4289 172 13 ) ) PUNCT dpc-4289 172 14 . . PUNCT dpc-4289 173 1 posterior posterior ADJ dpc-4289 173 2 blepharitis blepharitis NOUN dpc-4289 173 3 was be AUX dpc-4289 173 4 reported report VERB dpc-4289 173 5 more more ADV dpc-4289 173 6 frequently frequently ADV dpc-4289 173 7 in in ADP dpc-4289 173 8 our our PRON dpc-4289 173 9 patients patient NOUN dpc-4289 173 10 denoting denote VERB dpc-4289 173 11 meibomian meibomian PROPN dpc-4289 173 12 gland gland NOUN dpc-4289 173 13 dysfunction dysfunction NOUN dpc-4289 173 14 , , PUNCT dpc-4289 173 15 which which PRON dpc-4289 173 16 may may AUX dpc-4289 173 17 be be AUX dpc-4289 173 18 related relate VERB dpc-4289 173 19 to to ADP dpc-4289 173 20 occlusion occlusion NOUN dpc-4289 173 21 of of ADP dpc-4289 173 22 meibomian meibomian ADJ dpc-4289 173 23 duct duct NOUN dpc-4289 173 24 by by ADP dpc-4289 173 25 psoriatic psoriatic ADJ dpc-4289 173 26 scale scale NOUN dpc-4289 173 27     SPACE dpc-4289 173 28 ( ( PUNCT dpc-4289 173 29 25 25 NUM dpc-4289 173 30 ) ) PUNCT dpc-4289 173 31 . . PUNCT dpc-4289 174 1 furthermore furthermore ADV dpc-4289 174 2 , , PUNCT dpc-4289 174 3 a a DET dpc-4289 174 4 prior prior ADJ dpc-4289 174 5 study study NOUN dpc-4289 174 6 has have AUX dpc-4289 174 7 documented document VERB dpc-4289 174 8 a a DET dpc-4289 174 9 variation variation NOUN dpc-4289 174 10 in in ADP dpc-4289 174 11 the the DET dpc-4289 174 12 consistency consistency NOUN dpc-4289 174 13 of of ADP dpc-4289 174 14 secretions secretion NOUN dpc-4289 174 15 from from ADP dpc-4289 174 16 the the DET dpc-4289 174 17 meibomian meibomian ADJ dpc-4289 174 18 gland gland NOUN dpc-4289 174 19 , , PUNCT dpc-4289 174 20 which which PRON dpc-4289 174 21 are be AUX dpc-4289 174 22 thicker thick ADJ dpc-4289 174 23 in in ADP dpc-4289 174 24 nature nature NOUN dpc-4289 174 25 in in ADP dpc-4289 174 26 psoriatic psoriatic ADJ dpc-4289 174 27 patients patient NOUN dpc-4289 174 28 . . PUNCT dpc-4289 175 1 this this DET dpc-4289 175 2 variation variation NOUN dpc-4289 175 3 may may AUX dpc-4289 175 4 lead lead VERB dpc-4289 175 5 to to ADP dpc-4289 175 6 stagnation stagnation NOUN dpc-4289 175 7 and and CCONJ dpc-4289 175 8 to to ADP dpc-4289 175 9 meibomian meibomian ADJ dpc-4289 175 10 gland gland NOUN dpc-4289 175 11 ducts duct NOUN dpc-4289 175 12 blockage blockage NOUN dpc-4289 175 13 ( ( PUNCT dpc-4289 175 14 27 27 NUM dpc-4289 175 15 ) ) PUNCT dpc-4289 175 16 . . PUNCT dpc-4289 176 1 regarding regard VERB dpc-4289 176 2 lens lens NOUN dpc-4289 176 3 abnormalities abnormality NOUN dpc-4289 176 4 reported report VERB dpc-4289 176 5 in in ADP dpc-4289 176 6 our our PRON dpc-4289 176 7 study study NOUN dpc-4289 176 8 , , PUNCT dpc-4289 176 9 60.0 60.0 NUM dpc-4289 176 10 % % NOUN dpc-4289 176 11 of of ADP dpc-4289 176 12 patients patient NOUN dpc-4289 176 13 developed develop VERB dpc-4289 176 14 cataract cataract NOUN dpc-4289 176 15 . . PUNCT dpc-4289 177 1 previous previous ADJ dpc-4289 177 2 research research NOUN dpc-4289 177 3 has have AUX dpc-4289 177 4 shown show VERB dpc-4289 177 5 that that SCONJ dpc-4289 177 6 patients patient NOUN dpc-4289 177 7 with with ADP dpc-4289 177 8 psoriasis psoriasis NOUN dpc-4289 177 9 may may AUX dpc-4289 177 10 develop develop VERB dpc-4289 177 11 cataract cataract NOUN dpc-4289 177 12 ( ( PUNCT dpc-4289 177 13 22 22 NUM dpc-4289 177 14 , , PUNCT dpc-4289 177 15     SPACE dpc-4289 177 16 28 28 NUM dpc-4289 177 17 ) ) PUNCT dpc-4289 177 18 . . PUNCT dpc-4289 178 1 because because SCONJ dpc-4289 178 2 light light NOUN dpc-4289 178 3 with with ADP dpc-4289 178 4 wavelengths wavelength NOUN dpc-4289 178 5 between between ADP dpc-4289 178 6 300 300 NUM dpc-4289 178 7 and and CCONJ dpc-4289 178 8 400 400 NUM dpc-4289 178 9 nm nm NOUN dpc-4289 178 10 is be AUX dpc-4289 178 11 absorbed absorb VERB dpc-4289 178 12 in in ADP dpc-4289 178 13 the the DET dpc-4289 178 14 lens lens NOUN dpc-4289 178 15 and and CCONJ dpc-4289 178 16 may may AUX dpc-4289 178 17 result result VERB dpc-4289 178 18 in in ADP dpc-4289 178 19 photochemical photochemical ADJ dpc-4289 178 20 alterations alteration NOUN dpc-4289 178 21 in in ADP dpc-4289 178 22 the the DET dpc-4289 178 23 lens lens NOUN dpc-4289 178 24 proteins protein NOUN dpc-4289 178 25 , , PUNCT dpc-4289 178 26 ultraviolet ultraviolet ADJ dpc-4289 178 27 radiation radiation NOUN dpc-4289 178 28 may may AUX dpc-4289 178 29 play play VERB dpc-4289 178 30 a a DET dpc-4289 178 31 role role NOUN dpc-4289 178 32 in in ADP dpc-4289 178 33 the the DET dpc-4289 178 34 development development NOUN dpc-4289 178 35 of of ADP dpc-4289 178 36 cataracts cataract NOUN dpc-4289 178 37 . . PUNCT dpc-4289 179 1 ps ps NOUN dpc-4289 179 2 treatment treatment NOUN dpc-4289 179 3 using use VERB dpc-4289 179 4 psoralen psoralen NOUN dpc-4289 179 5 - - PUNCT dpc-4289 179 6 uva uva PROPN dpc-4289 179 7 has have AUX dpc-4289 179 8 been be AUX dpc-4289 179 9 suggested suggest VERB dpc-4289 179 10 to to PART dpc-4289 179 11 cause cause VERB dpc-4289 179 12 anterior anterior ADJ dpc-4289 179 13 cataracts cataract NOUN dpc-4289 179 14 ( ( PUNCT dpc-4289 179 15 28 28 NUM dpc-4289 179 16 ) ) PUNCT dpc-4289 179 17 . . PUNCT dpc-4289 180 1 kilic kilic PROPN dpc-4289 180 2     SPACE dpc-4289 180 3 et et PROPN dpc-4289 180 4 al al PROPN dpc-4289 180 5 . . PROPN dpc-4289 181 1 ( ( PUNCT dpc-4289 181 2 20 20 NUM dpc-4289 181 3 ) ) PUNCT dpc-4289 181 4 reported report VERB dpc-4289 181 5 corneal corneal ADJ dpc-4289 181 6 affections affection NOUN dpc-4289 181 7 including include VERB dpc-4289 181 8 punctate punctate ADJ dpc-4289 181 9 epithelial epithelial ADJ dpc-4289 181 10 erosion erosion NOUN dpc-4289 181 11 , , PUNCT dpc-4289 181 12 corneal corneal ADJ dpc-4289 181 13 opacity opacity NOUN dpc-4289 181 14 , , PUNCT dpc-4289 181 15 and and CCONJ dpc-4289 181 16 vascularization vascularization NOUN dpc-4289 181 17 in in ADP dpc-4289 181 18 16/100 16/100 NUM dpc-4289 181 19 of of ADP dpc-4289 181 20 psoriatic psoriatic ADJ dpc-4289 181 21 patients patient NOUN dpc-4289 181 22 . . PUNCT dpc-4289 182 1 similarly similarly ADV dpc-4289 182 2 , , PUNCT dpc-4289 182 3 we we PRON dpc-4289 182 4 reported report VERB dpc-4289 182 5 punctate punctate NOUN dpc-4289 182 6 epithelial epithelial ADJ dpc-4289 182 7 keratitis keratitis NOUN dpc-4289 182 8 in in ADP dpc-4289 182 9 25.0 25.0 NUM dpc-4289 182 10 % % NOUN dpc-4289 182 11 of of ADP dpc-4289 182 12 patients patient NOUN dpc-4289 182 13 with with ADP dpc-4289 182 14 psoriasis psoriasis NOUN dpc-4289 182 15 . . PUNCT dpc-4289 183 1 after after ADP dpc-4289 183 2 multivariate multivariate NOUN dpc-4289 183 3 correction correction NOUN dpc-4289 183 4 with with ADP dpc-4289 183 5 many many ADJ dpc-4289 183 6 risk risk NOUN dpc-4289 183 7 variables variable NOUN dpc-4289 183 8 , , PUNCT dpc-4289 183 9 psoriasis psoriasis NOUN dpc-4289 183 10 may may AUX dpc-4289 183 11 be be AUX dpc-4289 183 12 a a DET dpc-4289 183 13 distinct distinct ADJ dpc-4289 183 14 risk risk NOUN dpc-4289 183 15 factor factor NOUN dpc-4289 183 16 for for ADP dpc-4289 183 17 keratopathy keratopathy ADJ dpc-4289 183 18 in in ADP dpc-4289 183 19 patients patient NOUN dpc-4289 183 20 without without ADP dpc-4289 183 21 a a DET dpc-4289 183 22 history history NOUN dpc-4289 183 23 of of ADP dpc-4289 183 24 severe severe ADJ dpc-4289 183 25 corneal corneal ADJ dpc-4289 183 26 illness illness NOUN dpc-4289 183 27 . . PUNCT dpc-4289 184 1 furthermore furthermore ADV dpc-4289 184 2 , , PUNCT dpc-4289 184 3 dry dry ADJ dpc-4289 184 4 eye eye NOUN dpc-4289 184 5 disease disease NOUN dpc-4289 184 6 raised raise VERB dpc-4289 184 7 the the DET dpc-4289 184 8 possibility possibility NOUN dpc-4289 184 9 of of ADP dpc-4289 184 10 keratopathy keratopathy ADJ dpc-4289 184 11 in in ADP dpc-4289 184 12 psoriasis psoriasis NOUN dpc-4289 184 13 ( ( PUNCT dpc-4289 184 14 29 29 NUM dpc-4289 184 15 ) ) PUNCT dpc-4289 184 16 . . PUNCT dpc-4289 185 1 hyperemic hyperemic ADJ dpc-4289 185 2 conjunctivitis conjunctivitis NOUN dpc-4289 185 3 was be AUX dpc-4289 185 4 reported report VERB dpc-4289 185 5 in in ADP dpc-4289 185 6 62.5 62.5 NUM dpc-4289 185 7 % % NOUN dpc-4289 185 8 patients patient NOUN dpc-4289 185 9 in in ADP dpc-4289 185 10 the the DET dpc-4289 185 11 present present ADJ dpc-4289 185 12 study study NOUN dpc-4289 185 13 , , PUNCT dpc-4289 185 14 which which PRON dpc-4289 185 15 agrees agree VERB dpc-4289 185 16 with with ADP dpc-4289 185 17 previously previously ADV dpc-4289 185 18 published publish VERB dpc-4289 185 19 articles article NOUN dpc-4289 185 20 , , PUNCT dpc-4289 185 21 which which PRON dpc-4289 185 22 reported report VERB dpc-4289 185 23 a a DET dpc-4289 185 24 high high ADJ dpc-4289 185 25 prevalence prevalence NOUN dpc-4289 185 26 rate rate NOUN dpc-4289 185 27 of of ADP dpc-4289 185 28 conjunctivitis conjunctivitis NOUN dpc-4289 185 29 in in ADP dpc-4289 185 30 psoriasis psoriasis NOUN dpc-4289 185 31 ( ( PUNCT dpc-4289 185 32 64.5 64.5 NUM dpc-4289 185 33 % % NOUN dpc-4289 185 34 ) ) PUNCT dpc-4289 185 35 ( ( PUNCT dpc-4289 185 36 30 30 NUM dpc-4289 185 37 ) ) PUNCT dpc-4289 185 38 . . PUNCT dpc-4289 186 1 in in ADP dpc-4289 186 2 the the DET dpc-4289 186 3 present present ADJ dpc-4289 186 4 study study NOUN dpc-4289 186 5 , , PUNCT dpc-4289 186 6 psoriatic psoriatic ADJ dpc-4289 186 7 patients patient NOUN dpc-4289 186 8 showed show VERB dpc-4289 186 9 significantly significantly ADV dpc-4289 186 10 lower lower ADV dpc-4289 186 11 mean mean ADJ dpc-4289 186 12 bcva bcva NOUN dpc-4289 186 13 in in ADP dpc-4289 186 14 both both DET dpc-4289 186 15 eyes eye NOUN dpc-4289 186 16 than than ADP dpc-4289 186 17 in in ADP dpc-4289 186 18 controls control NOUN dpc-4289 186 19 with with ADP dpc-4289 186 20 mild mild ADJ dpc-4289 186 21 visual visual ADJ dpc-4289 186 22 impairment impairment NOUN dpc-4289 186 23 . . PUNCT dpc-4289 187 1 similar similar ADJ dpc-4289 187 2 to to ADP dpc-4289 187 3 our our PRON dpc-4289 187 4 observation observation NOUN dpc-4289 187 5 , , PUNCT dpc-4289 187 6 minimum minimum ADJ dpc-4289 187 7 impairment impairment NOUN dpc-4289 187 8 of of ADP dpc-4289 187 9 vision vision NOUN dpc-4289 187 10 in in ADP dpc-4289 187 11 psoriatic psoriatic ADJ dpc-4289 187 12 patients patient NOUN dpc-4289 187 13 has have AUX dpc-4289 187 14 been be AUX dpc-4289 187 15 observed observe VERB dpc-4289 187 16 ( ( PUNCT dpc-4289 187 17 31 31 NUM dpc-4289 187 18 ) ) PUNCT dpc-4289 187 19 , , PUNCT dpc-4289 187 20 while while SCONJ dpc-4289 187 21 kharolia kharolia PROPN dpc-4289 187 22 et et PROPN dpc-4289 187 23 al al PROPN dpc-4289 187 24 . . PROPN dpc-4289 188 1 ( ( PUNCT dpc-4289 188 2 19 19 NUM dpc-4289 188 3 ) ) PUNCT dpc-4289 188 4 did do AUX dpc-4289 188 5 not not PART dpc-4289 188 6 find find VERB dpc-4289 188 7 any any DET dpc-4289 188 8 visual visual ADJ dpc-4289 188 9 impairment impairment NOUN dpc-4289 188 10 . . PUNCT dpc-4289 189 1 in in ADP dpc-4289 189 2 the the DET dpc-4289 189 3 current current ADJ dpc-4289 189 4 study study NOUN dpc-4289 189 5 , , PUNCT dpc-4289 189 6 the the DET dpc-4289 189 7 mean mean ADJ dpc-4289 189 8 iop iop NOUN dpc-4289 189 9 in in ADP dpc-4289 189 10 psoriatic psoriatic ADJ dpc-4289 189 11 patients patient NOUN dpc-4289 189 12 did do AUX dpc-4289 189 13 not not PART dpc-4289 189 14 differ differ VERB dpc-4289 189 15 significantly significantly ADV dpc-4289 189 16 from from ADP dpc-4289 189 17 iop iop PROPN dpc-4289 189 18 in in ADP dpc-4289 189 19 controls control NOUN dpc-4289 189 20 and and CCONJ dpc-4289 189 21 was be AUX dpc-4289 189 22 within within ADP dpc-4289 189 23 the the DET dpc-4289 189 24 normal normal ADJ dpc-4289 189 25 range range NOUN dpc-4289 189 26 . . PUNCT dpc-4289 190 1 also also ADV dpc-4289 190 2 , , PUNCT dpc-4289 190 3 we we PRON dpc-4289 190 4 did do AUX dpc-4289 190 5 not not PART dpc-4289 190 6 record record VERB dpc-4289 190 7 any any DET dpc-4289 190 8 uveitis uveitis NOUN dpc-4289 190 9 or or CCONJ dpc-4289 190 10 retinal retinal ADJ dpc-4289 190 11 abnormalities abnormality NOUN dpc-4289 190 12 . . PUNCT dpc-4289 191 1 relationship relationship NOUN dpc-4289 191 2 between between ADP dpc-4289 191 3 opn opn PROPN dpc-4289 191 4 levels level NOUN dpc-4289 191 5 and and CCONJ dpc-4289 191 6 ocular ocular ADJ dpc-4289 191 7 changes change NOUN dpc-4289 191 8 in in ADP dpc-4289 191 9 psoriatic psoriatic ADJ dpc-4289 191 10 patients patient NOUN dpc-4289 191 11 our our PRON dpc-4289 191 12 findings finding NOUN dpc-4289 191 13 revealed reveal VERB dpc-4289 191 14 significantly significantly ADV dpc-4289 191 15 higher high ADJ dpc-4289 191 16 opn opn PROPN dpc-4289 191 17 levels level NOUN dpc-4289 191 18 in in ADP dpc-4289 191 19 cases case NOUN dpc-4289 191 20 with with ADP dpc-4289 191 21 cataract cataract NOUN dpc-4289 191 22 and and CCONJ dpc-4289 191 23 in in ADP dpc-4289 191 24 cases case NOUN dpc-4289 191 25 with with ADP dpc-4289 191 26 high high ADJ dpc-4289 191 27 iop iop NOUN dpc-4289 191 28 than than ADP dpc-4289 191 29 in in ADP dpc-4289 191 30 cases case NOUN dpc-4289 191 31 without without ADP dpc-4289 191 32 these these DET dpc-4289 191 33 findings finding NOUN dpc-4289 191 34 . . PUNCT dpc-4289 192 1 however however ADV dpc-4289 192 2 , , PUNCT dpc-4289 192 3 no no DET dpc-4289 192 4 significant significant ADJ dpc-4289 192 5 relationships relationship NOUN dpc-4289 192 6 were be AUX dpc-4289 192 7 found find VERB dpc-4289 192 8 with with ADP dpc-4289 192 9 other other ADJ dpc-4289 192 10 ocular ocular ADJ dpc-4289 192 11 findings finding NOUN dpc-4289 192 12 . . PUNCT dpc-4289 193 1 opn opn PROPN dpc-4289 193 2 modulates modulate VERB dpc-4289 193 3 corneal corneal ADJ dpc-4289 193 4 healing healing NOUN dpc-4289 193 5 and and CCONJ dpc-4289 193 6 neovascularization neovascularization NOUN dpc-4289 193 7 and and CCONJ dpc-4289 193 8 controls control NOUN dpc-4289 193 9 lens lens NOUN dpc-4289 193 10 epithelial epithelial ADJ dpc-4289 193 11 - - PUNCT dpc-4289 193 12 mesenchymal mesenchymal ADJ dpc-4289 193 13 transition transition NOUN dpc-4289 193 14 in in ADP dpc-4289 193 15 mice mouse NOUN dpc-4289 193 16 . . PUNCT dpc-4289 194 1 it it PRON dpc-4289 194 2 is be AUX dpc-4289 194 3 upregulated upregulate VERB dpc-4289 194 4 in in ADP dpc-4289 194 5 rat rat NOUN dpc-4289 194 6 retinal retinal ADJ dpc-4289 194 7 ganglionic ganglionic ADJ dpc-4289 194 8 cells cell NOUN dpc-4289 194 9 in in ADP dpc-4289 194 10 response response NOUN dpc-4289 194 11 to to ADP dpc-4289 194 12 excitotoxic excitotoxic ADJ dpc-4289 194 13 and and CCONJ dpc-4289 194 14 ischemic ischemic ADJ dpc-4289 194 15 injury injury NOUN dpc-4289 194 16 ( ( PUNCT dpc-4289 194 17 32 32 NUM dpc-4289 194 18 ) ) PUNCT dpc-4289 194 19 . . PUNCT dpc-4289 195 1 it it PRON dpc-4289 195 2 has have AUX dpc-4289 195 3 been be AUX dpc-4289 195 4 reported report VERB dpc-4289 195 5 that that SCONJ dpc-4289 195 6 opn opn PROPN dpc-4289 195 7 is be AUX dpc-4289 195 8 present present ADJ dpc-4289 195 9 in in ADP dpc-4289 195 10 the the DET dpc-4289 195 11 extracellular extracellular ADJ dpc-4289 195 12 matrix matrix NOUN dpc-4289 195 13 in in ADP dpc-4289 195 14 anterior anterior ADJ dpc-4289 195 15 subcapsular subcapsular ADJ dpc-4289 195 16 cataract cataract NOUN dpc-4289 195 17 and and CCONJ dpc-4289 195 18 human human ADJ dpc-4289 195 19 postoperative postoperative ADJ dpc-4289 195 20 capsular capsular ADJ dpc-4289 195 21 opacification opacification NOUN dpc-4289 195 22 ( ( PUNCT dpc-4289 195 23 33 33 NUM dpc-4289 195 24 ) ) PUNCT dpc-4289 195 25 . . PUNCT dpc-4289 196 1 mouse mouse NOUN dpc-4289 196 2 lens lens NOUN dpc-4289 196 3 epithelial epithelial ADJ dpc-4289 196 4 cells cell NOUN dpc-4289 196 5 express express VERB dpc-4289 196 6 opn opn PROPN dpc-4289 196 7 ectopically ectopically ADV dpc-4289 196 8 in in ADP dpc-4289 196 9 response response NOUN dpc-4289 196 10 to to PART dpc-4289 196 11 capsular capsular VERB dpc-4289 196 12 injury injury NOUN dpc-4289 196 13 , , PUNCT dpc-4289 196 14 suggesting suggest VERB dpc-4289 196 15 a a DET dpc-4289 196 16 potential potential ADJ dpc-4289 196 17 role role NOUN dpc-4289 196 18 in in ADP dpc-4289 196 19 maintaining maintain VERB dpc-4289 196 20 healthy healthy ADJ dpc-4289 196 21 trabecular trabecular ADJ dpc-4289 196 22 meshwork meshwork NOUN dpc-4289 196 23 by by ADP dpc-4289 196 24 inhibiting inhibit VERB dpc-4289 196 25 calcification calcification NOUN dpc-4289 196 26 and and CCONJ dpc-4289 196 27 promoting promote VERB dpc-4289 196 28 original original ADJ dpc-4289 196 29 article article NOUN dpc-4289 196 30 | | ADV dpc-4289 196 31 dermatol dermatol ADJ dpc-4289 196 32 pract pract NOUN dpc-4289 196 33 concept concept NOUN dpc-4289 196 34 . . PUNCT dpc-4289 197 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 197 2 9 9 NUM dpc-4289 197 3 5 5 NUM dpc-4289 197 4 . . PUNCT dpc-4289 197 5 orsini orsini PROPN dpc-4289 197 6 c c PROPN dpc-4289 197 7 , , PUNCT dpc-4289 197 8 trovato trovato PROPN dpc-4289 197 9 e e PROPN dpc-4289 197 10 , , PUNCT dpc-4289 197 11 cortonesi cortonesi VERB dpc-4289 197 12 g g PROPN dpc-4289 197 13 , , PUNCT dpc-4289 197 14 et et PROPN dpc-4289 197 15 al al PROPN dpc-4289 197 16 . . PROPN dpc-4289 197 17 line line NOUN dpc-4289 197 18 - - PUNCT dpc-4289 197 19 field field NOUN dpc-4289 197 20 confocal confocal ADJ dpc-4289 197 21 optical optical ADJ dpc-4289 197 22 coherence coherence NOUN dpc-4289 197 23 tomography tomography NOUN dpc-4289 197 24 : : PUNCT dpc-4289 197 25 new new ADJ dpc-4289 197 26 insights insight NOUN dpc-4289 197 27 for for ADP dpc-4289 197 28 psoriasis psoriasis NOUN dpc-4289 197 29 treatment treatment NOUN dpc-4289 197 30 monitoring monitoring NOUN dpc-4289 197 31 . . PUNCT dpc-4289 198 1 j j PROPN dpc-4289 198 2 eur eur PROPN dpc-4289 198 3 acad acad PROPN dpc-4289 198 4 dermatol dermatol NOUN dpc-4289 198 5 venereol venereol NOUN dpc-4289 198 6 . . PUNCT dpc-4289 199 1 2024;38(2):325 2024;38(2):325 PROPN dpc-4289 199 2 - - PUNCT dpc-4289 199 3 31 31 NUM dpc-4289 199 4 . . PUNCT dpc-4289 200 1 doi:10.1111 doi:10.1111 PROPN dpc-4289 200 2 / / SYM dpc-4289 200 3 jdv.19568 jdv.19568 NOUN dpc-4289 200 4 . . PROPN dpc-4289 201 1 6 6 NUM dpc-4289 201 2 . . X dpc-4289 201 3 sanchez sanchez PROPN dpc-4289 201 4 lr lr PROPN dpc-4289 201 5 , , PUNCT dpc-4289 201 6 borriello borriello PROPN dpc-4289 201 7 l l PROPN dpc-4289 201 8 , , PUNCT dpc-4289 201 9 entenberg entenberg PROPN dpc-4289 201 10 d d PROPN dpc-4289 201 11 , , PUNCT dpc-4289 201 12 condeelis condeelis PROPN dpc-4289 201 13 js js PROPN dpc-4289 201 14 , , PUNCT dpc-4289 201 15 oktay oktay PROPN dpc-4289 201 16 mh mh PROPN dpc-4289 201 17 , , PUNCT dpc-4289 201 18 karagiannis karagiannis PROPN dpc-4289 201 19 gs gs PROPN dpc-4289 201 20 . . PUNCT dpc-4289 202 1 the the DET dpc-4289 202 2 emerging emerge VERB dpc-4289 202 3 roles role NOUN dpc-4289 202 4 of of ADP dpc-4289 202 5 macrophages macrophage NOUN dpc-4289 202 6 in in ADP dpc-4289 202 7 cancer cancer NOUN dpc-4289 202 8 metastasis metastasis NOUN dpc-4289 202 9 and and CCONJ dpc-4289 202 10 response response NOUN dpc-4289 202 11 to to ADP dpc-4289 202 12 chemotherapy chemotherapy NOUN dpc-4289 202 13 . . PUNCT dpc-4289 203 1 j j PROPN dpc-4289 203 2 leukoc leukoc VERB dpc-4289 203 3 biol biol PROPN dpc-4289 203 4 . . PUNCT dpc-4289 204 1 2019 2019 NUM dpc-4289 204 2 ; ; PUNCT dpc-4289 204 3 106(2):259 106(2):259 NUM dpc-4289 204 4 - - SYM dpc-4289 204 5 74 74 NUM dpc-4289 204 6 . . PUNCT dpc-4289 205 1 doi:10.1002 doi:10.1002 NOUN dpc-4289 205 2 / / SYM dpc-4289 205 3 jlb.mr0218 jlb.mr0218 PROPN dpc-4289 205 4 - - PUNCT dpc-4289 205 5 056rr 056rr ADJ dpc-4289 205 6 . . PUNCT dpc-4289 206 1 7 7 X dpc-4289 206 2 . . X dpc-4289 206 3 bartosińska bartosińska PROPN dpc-4289 206 4 j j PROPN dpc-4289 206 5 , , PUNCT dpc-4289 206 6 przepiórka przepiórka PROPN dpc-4289 206 7 - - PUNCT dpc-4289 206 8 kosińska kosińska PROPN dpc-4289 206 9 j j PROPN dpc-4289 206 10 , , PUNCT dpc-4289 206 11 sarecka sarecka PROPN dpc-4289 206 12 - - PUNCT dpc-4289 206 13 hujar hujar PROPN dpc-4289 206 14 b b NOUN dpc-4289 206 15 , , PUNCT dpc-4289 206 16 et et PROPN dpc-4289 206 17 al al PROPN dpc-4289 206 18 . . PUNCT dpc-4289 207 1 osteopontin osteopontin PROPN dpc-4289 207 2 serum serum NOUN dpc-4289 207 3 concentration concentration NOUN dpc-4289 207 4 and and CCONJ dpc-4289 207 5 metabolic metabolic NOUN dpc-4289 207 6 syndrome syndrome NOUN dpc-4289 207 7 in in ADP dpc-4289 207 8 male male ADJ dpc-4289 207 9 psoriatic psoriatic ADJ dpc-4289 207 10 patients patient NOUN dpc-4289 207 11 . . PUNCT dpc-4289 208 1 j j PROPN dpc-4289 208 2 clin clin PROPN dpc-4289 208 3 med me VERB dpc-4289 208 4 . . PUNCT dpc-4289 209 1 2021;10(4 2021;10(4 NUM dpc-4289 209 2 ) ) PUNCT dpc-4289 209 3 . . PUNCT dpc-4289 210 1 doi:10.3390 doi:10.3390 NOUN dpc-4289 210 2 /jcm10040755 /jcm10040755 PUNCT dpc-4289 210 3 . . PROPN dpc-4289 211 1 8 8 X dpc-4289 211 2 . . PUNCT dpc-4289 212 1 kim kim PROPN dpc-4289 212 2 j j PROPN dpc-4289 212 3 , , PUNCT dpc-4289 212 4 ahn ahn PROPN dpc-4289 212 5 m m PROPN dpc-4289 212 6 , , PUNCT dpc-4289 212 7 choi choi PROPN dpc-4289 212 8 y y PROPN dpc-4289 212 9 , , PUNCT dpc-4289 212 10 et et PROPN dpc-4289 212 11 al al PROPN dpc-4289 212 12 . . PUNCT dpc-4289 213 1 osteopontin osteopontin PROPN dpc-4289 213 2 is be AUX dpc-4289 213 3 a a DET dpc-4289 213 4 biomarker biomarker NOUN dpc-4289 213 5 for for ADP dpc-4289 213 6 early early ADJ dpc-4289 213 7 autoimmune autoimmune ADJ dpc-4289 213 8 uveoretinitis uveoretinitis PROPN dpc-4289 213 9 . . PUNCT dpc-4289 214 1 neural neural PROPN dpc-4289 214 2 regen regen PROPN dpc-4289 214 3 res re NOUN dpc-4289 214 4 . . PUNCT dpc-4289 215 1 2022;17(7 2022;17(7 NUM dpc-4289 215 2 ): ): PUNCT dpc-4289 215 3 1604 1604 NUM dpc-4289 215 4 - - SYM dpc-4289 215 5 8 8 NUM dpc-4289 215 6 . . PUNCT dpc-4289 216 1 doi:10.4103/1673 doi:10.4103/1673 PROPN dpc-4289 216 2 - - PUNCT dpc-4289 216 3 5374.330614 5374.330614 NUM dpc-4289 216 4 . . PUNCT dpc-4289 217 1 9 9 NUM dpc-4289 217 2 . . X dpc-4289 217 3 naldi naldi PROPN dpc-4289 217 4 l. l. PROPN dpc-4289 217 5 scoring scoring PROPN dpc-4289 217 6 and and CCONJ dpc-4289 217 7 monitoring monitor VERB dpc-4289 217 8 the the DET dpc-4289 217 9 severity severity NOUN dpc-4289 217 10 of of ADP dpc-4289 217 11 psoriasis psoriasis NOUN dpc-4289 217 12 . . PUNCT dpc-4289 218 1 what what PRON dpc-4289 218 2 is be AUX dpc-4289 218 3 the the DET dpc-4289 218 4 preferred preferred ADJ dpc-4289 218 5 method method NOUN dpc-4289 218 6 ? ? PUNCT dpc-4289 219 1 what what PRON dpc-4289 219 2 is be AUX dpc-4289 219 3 the the DET dpc-4289 219 4 ideal ideal ADJ dpc-4289 219 5 method method NOUN dpc-4289 219 6 ? ? PUNCT dpc-4289 219 7 is be AUX dpc-4289 219 8 pasi pasi ADJ dpc-4289 219 9 passé passé NOUN dpc-4289 219 10 ? ? PUNCT dpc-4289 220 1 facts fact NOUN dpc-4289 220 2 and and CCONJ dpc-4289 220 3 controversies controversy NOUN dpc-4289 220 4 . . PUNCT dpc-4289 221 1 clin clin PROPN dpc-4289 221 2 dermatol dermatol NOUN dpc-4289 221 3 . . PUNCT dpc-4289 222 1 2010;28(1 2010;28(1 NOUN dpc-4289 222 2 ): ): PUNCT dpc-4289 222 3 67 67 NUM dpc-4289 222 4 - - SYM dpc-4289 222 5 72 72 NUM dpc-4289 222 6 . . PUNCT dpc-4289 223 1 doi:10.1016 doi:10.1016 PROPN dpc-4289 223 2 / / SYM dpc-4289 223 3 j.clindermatol.2009.03.001 j.clindermatol.2009.03.001 PROPN dpc-4289 223 4 . . PUNCT dpc-4289 224 1 10 10 NUM dpc-4289 224 2 . . PUNCT dpc-4289 225 1 omar omar PROPN dpc-4289 225 2 ss ss PROPN dpc-4289 225 3 , , PUNCT dpc-4289 225 4 helaly helaly PROPN dpc-4289 225 5 ha ha INTJ dpc-4289 225 6 . . PUNCT dpc-4289 225 7 prevalence prevalence NOUN dpc-4289 225 8 of of ADP dpc-4289 225 9 ocular ocular ADJ dpc-4289 225 10 findings finding NOUN dpc-4289 225 11 in in ADP dpc-4289 225 12 a a DET dpc-4289 225 13 sample sample NOUN dpc-4289 225 14 of of ADP dpc-4289 225 15 egyptian egyptian ADJ dpc-4289 225 16 patients patient NOUN dpc-4289 225 17 with with ADP dpc-4289 225 18 psoriasis psoriasis NOUN dpc-4289 225 19 . . PUNCT dpc-4289 226 1 indian indian PROPN dpc-4289 226 2 j j PROPN dpc-4289 226 3 dermatol dermatol PROPN dpc-4289 226 4 venereol venereol ADJ dpc-4289 226 5 leprol leprol NOUN dpc-4289 226 6 . . PUNCT dpc-4289 227 1 2018;84(1):34 2018;84(1):34 NUM dpc-4289 227 2 - - SYM dpc-4289 227 3 38 38 NUM dpc-4289 227 4 . . PUNCT dpc-4289 228 1 doi:10.4103 doi:10.4103 ADJ dpc-4289 228 2 / / SYM dpc-4289 228 3 ijdvl.ijdvl_1239_15 ijdvl.ijdvl_1239_15 NOUN dpc-4289 228 4 . . NOUN dpc-4289 228 5 11 11 NUM dpc-4289 228 6 . . PUNCT dpc-4289 229 1 przepiórka przepiórka PROPN dpc-4289 229 2 - - PUNCT dpc-4289 229 3 kosińska kosińska PROPN dpc-4289 229 4 jm jm PROPN dpc-4289 229 5 , , PUNCT dpc-4289 229 6 bartosińska bartosińska PROPN dpc-4289 229 7 j j PROPN dpc-4289 229 8 , , PUNCT dpc-4289 229 9 raczkiewicz raczkiewicz VERB dpc-4289 229 10 d d PROPN dpc-4289 229 11 , , PUNCT dpc-4289 229 12 et et PROPN dpc-4289 229 13 al al PROPN dpc-4289 229 14 . . PROPN dpc-4289 230 1 serum serum PROPN dpc-4289 230 2 concentration concentration NOUN dpc-4289 230 3 of of ADP dpc-4289 230 4 osteopontin osteopontin NOUN dpc-4289 230 5 and and CCONJ dpc-4289 230 6 interleukin interleukin NOUN dpc-4289 230 7 17 17 NUM dpc-4289 230 8 in in ADP dpc-4289 230 9 psoriatic psoriatic ADJ dpc-4289 230 10 patients patient NOUN dpc-4289 230 11 . . PUNCT dpc-4289 231 1 adv adv PROPN dpc-4289 231 2 clin clin PROPN dpc-4289 231 3 exp exp NOUN dpc-4289 231 4 med med PROPN dpc-4289 231 5 . . PUNCT dpc-4289 232 1 2020;29(2):203 2020;29(2):203 NUM dpc-4289 232 2 - - SYM dpc-4289 232 3 8 8 NUM dpc-4289 232 4 . . PUNCT dpc-4289 232 5 doi:10.17219 doi:10.17219 PROPN dpc-4289 232 6 / / SYM dpc-4289 232 7 acem/112604 acem/112604 PROPN dpc-4289 232 8 . . PUNCT dpc-4289 233 1 12 12 NUM dpc-4289 233 2 . . PUNCT dpc-4289 233 3 abdou abdou PROPN dpc-4289 233 4 ag ag PROPN dpc-4289 233 5 , , PUNCT dpc-4289 233 6 el el PROPN dpc-4289 233 7 farargy farargy PROPN dpc-4289 233 8 s s PROPN dpc-4289 233 9 , , PUNCT dpc-4289 233 10 seleit seleit PROPN dpc-4289 233 11 i i PROPN dpc-4289 233 12 , , PUNCT dpc-4289 233 13 antar antar PROPN dpc-4289 233 14 ag ag PROPN dpc-4289 233 15 , , PUNCT dpc-4289 233 16 elhefny elhefny PROPN dpc-4289 233 17 m m PROPN dpc-4289 233 18 , , PUNCT dpc-4289 233 19 elnaidany elnaidany NOUN dpc-4289 233 20 nf nf NOUN dpc-4289 233 21 . . PUNCT dpc-4289 234 1 osteopontin osteopontin ADJ dpc-4289 234 2 expression expression NOUN dpc-4289 234 3 in in ADP dpc-4289 234 4 chronic chronic ADJ dpc-4289 234 5 plaque plaque NOUN dpc-4289 234 6 psoriasis psoriasis NOUN dpc-4289 234 7 : : PUNCT dpc-4289 234 8 an an DET dpc-4289 234 9 association association NOUN dpc-4289 234 10 with with ADP dpc-4289 234 11 the the DET dpc-4289 234 12 severity severity NOUN dpc-4289 234 13 of of ADP dpc-4289 234 14 disease disease NOUN dpc-4289 234 15 . . PUNCT dpc-4289 235 1 anal anal ADJ dpc-4289 235 2 quant quant ADJ dpc-4289 235 3 cytol cytol NOUN dpc-4289 235 4 histol histol NOUN dpc-4289 235 5 . . PUNCT dpc-4289 236 1 2012;34(2):79 2012;34(2):79 X dpc-4289 236 2 - - SYM dpc-4289 236 3 85 85 NUM dpc-4289 236 4 . . NOUN dpc-4289 236 5 13 13 NUM dpc-4289 236 6 . . PUNCT dpc-4289 236 7 buommino buommino PROPN dpc-4289 236 8 e e PROPN dpc-4289 236 9 , , PUNCT dpc-4289 236 10 tufano tufano ADJ dpc-4289 236 11 ma ma PROPN dpc-4289 236 12 , , PUNCT dpc-4289 236 13 balato balato PROPN dpc-4289 236 14 n n CCONJ dpc-4289 236 15 , , PUNCT dpc-4289 236 16 et et PROPN dpc-4289 236 17 al al PROPN dpc-4289 236 18 . . PUNCT dpc-4289 237 1 osteopontin osteopontin PROPN dpc-4289 237 2 : : PUNCT dpc-4289 237 3 a a DET dpc-4289 237 4 new new ADJ dpc-4289 237 5 emerging emerge VERB dpc-4289 237 6 role role NOUN dpc-4289 237 7 in in ADP dpc-4289 237 8 psoriasis psoriasis NOUN dpc-4289 237 9 . . PUNCT dpc-4289 238 1 arch arch ADJ dpc-4289 238 2 dermatol dermatol NOUN dpc-4289 238 3 res re NOUN dpc-4289 238 4 . . PUNCT dpc-4289 239 1 2009;301(6 2009;301(6 NUM dpc-4289 239 2 ): ): PUNCT dpc-4289 239 3 397 397 NUM dpc-4289 239 4 - - SYM dpc-4289 239 5 404 404 NUM dpc-4289 239 6 . . PUNCT dpc-4289 240 1 doi:10.1007 doi:10.1007 VERB dpc-4289 240 2 / / SYM dpc-4289 240 3 s00403 s00403 PROPN dpc-4289 240 4 - - PUNCT dpc-4289 240 5 009 009 NUM dpc-4289 240 6 - - PUNCT dpc-4289 240 7 0939 0939 NUM dpc-4289 240 8 - - SYM dpc-4289 240 9 5 5 NUM dpc-4289 240 10 . . NOUN dpc-4289 240 11 14 14 NUM dpc-4289 240 12 . . PUNCT dpc-4289 241 1 kahles kahle NOUN dpc-4289 241 2 f f PROPN dpc-4289 241 3 , , PUNCT dpc-4289 241 4 findeisen findeisen PROPN dpc-4289 241 5 hm hm INTJ dpc-4289 241 6 , , PUNCT dpc-4289 241 7 bruemmer bruemmer VERB dpc-4289 241 8 d. d. PROPN dpc-4289 241 9 osteopontin osteopontin PROPN dpc-4289 241 10 : : PUNCT dpc-4289 241 11 a a DET dpc-4289 241 12 novel novel ADJ dpc-4289 241 13 regulator regulator NOUN dpc-4289 241 14 at at ADP dpc-4289 241 15 the the DET dpc-4289 241 16 cross cross ADJ dpc-4289 241 17 roads road NOUN dpc-4289 241 18 of of ADP dpc-4289 241 19 inflammation inflammation NOUN dpc-4289 241 20 , , PUNCT dpc-4289 241 21 obesity obesity NOUN dpc-4289 241 22 and and CCONJ dpc-4289 241 23 diabetes diabetes NOUN dpc-4289 241 24 . . PUNCT dpc-4289 242 1 mol mol ADP dpc-4289 242 2 metab metab PROPN dpc-4289 242 3 . . PUNCT dpc-4289 243 1 2014;3(4):384 2014;3(4):384 X dpc-4289 243 2 - - SYM dpc-4289 243 3 93 93 NUM dpc-4289 243 4 . . PUNCT dpc-4289 244 1 doi:10.1016 doi:10.1016 PROPN dpc-4289 244 2 / / PUNCT dpc-4289 244 3 j.molmet j.molmet VERB dpc-4289 244 4 .2014.03.004 .2014.03.004 NOUN dpc-4289 244 5 . . PUNCT dpc-4289 245 1 15 15 NUM dpc-4289 245 2 . . X dpc-4289 245 3 kılınç kılınç PROPN dpc-4289 245 4 c c PROPN dpc-4289 245 5 , , PUNCT dpc-4289 245 6 korkmaz korkmaz PROPN dpc-4289 245 7 s s PROPN dpc-4289 245 8 , , PUNCT dpc-4289 245 9 özgün özgün VERB dpc-4289 245 10 g g NOUN dpc-4289 245 11 , , PUNCT dpc-4289 245 12 fiçicioğlu fiçicioğlu NOUN dpc-4289 245 13 s s SYM dpc-4289 245 14 , , PUNCT dpc-4289 245 15 pişkin pişkin PROPN dpc-4289 245 16 s. s. PROPN dpc-4289 245 17 serum serum VERB dpc-4289 245 18 osteopontin osteopontin PROPN dpc-4289 245 19 levels level NOUN dpc-4289 245 20 in in ADP dpc-4289 245 21 patients patient NOUN dpc-4289 245 22 with with ADP dpc-4289 245 23 psoriasis psoriasis NOUN dpc-4289 245 24 vulgaris vulgaris NOUN dpc-4289 245 25 and and CCONJ dpc-4289 245 26 its its PRON dpc-4289 245 27 relation relation NOUN dpc-4289 245 28 with with ADP dpc-4289 245 29 oxidative oxidative ADJ dpc-4289 245 30 stress stress NOUN dpc-4289 245 31 . . PUNCT dpc-4289 246 1 türkderm türkderm NOUN dpc-4289 246 2 türk türk PROPN dpc-4289 246 3 deri deri PROPN dpc-4289 246 4 hastalıkları hastalıkları PROPN dpc-4289 246 5 ve ve AUX dpc-4289 246 6 frengi frengi PROPN dpc-4289 246 7 arşivi arşivi NOUN dpc-4289 246 8 . . PUNCT dpc-4289 247 1 2023;57(2):61 2023;57(2):61 NUM dpc-4289 247 2 - - SYM dpc-4289 247 3 5 5 NUM dpc-4289 247 4 . . NOUN dpc-4289 247 5 16 16 NUM dpc-4289 247 6 . . PUNCT dpc-4289 248 1 kadry kadry PROPN dpc-4289 248 2 d d PROPN dpc-4289 248 3 , , PUNCT dpc-4289 248 4 hegazy hegazy PROPN dpc-4289 248 5 ra ra PROPN dpc-4289 248 6 , , PUNCT dpc-4289 248 7 rashed rashe VERB dpc-4289 248 8 l. l. PROPN dpc-4289 248 9 osteopontin osteopontin PROPN dpc-4289 248 10 and and CCONJ dpc-4289 248 11 adiponectin adiponectin NOUN dpc-4289 248 12 : : PUNCT dpc-4289 248 13 how how SCONJ dpc-4289 248 14 far far ADV dpc-4289 248 15 are be AUX dpc-4289 248 16 they they PRON dpc-4289 248 17 related relate VERB dpc-4289 248 18 in in ADP dpc-4289 248 19 the the DET dpc-4289 248 20 complexity complexity NOUN dpc-4289 248 21 of of ADP dpc-4289 248 22 psoriasis psoriasis NOUN dpc-4289 248 23 ? ? PUNCT dpc-4289 249 1 arch arch ADJ dpc-4289 249 2 dermatol dermatol NOUN dpc-4289 249 3 res re NOUN dpc-4289 249 4 . . PUNCT dpc-4289 250 1 2013;305(10):939 2013;305(10):939 NUM dpc-4289 250 2 - - SYM dpc-4289 250 3 44 44 NUM dpc-4289 250 4 . . PUNCT dpc-4289 251 1 doi:10.1007 doi:10.1007 VERB dpc-4289 251 2 / / SYM dpc-4289 251 3 s00403 s00403 NOUN dpc-4289 251 4 - - PUNCT dpc-4289 251 5 013 013 NUM dpc-4289 251 6 -1392 -1392 PROPN dpc-4289 251 7 - - PUNCT dpc-4289 251 8 z. z. PROPN dpc-4289 251 9 17 17 NUM dpc-4289 251 10 . . PUNCT dpc-4289 252 1 abdel abdel PROPN dpc-4289 252 2 - - PUNCT dpc-4289 252 3 mawla mawla PROPN dpc-4289 252 4 my my PRON dpc-4289 252 5 , , PUNCT dpc-4289 252 6 el el PROPN dpc-4289 252 7 - - PUNCT dpc-4289 252 8 kasheshy kasheshy PROPN dpc-4289 252 9 ka ka PROPN dpc-4289 252 10 , , PUNCT dpc-4289 252 11 ghonemy ghonemy PROPN dpc-4289 252 12 s s PROPN dpc-4289 252 13 , , PUNCT dpc-4289 252 14 al al PROPN dpc-4289 252 15 balat balat PROPN dpc-4289 252 16 w w PROPN dpc-4289 252 17 , , PUNCT dpc-4289 252 18 elsayed elsaye VERB dpc-4289 252 19 aa aa NOUN dpc-4289 252 20 . . PUNCT dpc-4289 253 1 role role NOUN dpc-4289 253 2 of of ADP dpc-4289 253 3 osteopontin osteopontin NOUN dpc-4289 253 4 in in ADP dpc-4289 253 5 psoriasis psoriasis NOUN dpc-4289 253 6 : : PUNCT dpc-4289 253 7 an an DET dpc-4289 253 8 immunohistochemical immunohistochemical ADJ dpc-4289 253 9 study study NOUN dpc-4289 253 10 . . PUNCT dpc-4289 254 1 indian indian PROPN dpc-4289 254 2 j j PROPN dpc-4289 254 3 dermatol dermatol NOUN dpc-4289 254 4 . . PUNCT dpc-4289 255 1 2016;61(3):301 2016;61(3):301 NUM dpc-4289 255 2 - - SYM dpc-4289 255 3 7 7 NUM dpc-4289 255 4 . . PUNCT dpc-4289 256 1 doi:10.4103/0019 doi:10.4103/0019 PROPN dpc-4289 256 2 - - PUNCT dpc-4289 256 3 5154.182434 5154.182434 NUM dpc-4289 256 4 . . PROPN dpc-4289 257 1 18 18 NUM dpc-4289 257 2 . . PUNCT dpc-4289 258 1 chen chen PROPN dpc-4289 258 2 yj yj PROPN dpc-4289 258 3 , , PUNCT dpc-4289 258 4 shen shen PROPN dpc-4289 258 5 jl jl PROPN dpc-4289 258 6 , , PUNCT dpc-4289 258 7 wu wu PROPN dpc-4289 258 8 cy cy PROPN dpc-4289 258 9 , , PUNCT dpc-4289 258 10 chang chang PROPN dpc-4289 258 11 yt yt PROPN dpc-4289 258 12 , , PUNCT dpc-4289 258 13 chen chen PROPN dpc-4289 258 14 cm cm PROPN dpc-4289 258 15 , , PUNCT dpc-4289 258 16 lee lee PROPN dpc-4289 258 17 fy fy PROPN dpc-4289 258 18 . . PROPN dpc-4289 258 19 elevated elevate VERB dpc-4289 258 20 plasma plasma NOUN dpc-4289 258 21 osteopontin osteopontin NOUN dpc-4289 258 22 level level NOUN dpc-4289 258 23 is be AUX dpc-4289 258 24 associated associate VERB dpc-4289 258 25 with with ADP dpc-4289 258 26 occurrence occurrence NOUN dpc-4289 258 27 of of ADP dpc-4289 258 28 psoriasis psoriasis NOUN dpc-4289 258 29 and and CCONJ dpc-4289 258 30 is be AUX dpc-4289 258 31 an an DET dpc-4289 258 32 unfavorable unfavorable ADJ dpc-4289 258 33 cardiovascular cardiovascular ADJ dpc-4289 258 34 risk risk NOUN dpc-4289 258 35 factor factor NOUN dpc-4289 258 36 in in ADP dpc-4289 258 37 patients patient NOUN dpc-4289 258 38 with with ADP dpc-4289 258 39 psoriasis psoriasis NOUN dpc-4289 258 40 . . PUNCT dpc-4289 259 1 j j PROPN dpc-4289 259 2 am be AUX dpc-4289 259 3 acad acad ADJ dpc-4289 259 4 dermatol dermatol NOUN dpc-4289 259 5 . . PUNCT dpc-4289 260 1 2009;60(2):225 2009;60(2):225 NUM dpc-4289 260 2 - - SYM dpc-4289 260 3 30 30 NUM dpc-4289 260 4 . . PUNCT dpc-4289 260 5 doi:10.1016 doi:10.1016 PROPN dpc-4289 260 6 / / SYM dpc-4289 260 7 j.jaad.2008.09.046 j.jaad.2008.09.046 PROPN dpc-4289 260 8 . . PUNCT dpc-4289 261 1 19 19 NUM dpc-4289 261 2 . . PUNCT dpc-4289 261 3 kharolia kharolia PROPN dpc-4289 261 4 a a PROPN dpc-4289 261 5 , , PUNCT dpc-4289 261 6 parija parija NOUN dpc-4289 261 7 s s PROPN dpc-4289 261 8 , , PUNCT dpc-4289 261 9 moharana moharana PROPN dpc-4289 261 10 b b PROPN dpc-4289 261 11 , , PUNCT dpc-4289 261 12 sirka sirka NOUN dpc-4289 261 13 cs cs PROPN dpc-4289 261 14 , , PUNCT dpc-4289 261 15 sahu sahu PROPN dpc-4289 261 16 sk sk PROPN dpc-4289 261 17 . . PROPN dpc-4289 261 18 ocular ocular ADJ dpc-4289 261 19 manifestations manifestation NOUN dpc-4289 261 20 in in ADP dpc-4289 261 21 moderate moderate ADJ dpc-4289 261 22 - - PUNCT dpc-4289 261 23 to to ADP dpc-4289 261 24 - - PUNCT dpc-4289 261 25 severe severe ADJ dpc-4289 261 26 psoriasis psoriasis NOUN dpc-4289 261 27 in in ADP dpc-4289 261 28 india india PROPN dpc-4289 261 29 : : PUNCT dpc-4289 261 30 a a DET dpc-4289 261 31 prospective prospective ADJ dpc-4289 261 32 observational observational ADJ dpc-4289 261 33 study study NOUN dpc-4289 261 34 . . PUNCT dpc-4289 262 1 indian indian PROPN dpc-4289 262 2 j j PROPN dpc-4289 262 3 ophthalmol ophthalmol PROPN dpc-4289 262 4 . . PUNCT dpc-4289 263 1 2022;70(9):3328 2022;70(9):3328 NUM dpc-4289 263 2 - - SYM dpc-4289 263 3 32 32 NUM dpc-4289 263 4 . . PUNCT dpc-4289 264 1 doi:10.4103 doi:10.4103 ADJ dpc-4289 264 2 / / SYM dpc-4289 264 3 ijo.ijo_551_22 ijo.ijo_551_22 NOUN dpc-4289 264 4 . . PUNCT dpc-4289 265 1 20 20 NUM dpc-4289 265 2 . . PUNCT dpc-4289 266 1 kilic kilic PROPN dpc-4289 266 2 b b PROPN dpc-4289 266 3 , , PUNCT dpc-4289 266 4 dogan dogan PROPN dpc-4289 266 5 u u PROPN dpc-4289 266 6 , , PUNCT dpc-4289 266 7 parlak parlak NOUN dpc-4289 266 8 ah ah INTJ dpc-4289 266 9 , , PUNCT dpc-4289 266 10 et et PROPN dpc-4289 266 11 al al PROPN dpc-4289 266 12 . . PROPN dpc-4289 266 13 ocular ocular ADJ dpc-4289 266 14 findings finding NOUN dpc-4289 266 15 in in ADP dpc-4289 266 16 patients patient NOUN dpc-4289 266 17 with with ADP dpc-4289 266 18 psoriasis psoriasis NOUN dpc-4289 266 19 . . PUNCT dpc-4289 267 1 int int NOUN dpc-4289 267 2 j j PROPN dpc-4289 267 3 dermatol dermatol NOUN dpc-4289 267 4 . . PUNCT dpc-4289 268 1 2013;52(5):554 2013;52(5):554 NUM dpc-4289 268 2 - - SYM dpc-4289 268 3 9 9 NUM dpc-4289 268 4 . . PUNCT dpc-4289 269 1 doi:10.1111 doi:10.1111 NOUN dpc-4289 269 2 /j.1365 /j.1365 NOUN dpc-4289 269 3 - - PUNCT dpc-4289 269 4 4632.2011.05424.x 4632.2011.05424.x NUM dpc-4289 269 5 . . PUNCT dpc-4289 270 1 a a DET dpc-4289 270 2 healthy healthy ADJ dpc-4289 270 3 meshwork meshwork NOUN dpc-4289 270 4 . . PUNCT dpc-4289 271 1 ( ( PUNCT dpc-4289 271 2 34 34 NUM dpc-4289 271 3 ) ) PUNCT dpc-4289 271 4 . . PUNCT dpc-4289 272 1 in in ADP dpc-4289 272 2 addition addition NOUN dpc-4289 272 3 , , PUNCT dpc-4289 272 4 opn opn PROPN dpc-4289 272 5 has have AUX dpc-4289 272 6 been be AUX dpc-4289 272 7 identified identify VERB dpc-4289 272 8 as as ADP dpc-4289 272 9 one one NUM dpc-4289 272 10 of of ADP dpc-4289 272 11 the the DET dpc-4289 272 12 most most ADV dpc-4289 272 13 abundant abundant ADJ dpc-4289 272 14 proteins protein NOUN dpc-4289 272 15 in in ADP dpc-4289 272 16 human human ADJ dpc-4289 272 17 aqueous aqueous ADJ dpc-4289 272 18 humor humor NOUN dpc-4289 272 19 ( ( PUNCT dpc-4289 272 20 35 35 NUM dpc-4289 272 21 ) ) PUNCT dpc-4289 272 22 . . PUNCT dpc-4289 273 1 correlation correlation NOUN dpc-4289 273 2 between between ADP dpc-4289 273 3 opn opn PROPN dpc-4289 273 4 levels level NOUN dpc-4289 273 5 and and CCONJ dpc-4289 273 6 ocular ocular ADJ dpc-4289 273 7 surface surface NOUN dpc-4289 273 8 tests test NOUN dpc-4289 273 9 and and CCONJ dpc-4289 273 10 iop iop NOUN dpc-4289 273 11 in in ADP dpc-4289 273 12 psoriatic psoriatic ADJ dpc-4289 273 13 patients patient NOUN dpc-4289 273 14 our our PRON dpc-4289 273 15 results result NOUN dpc-4289 273 16 showed show VERB dpc-4289 273 17 significantly significantly ADV dpc-4289 273 18 higher high ADJ dpc-4289 273 19 opn opn PROPN dpc-4289 273 20 levels level NOUN dpc-4289 273 21 , , PUNCT dpc-4289 273 22 which which PRON dpc-4289 273 23 were be AUX dpc-4289 273 24 associated associate VERB dpc-4289 273 25 with with ADP dpc-4289 273 26 lower low ADJ dpc-4289 273 27 values value NOUN dpc-4289 273 28 of of ADP dpc-4289 273 29 both both CCONJ dpc-4289 273 30 the the DET dpc-4289 273 31 schirmer schirmer PROPN dpc-4289 273 32 and and CCONJ dpc-4289 273 33 tbut tbut ADV dpc-4289 273 34 tests test NOUN dpc-4289 273 35 . . PUNCT dpc-4289 274 1 in in ADP dpc-4289 274 2 addition addition NOUN dpc-4289 274 3 to to ADP dpc-4289 274 4 a a DET dpc-4289 274 5 significant significant ADJ dpc-4289 274 6 negative negative ADJ dpc-4289 274 7 correlation correlation NOUN dpc-4289 274 8 between between ADP dpc-4289 274 9 serum serum PROPN dpc-4289 274 10 opn opn PROPN dpc-4289 274 11 levels level NOUN dpc-4289 274 12 and and CCONJ dpc-4289 274 13 bcva bcva NOUN dpc-4289 274 14 , , PUNCT dpc-4289 274 15 schirmer schirmer PROPN dpc-4289 274 16 , , PUNCT dpc-4289 274 17 and and CCONJ dpc-4289 274 18 but but CCONJ dpc-4289 274 19 tests test NOUN dpc-4289 274 20 . . PUNCT dpc-4289 275 1 while while SCONJ dpc-4289 275 2 significant significant ADJ dpc-4289 275 3 positive positive ADJ dpc-4289 275 4 correlation correlation NOUN dpc-4289 275 5 was be AUX dpc-4289 275 6 present present ADJ dpc-4289 275 7 between between ADP dpc-4289 275 8 serum serum NOUN dpc-4289 275 9 opn opn PROPN dpc-4289 275 10 level level NOUN dpc-4289 275 11 and and CCONJ dpc-4289 275 12 iop iop PROPN dpc-4289 275 13 . . PUNCT dpc-4289 276 1 this this PRON dpc-4289 276 2 may may AUX dpc-4289 276 3 be be AUX dpc-4289 276 4 attributed attribute VERB dpc-4289 276 5 to to ADP dpc-4289 276 6 the the DET dpc-4289 276 7 crosstalk crosstalk NOUN dpc-4289 276 8 between between ADP dpc-4289 276 9 opn opn PROPN dpc-4289 276 10 and and CCONJ dpc-4289 276 11 oxidative oxidative ADJ dpc-4289 276 12 stress stress NOUN dpc-4289 276 13 involved involve VERB dpc-4289 276 14 in in ADP dpc-4289 276 15 the the DET dpc-4289 276 16 pathogenesis pathogenesis NOUN dpc-4289 276 17 of of ADP dpc-4289 276 18 several several ADJ dpc-4289 276 19 eye eye NOUN dpc-4289 276 20 diseases disease NOUN dpc-4289 276 21 , , PUNCT dpc-4289 276 22 including include VERB dpc-4289 276 23 senile senile ADJ dpc-4289 276 24 cataract cataract NOUN dpc-4289 276 25 , , PUNCT dpc-4289 276 26 uveitis uveitis NOUN dpc-4289 276 27 , , PUNCT dpc-4289 276 28 age age NOUN dpc-4289 276 29 - - PUNCT dpc-4289 276 30 related relate VERB dpc-4289 276 31 macular macular ADJ dpc-4289 276 32 degeneration degeneration NOUN dpc-4289 276 33 , , PUNCT dpc-4289 276 34 keratitis keratitis NOUN dpc-4289 276 35 , , PUNCT dpc-4289 276 36 ocular ocular ADJ dpc-4289 276 37 inflammation inflammation NOUN dpc-4289 276 38 , , PUNCT dpc-4289 276 39 and and CCONJ dpc-4289 276 40 premature premature ADJ dpc-4289 276 41 retinopathy retinopathy ADJ dpc-4289 276 42 ( ( PUNCT dpc-4289 276 43 36 36 NUM dpc-4289 276 44 ) ) PUNCT dpc-4289 276 45 . . PUNCT dpc-4289 277 1 the the DET dpc-4289 277 2 study study NOUN dpc-4289 277 3 ’s ’s PART dpc-4289 277 4 main main ADJ dpc-4289 277 5 limitations limitation NOUN dpc-4289 277 6 include include VERB dpc-4289 277 7 a a DET dpc-4289 277 8 small small ADJ dpc-4289 277 9 sample sample NOUN dpc-4289 277 10 size size NOUN dpc-4289 277 11 and and CCONJ dpc-4289 277 12 the the DET dpc-4289 277 13 inability inability NOUN dpc-4289 277 14 to to PART dpc-4289 277 15 detect detect VERB dpc-4289 277 16 tissue tissue NOUN dpc-4289 277 17 osteopontin osteopontin ADJ dpc-4289 277 18 expression expression NOUN dpc-4289 277 19 , , PUNCT dpc-4289 277 20 crucial crucial ADJ dpc-4289 277 21 for for ADP dpc-4289 277 22 assessing assess VERB dpc-4289 277 23 disease disease NOUN dpc-4289 277 24 progression progression NOUN dpc-4289 277 25 , , PUNCT dpc-4289 277 26 especially especially ADV dpc-4289 277 27 ocular ocular ADJ dpc-4289 277 28 abnormalities abnormality NOUN dpc-4289 277 29 . . PUNCT dpc-4289 278 1 we we PRON dpc-4289 278 2 would would AUX dpc-4289 278 3 like like VERB dpc-4289 278 4     SPACE dpc-4289 278 5 to to PART dpc-4289 278 6 highlight highlight VERB dpc-4289 278 7 that that SCONJ dpc-4289 278 8 psoriatic psoriatic ADJ dpc-4289 278 9 patients patient NOUN dpc-4289 278 10 have have AUX dpc-4289 278 11 elevated elevate VERB dpc-4289 278 12 osteopontin osteopontin ADJ dpc-4289 278 13 levels level NOUN dpc-4289 278 14 , , PUNCT dpc-4289 278 15 correlated correlate VERB dpc-4289 278 16 with with ADP dpc-4289 278 17 pasi pasi NOUN dpc-4289 278 18 score score NOUN dpc-4289 278 19 , , PUNCT dpc-4289 278 20 suggesting suggest VERB dpc-4289 278 21 that that SCONJ dpc-4289 278 22 this this PRON dpc-4289 278 23 indicates indicate VERB dpc-4289 278 24 ps ps NOUN dpc-4289 278 25 severity severity NOUN dpc-4289 278 26 and and CCONJ dpc-4289 278 27 pathophysiology pathophysiology NOUN dpc-4289 278 28 . . PUNCT dpc-4289 279 1 the the DET dpc-4289 279 2 study study NOUN dpc-4289 279 3 suggests suggest VERB dpc-4289 279 4 that that SCONJ dpc-4289 279 5 osteopontin osteopontin NOUN dpc-4289 279 6 may may AUX dpc-4289 279 7 contribute contribute VERB dpc-4289 279 8 to to ADP dpc-4289 279 9 ocular ocular ADJ dpc-4289 279 10 alterations alteration NOUN dpc-4289 279 11 in in ADP dpc-4289 279 12 psoriasis psoriasis NOUN dpc-4289 279 13 . . PUNCT dpc-4289 280 1 ocular ocular ADJ dpc-4289 280 2 comorbidities comorbiditie NOUN dpc-4289 280 3 are be AUX dpc-4289 280 4 common common ADJ dpc-4289 280 5 in in ADP dpc-4289 280 6 psoriatic psoriatic ADJ dpc-4289 280 7 patients patient NOUN dpc-4289 280 8 , , PUNCT dpc-4289 280 9 and and CCONJ dpc-4289 280 10 close close ADJ dpc-4289 280 11 follow follow NOUN dpc-4289 280 12 - - PUNCT dpc-4289 280 13 up up NOUN dpc-4289 280 14 is be AUX dpc-4289 280 15 recommended recommend VERB dpc-4289 280 16 for for ADP dpc-4289 280 17 early early ADJ dpc-4289 280 18 - - PUNCT dpc-4289 280 19 onset onset NOUN dpc-4289 280 20 cataracts cataract NOUN dpc-4289 280 21 and and CCONJ dpc-4289 280 22 high high ADJ dpc-4289 280 23 iop iop PROPN dpc-4289 280 24 . . PUNCT dpc-4289 281 1 larger large ADJ dpc-4289 281 2 - - PUNCT dpc-4289 281 3 scale scale NOUN dpc-4289 281 4 studies study NOUN dpc-4289 281 5 are be AUX dpc-4289 281 6 needed need VERB dpc-4289 281 7 to to PART dpc-4289 281 8 understand understand VERB dpc-4289 281 9 the the DET dpc-4289 281 10 impact impact NOUN dpc-4289 281 11 of of ADP dpc-4289 281 12 osteopontin osteopontin NOUN dpc-4289 281 13 on on ADP dpc-4289 281 14 the the DET dpc-4289 281 15 eyes eye NOUN dpc-4289 281 16 of of ADP dpc-4289 281 17 psoriatic psoriatic ADJ dpc-4289 281 18 patients patient NOUN dpc-4289 281 19 . . PUNCT dpc-4289 282 1 ethical ethical ADJ dpc-4289 282 2 approval approval NOUN dpc-4289 282 3 : : PUNCT dpc-4289 282 4 the the DET dpc-4289 282 5 study study NOUN dpc-4289 282 6 approved approve VERB dpc-4289 282 7 by by ADP dpc-4289 282 8 the the DET dpc-4289 282 9 research research NOUN dpc-4289 282 10 ethics ethic NOUN dpc-4289 282 11 committee committee PROPN dpc-4289 282 12 of of ADP dpc-4289 282 13 the the DET dpc-4289 282 14 faculty faculty NOUN dpc-4289 282 15 of of ADP dpc-4289 282 16 medicine medicine NOUN dpc-4289 282 17 , , PUNCT dpc-4289 282 18 al al PROPN dpc-4289 282 19 - - PUNCT dpc-4289 282 20 azhar azhar PROPN dpc-4289 282 21 university university PROPN dpc-4289 282 22 ( ( PUNCT dpc-4289 282 23 reference reference NOUN dpc-4289 282 24 number number NOUN dpc-4289 282 25 rhdirb rhdirb VERB dpc-4289 282 26 2022121668 2022121668 NUM dpc-4289 282 27 ) ) PUNCT dpc-4289 282 28 . . PUNCT dpc-4289 283 1 additionally additionally ADV dpc-4289 283 2 , , PUNCT dpc-4289 283 3 it it PRON dpc-4289 283 4 fulfilled fulfil VERB dpc-4289 283 5 all all DET dpc-4289 283 6 the the DET dpc-4289 283 7 ethical ethical ADJ dpc-4289 283 8 aspects aspect NOUN dpc-4289 283 9 necessary necessary ADJ dpc-4289 283 10 in in ADP dpc-4289 283 11 human human ADJ dpc-4289 283 12 research research NOUN dpc-4289 283 13 . . PUNCT dpc-4289 284 1 patient patient ADJ dpc-4289 284 2 consent consent NOUN dpc-4289 284 3 for for ADP dpc-4289 284 4 publication publication NOUN dpc-4289 284 5 : : PUNCT dpc-4289 284 6 prior prior ADV dpc-4289 284 7 to to ADP dpc-4289 284 8 their their PRON dpc-4289 284 9 involvement involvement NOUN dpc-4289 284 10 in in ADP dpc-4289 284 11 the the DET dpc-4289 284 12 study study NOUN dpc-4289 284 13 , , PUNCT dpc-4289 284 14 the the DET dpc-4289 284 15 subjects subject NOUN dpc-4289 284 16 provided provide VERB dpc-4289 284 17 written write VERB dpc-4289 284 18 , , PUNCT dpc-4289 284 19 informed informed ADJ dpc-4289 284 20 consent consent NOUN dpc-4289 284 21 . . PUNCT dpc-4289 285 1 references reference NOUN dpc-4289 285 2 1 1 NUM dpc-4289 285 3 . . X dpc-4289 286 1 abd abd NOUN dpc-4289 286 2 - - PUNCT dpc-4289 286 3 elazim elazim PROPN dpc-4289 286 4 sm sm PROPN dpc-4289 286 5 , , PUNCT dpc-4289 286 6 el el PROPN dpc-4289 286 7 - - NOUN dpc-4289 286 8 rifaie rifaie NOUN dpc-4289 286 9 a a NOUN dpc-4289 286 10 - - PUNCT dpc-4289 286 11 e e NOUN dpc-4289 286 12 , , PUNCT dpc-4289 286 13 rashed rashe VERB dpc-4289 286 14 la la PROPN dpc-4289 286 15 , , PUNCT dpc-4289 286 16 kamel kamel PROPN dpc-4289 286 17 ha ha PROPN dpc-4289 286 18 - - PROPN dpc-4289 286 19 e. e. PROPN dpc-4289 286 20 detection detection NOUN dpc-4289 286 21 of of ADP dpc-4289 286 22 cyclophilin cyclophilin PROPN dpc-4289 286 23 d d PROPN dpc-4289 286 24 in in ADP dpc-4289 286 25 psoriasis psoriasis NOUN dpc-4289 286 26 and and CCONJ dpc-4289 286 27 its its PRON dpc-4289 286 28 correlation correlation NOUN dpc-4289 286 29 with with ADP dpc-4289 286 30 disease disease NOUN dpc-4289 286 31 severity severity NOUN dpc-4289 286 32 egy egy PROPN dpc-4289 286 33 j j PROPN dpc-4289 286 34 med med PROPN dpc-4289 286 35 res re NOUN dpc-4289 286 36 . . PUNCT dpc-4289 287 1 2022;3(1):291 2022;3(1):291 NUM dpc-4289 287 2 - - SYM dpc-4289 287 3 302 302 NUM dpc-4289 287 4 . . PUNCT dpc-4289 288 1 doi:10.21608 doi:10.21608 NOUN dpc-4289 288 2 / / SYM dpc-4289 288 3 ejmr.2022.222586 ejmr.2022.222586 NOUN dpc-4289 288 4 . . PUNCT dpc-4289 289 1 2 2 X dpc-4289 289 2 . . X dpc-4289 289 3 daugaard daugaard PROPN dpc-4289 289 4 c c PROPN dpc-4289 289 5 , , PUNCT dpc-4289 289 6 iversen iversen PROPN dpc-4289 289 7 l l PROPN dpc-4289 289 8 , , PUNCT dpc-4289 289 9 hjuler hjuler PROPN dpc-4289 289 10 kf kf PROPN dpc-4289 289 11 . . PUNCT dpc-4289 289 12 comorbidity comorbidity NOUN dpc-4289 289 13 in in ADP dpc-4289 289 14 adult adult NOUN dpc-4289 289 15 psoriasis psoriasis NOUN dpc-4289 289 16 : : PUNCT dpc-4289 289 17 considerations consideration NOUN dpc-4289 289 18 for for ADP dpc-4289 289 19 the the DET dpc-4289 289 20 clinician clinician NOUN dpc-4289 289 21 . . PUNCT dpc-4289 290 1 psoriasis psoriasis NOUN dpc-4289 290 2 ( ( PUNCT dpc-4289 290 3 auckl auckl NOUN dpc-4289 290 4 ) ) PUNCT dpc-4289 290 5 . . PUNCT dpc-4289 291 1 2022 2022 NUM dpc-4289 291 2 ; ; PUNCT dpc-4289 291 3 12:139 12:139 NUM dpc-4289 291 4 - - SYM dpc-4289 291 5 50 50 NUM dpc-4289 291 6 . . PUNCT dpc-4289 292 1 doi:10.2147 doi:10.2147 NOUN dpc-4289 292 2 / / SYM dpc-4289 292 3 ptt.s328572 ptt.s328572 NOUN dpc-4289 292 4 . . PUNCT dpc-4289 293 1 3 3 X dpc-4289 293 2 . . X dpc-4289 293 3 kolli kolli PROPN dpc-4289 293 4 sr sr PROPN dpc-4289 293 5 , , PUNCT dpc-4289 293 6 boda boda PROPN dpc-4289 293 7 n n PRON dpc-4289 293 8 , , PUNCT dpc-4289 293 9 reddy reddy PROPN dpc-4289 293 10 ea ea PROPN dpc-4289 293 11 . . PUNCT dpc-4289 294 1 ocular ocular ADJ dpc-4289 294 2 manifestations manifestation NOUN dpc-4289 294 3 in in ADP dpc-4289 294 4 psoriasis psoriasis NOUN dpc-4289 294 5 . . PUNCT dpc-4289 295 1 nation nation NOUN dpc-4289 295 2 j j PROPN dpc-4289 295 3 med med PROPN dpc-4289 295 4 dent dent PROPN dpc-4289 295 5 res re NOUN dpc-4289 295 6 2016;4:101 2016;4:101 NUM dpc-4289 295 7 - - SYM dpc-4289 295 8 4 4 NUM dpc-4289 295 9 . . NOUN dpc-4289 295 10 4 4 NUM dpc-4289 295 11 . . PUNCT dpc-4289 296 1 mashal mashal PROPN dpc-4289 296 2 zr zr PROPN dpc-4289 296 3 , , PUNCT dpc-4289 296 4 elgamal elgamal PROPN dpc-4289 296 5 eea eea PROPN dpc-4289 296 6 , , PUNCT dpc-4289 296 7 zaky zaky PROPN dpc-4289 296 8 ms ms PROPN dpc-4289 296 9 , , PUNCT dpc-4289 296 10 elsaie elsaie PROPN dpc-4289 296 11 ml ml PROPN dpc-4289 296 12 . . PUNCT dpc-4289 296 13 dermoscopic dermoscopic PROPN dpc-4289 296 14 features feature NOUN dpc-4289 296 15 of of ADP dpc-4289 296 16 psoriatic psoriatic ADJ dpc-4289 296 17 nails nail NOUN dpc-4289 296 18 and and CCONJ dpc-4289 296 19 their their PRON dpc-4289 296 20 correlation correlation NOUN dpc-4289 296 21 to to ADP dpc-4289 296 22 disease disease NOUN dpc-4289 296 23 severity severity NOUN dpc-4289 296 24 . . PUNCT dpc-4289 297 1 dermatol dermatol NOUN dpc-4289 297 2 res re NOUN dpc-4289 297 3 pract pract NOUN dpc-4289 297 4 . . PUNCT dpc-4289 298 1 2023;2023:4653177 2023;2023:4653177 NUM dpc-4289 298 2 . . PUNCT dpc-4289 298 3 doi:10.1155 doi:10.1155 PROPN dpc-4289 298 4 /2023/4653177 /2023/4653177 PUNCT dpc-4289 298 5 . . PUNCT dpc-4289 299 1 10 10 NUM dpc-4289 299 2 original original ADJ dpc-4289 299 3 article article NOUN dpc-4289 299 4 | | ADV dpc-4289 299 5 dermatol dermatol ADJ dpc-4289 299 6 pract pract NOUN dpc-4289 299 7 concept concept NOUN dpc-4289 299 8 . . PUNCT dpc-4289 300 1 2024;14(4):e2024226 2024;14(4):e2024226 NUM dpc-4289 300 2 2022 2022 NUM dpc-4289 300 3 sep;70(9):3332 sep;70(9):3332 NOUN dpc-4289 300 4 - - PUNCT dpc-4289 300 5 3334 3334 NUM dpc-4289 300 6 . . PUNCT dpc-4289 301 1 doi doi NOUN dpc-4289 301 2 : : PUNCT dpc-4289 301 3 10.4103 10.4103 NUM dpc-4289 301 4 / / SYM dpc-4289 301 5 ijo.ijo_1547_22 ijo.ijo_1547_22 PROPN dpc-4289 301 6 . . PUNCT dpc-4289 302 1 pmid pmid NOUN dpc-4289 302 2 : : PUNCT dpc-4289 302 3 36018115 36018115 NUM dpc-4289 302 4 ; ; PUNCT dpc-4289 302 5 pmcid pmcid PROPN dpc-4289 302 6 : : PUNCT dpc-4289 302 7 pmc9675510 pmc9675510 ADJ dpc-4289 302 8 . . PUNCT dpc-4289 303 1 29 29 NUM dpc-4289 303 2 . . PUNCT dpc-4289 304 1 lee lee PROPN dpc-4289 304 2 cy cy PROPN dpc-4289 304 3 , , PUNCT dpc-4289 304 4 chen chen PROPN dpc-4289 304 5 hc hc PROPN dpc-4289 304 6 , , PUNCT dpc-4289 304 7 lin lin PROPN dpc-4289 304 8 hw hw PROPN dpc-4289 304 9 , , PUNCT dpc-4289 304 10 et et PROPN dpc-4289 304 11 al al PROPN dpc-4289 304 12 . . PROPN dpc-4289 304 13 increased increase VERB dpc-4289 304 14 risk risk NOUN dpc-4289 304 15 of of ADP dpc-4289 304 16 keratopathy keratopathy ADJ dpc-4289 304 17 after after ADP dpc-4289 304 18 psoriasis psoriasis NOUN dpc-4289 304 19 : : PUNCT dpc-4289 304 20 a a DET dpc-4289 304 21 nationwide nationwide ADJ dpc-4289 304 22 population population NOUN dpc-4289 304 23 - - PUNCT dpc-4289 304 24 based base VERB dpc-4289 304 25 study study NOUN dpc-4289 304 26 . . PUNCT dpc-4289 305 1 plos plos PROPN dpc-4289 305 2 one one NUM dpc-4289 305 3 . . PUNCT dpc-4289 306 1 2018;13(7):e0201285 2018;13(7):e0201285 NUM dpc-4289 306 2 . . PUNCT dpc-4289 306 3 doi:10.1371 doi:10.1371 PROPN dpc-4289 306 4 / / SYM dpc-4289 307 1 journal.pone.0201285 journal.pone.0201285 PROPN dpc-4289 307 2 . . PROPN dpc-4289 307 3 30 30 NUM dpc-4289 307 4 . . PUNCT dpc-4289 308 1 rajguru rajguru PROPN dpc-4289 308 2 jp jp PROPN dpc-4289 308 3 , , PUNCT dpc-4289 308 4 maya maya PROPN dpc-4289 308 5 d d PROPN dpc-4289 308 6 , , PUNCT dpc-4289 308 7 kumar kumar PROPN dpc-4289 308 8 d d PROPN dpc-4289 308 9 , , PUNCT dpc-4289 308 10 suri suri PROPN dpc-4289 308 11 p p PROPN dpc-4289 308 12 , , PUNCT dpc-4289 308 13 bhardwaj bhardwaj PROPN dpc-4289 308 14 s s PROPN dpc-4289 308 15 , , PUNCT dpc-4289 308 16 patel patel PROPN dpc-4289 308 17 nd nd PROPN dpc-4289 308 18 . . PROPN dpc-4289 308 19 update update NOUN dpc-4289 308 20 on on ADP dpc-4289 308 21 psoriasis psoriasis NOUN dpc-4289 308 22 : : PUNCT dpc-4289 308 23 a a DET dpc-4289 308 24 review review NOUN dpc-4289 308 25 . . PUNCT dpc-4289 309 1 j j PROPN dpc-4289 309 2 family family PROPN dpc-4289 309 3 med me VERB dpc-4289 309 4 prim prim PROPN dpc-4289 309 5 care care NOUN dpc-4289 309 6 . . PUNCT dpc-4289 310 1 2020;9(1):20 2020;9(1):20 NUM dpc-4289 310 2 - - SYM dpc-4289 310 3 4 4 NUM dpc-4289 310 4 . . PUNCT dpc-4289 310 5 doi:10.4103 doi:10.4103 ADJ dpc-4289 310 6 / / SYM dpc-4289 310 7 jfmpc.jfmpc_689_19 jfmpc.jfmpc_689_19 PROPN dpc-4289 310 8 . . PROPN dpc-4289 311 1 31 31 NUM dpc-4289 311 2 . . PUNCT dpc-4289 312 1 aragona aragona PROPN dpc-4289 312 2 e e PROPN dpc-4289 312 3 , , PUNCT dpc-4289 312 4 rania rania PROPN dpc-4289 312 5 l l PROPN dpc-4289 312 6 , , PUNCT dpc-4289 312 7 postorino postorino ADJ dpc-4289 312 8 ei ei PROPN dpc-4289 312 9 , , PUNCT dpc-4289 312 10 et et PROPN dpc-4289 312 11 al al PROPN dpc-4289 312 12 . . PUNCT dpc-4289 312 13 tear tear ADJ dpc-4289 312 14 film film NOUN dpc-4289 312 15 and and CCONJ dpc-4289 312 16 ocular ocular ADJ dpc-4289 312 17 surface surface NOUN dpc-4289 312 18 assessment assessment NOUN dpc-4289 312 19 in in ADP dpc-4289 312 20 psoriasis psoriasis NOUN dpc-4289 312 21 . . PUNCT dpc-4289 313 1 br br PROPN dpc-4289 314 1 j j PROPN dpc-4289 314 2 ophthalmol ophthalmol PROPN dpc-4289 314 3 . . PUNCT dpc-4289 315 1 2018;102(3 2018;102(3 NUM dpc-4289 315 2 ): ): PUNCT dpc-4289 315 3 302 302 NUM dpc-4289 315 4 - - SYM dpc-4289 315 5 8 8 NUM dpc-4289 315 6 . . PUNCT dpc-4289 315 7 doi:10.1136 doi:10.1136 NOUN dpc-4289 315 8 / / SYM dpc-4289 315 9 bjophthalmol-2017 bjophthalmol-2017 NOUN dpc-4289 315 10 - - PUNCT dpc-4289 315 11 310307 310307 NUM dpc-4289 315 12 . . PUNCT dpc-4289 316 1 32 32 NUM dpc-4289 316 2 . . PUNCT dpc-4289 316 3 saika saika PROPN dpc-4289 316 4 s s PROPN dpc-4289 316 5 , , PUNCT dpc-4289 316 6 shirai shirai ADJ dpc-4289 316 7 k k PROPN dpc-4289 316 8 , , PUNCT dpc-4289 316 9 yamanaka yamanaka PROPN dpc-4289 316 10 o o PROPN dpc-4289 316 11 , , PUNCT dpc-4289 316 12 et et PROPN dpc-4289 316 13 al al PROPN dpc-4289 316 14 . . PUNCT dpc-4289 316 15 loss loss NOUN dpc-4289 316 16 of of ADP dpc-4289 316 17 osteopontin osteopontin NOUN dpc-4289 316 18 perturbs perturb VERB dpc-4289 316 19 the the DET dpc-4289 316 20 epithelial epithelial ADJ dpc-4289 316 21 - - PUNCT dpc-4289 316 22 mesenchymal mesenchymal NOUN dpc-4289 316 23 transition transition NOUN dpc-4289 316 24 in in ADP dpc-4289 316 25 an an DET dpc-4289 316 26 injured injure VERB dpc-4289 316 27 mouse mouse NOUN dpc-4289 316 28 lens lens NOUN dpc-4289 316 29 epithelium epithelium NOUN dpc-4289 316 30 . . PUNCT dpc-4289 317 1 lab lab PROPN dpc-4289 317 2 invest invest PROPN dpc-4289 317 3 . . PUNCT dpc-4289 318 1 2007;87(2):130 2007;87(2):130 NUM dpc-4289 318 2 - - SYM dpc-4289 318 3 8 8 NUM dpc-4289 318 4 . . PUNCT dpc-4289 318 5 doi:10.1038 doi:10.1038 NOUN dpc-4289 318 6 /labinvest.3700508 /labinvest.3700508 PUNCT dpc-4289 318 7 . . PUNCT dpc-4289 319 1 33 33 NUM dpc-4289 319 2 . . PUNCT dpc-4289 320 1 saika saika PROPN dpc-4289 320 2 s s PROPN dpc-4289 320 3 , , PUNCT dpc-4289 320 4 miyamoto miyamoto PROPN dpc-4289 320 5 t t PROPN dpc-4289 320 6 , , PUNCT dpc-4289 320 7 ishida ishida PROPN dpc-4289 320 8 i i PROPN dpc-4289 320 9 , , PUNCT dpc-4289 320 10 ohnishi ohnishi PROPN dpc-4289 320 11 y y PROPN dpc-4289 320 12 , , PUNCT dpc-4289 320 13 ooshima ooshima PROPN dpc-4289 320 14 a. a. NOUN dpc-4289 320 15 osteopontin osteopontin PROPN dpc-4289 320 16 : : PUNCT dpc-4289 320 17 a a DET dpc-4289 320 18 component component NOUN dpc-4289 320 19 of of ADP dpc-4289 320 20 matrix matrix NOUN dpc-4289 320 21 in in ADP dpc-4289 320 22 capsular capsular ADJ dpc-4289 320 23 opacification opacification NOUN dpc-4289 320 24 and and CCONJ dpc-4289 320 25 subcapsular subcapsular ADJ dpc-4289 320 26 cataract cataract NOUN dpc-4289 320 27 . . PUNCT dpc-4289 321 1 invest invest VERB dpc-4289 321 2 ophthalmol ophthalmol PROPN dpc-4289 321 3 vis vis X dpc-4289 321 4 sci sci PROPN dpc-4289 321 5 . . PUNCT dpc-4289 322 1 2003;44(4):1622 2003;44(4):1622 NUM dpc-4289 322 2 - - SYM dpc-4289 322 3 8 8 NUM dpc-4289 322 4 . . PUNCT dpc-4289 322 5 doi:10.1167 doi:10.1167 ADJ dpc-4289 322 6 / / SYM dpc-4289 322 7 iovs.02 iovs.02 PROPN dpc-4289 322 8 - - PUNCT dpc-4289 322 9 0873 0873 NUM dpc-4289 322 10 . . PUNCT dpc-4289 323 1 34 34 NUM dpc-4289 323 2 . . PUNCT dpc-4289 324 1 xue xue PROPN dpc-4289 324 2 w w PROPN dpc-4289 324 3 , , PUNCT dpc-4289 324 4 comes come VERB dpc-4289 324 5 n n CCONJ dpc-4289 324 6 , , PUNCT dpc-4289 324 7 borrás borrás ADJ dpc-4289 324 8 t. t. NOUN dpc-4289 324 9 presence presence NOUN dpc-4289 324 10 of of ADP dpc-4289 324 11 an an DET dpc-4289 324 12 established establish VERB dpc-4289 324 13 calcification calcification NOUN dpc-4289 324 14 marker marker NOUN dpc-4289 324 15 in in ADP dpc-4289 324 16 trabecular trabecular ADJ dpc-4289 324 17 meshwork meshwork ADJ dpc-4289 324 18 tissue tissue NOUN dpc-4289 324 19 of of ADP dpc-4289 324 20 glaucoma glaucoma NOUN dpc-4289 324 21 donors donor NOUN dpc-4289 324 22 . . PUNCT dpc-4289 325 1 invest invest VERB dpc-4289 325 2 ophthalmol ophthalmol PROPN dpc-4289 325 3 vis vis X dpc-4289 325 4 sci sci PROPN dpc-4289 325 5 . . PUNCT dpc-4289 326 1 2007;48(7):3184 2007;48(7):3184 NUM dpc-4289 326 2 - - SYM dpc-4289 326 3 94 94 NUM dpc-4289 326 4 . . PUNCT dpc-4289 327 1 doi:10.1167 doi:10.1167 ADJ dpc-4289 327 2 /iovs.06 /iovs.06 NOUN dpc-4289 327 3 - - PUNCT dpc-4289 327 4 1403 1403 NUM dpc-4289 327 5 . . PUNCT dpc-4289 328 1 35 35 NUM dpc-4289 328 2 . . PUNCT dpc-4289 329 1 chowdhury chowdhury PROPN dpc-4289 329 2 ur ur PROPN dpc-4289 329 3 , , PUNCT dpc-4289 329 4 madden madden PROPN dpc-4289 329 5 bj bj PROPN dpc-4289 329 6 , , PUNCT dpc-4289 329 7 charlesworth charlesworth PROPN dpc-4289 329 8 mc mc PROPN dpc-4289 329 9 , , PUNCT dpc-4289 329 10 fautsch fautsch PROPN dpc-4289 329 11 mp mp PROPN dpc-4289 329 12 . . PUNCT dpc-4289 329 13 proteome proteome PROPN dpc-4289 329 14 analysis analysis NOUN dpc-4289 329 15 of of ADP dpc-4289 329 16 human human ADJ dpc-4289 329 17 aqueous aqueous ADJ dpc-4289 329 18 humor humor NOUN dpc-4289 329 19 . . PUNCT dpc-4289 330 1 invest invest VERB dpc-4289 330 2 ophthalmol ophthalmol PROPN dpc-4289 330 3 vis vis X dpc-4289 330 4 sci sci PROPN dpc-4289 330 5 . . PUNCT dpc-4289 331 1 2010;51(10):4921 2010;51(10):4921 NUM dpc-4289 331 2 - - SYM dpc-4289 331 3 31 31 NUM dpc-4289 331 4 . . PUNCT dpc-4289 331 5 doi:10.1167 doi:10.1167 ADJ dpc-4289 331 6 / / SYM dpc-4289 331 7 iovs.10 iovs.10 NOUN dpc-4289 331 8 - - PUNCT dpc-4289 331 9 5531 5531 NUM dpc-4289 331 10 . . PUNCT dpc-4289 332 1 36 36 NUM dpc-4289 332 2 . . PUNCT dpc-4289 333 1 dogru dogru PROPN dpc-4289 333 2 m m PROPN dpc-4289 333 3 , , PUNCT dpc-4289 333 4 kojima kojima PROPN dpc-4289 333 5 t t PROPN dpc-4289 333 6 , , PUNCT dpc-4289 333 7 simsek simsek NOUN dpc-4289 333 8 c c NOUN dpc-4289 333 9 , , PUNCT dpc-4289 333 10 tsubota tsubota PROPN dpc-4289 333 11 k. k. PROPN dpc-4289 333 12 potential potential ADJ dpc-4289 333 13 role role NOUN dpc-4289 333 14 of of ADP dpc-4289 333 15 oxidative oxidative ADJ dpc-4289 333 16 stress stress NOUN dpc-4289 333 17 in in ADP dpc-4289 333 18 ocular ocular ADJ dpc-4289 333 19 surface surface NOUN dpc-4289 333 20 inflammation inflammation NOUN dpc-4289 333 21 and and CCONJ dpc-4289 333 22 dry dry ADJ dpc-4289 333 23 eye eye NOUN dpc-4289 333 24 disease disease NOUN dpc-4289 333 25 . . PUNCT dpc-4289 334 1 invest invest VERB dpc-4289 334 2 ophthalmol ophthalmol PROPN dpc-4289 334 3 vis vis X dpc-4289 334 4 sci sci PROPN dpc-4289 334 5 . . PROPN dpc-4289 334 6 2018;59(14):des163 2018;59(14):des163 PROPN dpc-4289 334 7 - - PROPN dpc-4289 334 8 des8 des8 PROPN dpc-4289 334 9 . . PUNCT dpc-4289 335 1 doi:10.1167 doi:10.1167 PROPN dpc-4289 335 2 / / SYM dpc-4289 335 3 iovs.17 iovs.17 NOUN dpc-4289 335 4 - - PUNCT dpc-4289 335 5 23402 23402 NUM dpc-4289 335 6 . . PUNCT dpc-4289 336 1 21 21 NUM dpc-4289 336 2 . . PUNCT dpc-4289 336 3 cruz cruz PROPN dpc-4289 336 4 n n CCONJ dpc-4289 336 5 , , PUNCT dpc-4289 336 6 brandão brandão PROPN dpc-4289 336 7 ls ls PROPN dpc-4289 336 8 , , PUNCT dpc-4289 336 9 cruz cruz PROPN dpc-4289 336 10 s s PROPN dpc-4289 336 11 , , PUNCT dpc-4289 336 12 cruz cruz PROPN dpc-4289 336 13 s s PROPN dpc-4289 336 14 , , PUNCT dpc-4289 336 15 pires pire NOUN dpc-4289 336 16 caa caa PROPN dpc-4289 336 17 , , PUNCT dpc-4289 336 18 carneiro carneiro PROPN dpc-4289 336 19 fro fro PROPN dpc-4289 336 20 . . PUNCT dpc-4289 337 1 ocular ocular ADJ dpc-4289 337 2 manifestations manifestation NOUN dpc-4289 337 3 of of ADP dpc-4289 337 4 psoriasis psoriasis NOUN dpc-4289 337 5 . . PUNCT dpc-4289 338 1 arq arq VERB dpc-4289 338 2 bras bras NOUN dpc-4289 338 3 oftalmol oftalmol NOUN dpc-4289 338 4 . . PUNCT dpc-4289 339 1 2018;81(3):219 2018;81(3):219 NUM dpc-4289 339 2 - - SYM dpc-4289 339 3 25 25 NUM dpc-4289 339 4 . . PUNCT dpc-4289 340 1 doi:10.5935/0004 doi:10.5935/0004 PROPN dpc-4289 340 2 - - PUNCT dpc-4289 340 3 2749.20180044 2749.20180044 NUM dpc-4289 340 4 . . PUNCT dpc-4289 341 1 22 22 NUM dpc-4289 341 2 . . PUNCT dpc-4289 342 1 ghalamkarpour ghalamkarpour PROPN dpc-4289 342 2 f f NOUN dpc-4289 342 3 , , PUNCT dpc-4289 342 4 baradaran baradaran NOUN dpc-4289 342 5 - - PUNCT dpc-4289 342 6 rafii rafii VERB dpc-4289 342 7 a a PRON dpc-4289 342 8 , , PUNCT dpc-4289 342 9 sadoughi sadoughi PROPN dpc-4289 342 10 mm mm PROPN dpc-4289 342 11 , , PUNCT dpc-4289 342 12 et et PROPN dpc-4289 342 13 al al PROPN dpc-4289 342 14 . . PROPN dpc-4289 343 1 ocular ocular ADJ dpc-4289 343 2 findings finding NOUN dpc-4289 343 3 in in ADP dpc-4289 343 4 patients patient NOUN dpc-4289 343 5 with with ADP dpc-4289 343 6 psoriasis psoriasis NOUN dpc-4289 343 7 : : PUNCT dpc-4289 343 8 is be AUX dpc-4289 343 9 it it PRON dpc-4289 343 10 related related ADJ dpc-4289 343 11 to to ADP dpc-4289 343 12 the the DET dpc-4289 343 13 side side NOUN dpc-4289 343 14 effects effect NOUN dpc-4289 343 15 of of ADP dpc-4289 343 16 treatment treatment NOUN dpc-4289 343 17 or or CCONJ dpc-4289 343 18 to to PART dpc-4289 343 19 psoriasis psoriasis VERB dpc-4289 343 20 itself itself PRON dpc-4289 343 21 ? ? PUNCT dpc-4289 344 1 a a DET dpc-4289 344 2 case case NOUN dpc-4289 344 3 - - PUNCT dpc-4289 344 4 control control NOUN dpc-4289 344 5 study study NOUN dpc-4289 344 6 . . PUNCT dpc-4289 345 1 j j PROPN dpc-4289 345 2 dermatolog dermatolog PROPN dpc-4289 345 3 treat treat NOUN dpc-4289 345 4 . . PUNCT dpc-4289 346 1 2020;31(1):27 2020;31(1):27 NUM dpc-4289 346 2 - - SYM dpc-4289 346 3 32 32 NUM dpc-4289 346 4 . . PUNCT dpc-4289 346 5 doi:10.1080/0954663 doi:10.1080/0954663 VERB dpc-4289 347 1 4.2019.1577947 4.2019.1577947 NUM dpc-4289 347 2 . . PUNCT dpc-4289 348 1 23 23 NUM dpc-4289 348 2 . . X dpc-4289 349 1 ruggiero ruggiero PROPN dpc-4289 349 2 a a DET dpc-4289 349 3 , , PUNCT dpc-4289 349 4 fabbrocini fabbrocini NOUN dpc-4289 349 5 g g NOUN dpc-4289 349 6 , , PUNCT dpc-4289 349 7 cacciapuoti cacciapuoti PROPN dpc-4289 349 8 s s PROPN dpc-4289 349 9 , , PUNCT dpc-4289 349 10 cinelli cinelli PROPN dpc-4289 349 11 e e PROPN dpc-4289 349 12 , , PUNCT dpc-4289 349 13 gallo gallo PROPN dpc-4289 349 14 l l PROPN dpc-4289 349 15 , , PUNCT dpc-4289 349 16 megna megna PROPN dpc-4289 349 17 m. m. NOUN dpc-4289 349 18 ocular ocular ADJ dpc-4289 349 19 manifestations manifestation NOUN dpc-4289 349 20 in in ADP dpc-4289 349 21 psoriasis psoriasis NOUN dpc-4289 349 22 screening screening NOUN dpc-4289 349 23 ( ( PUNCT dpc-4289 349 24 ocmaps ocmap NOUN dpc-4289 349 25 ) ) PUNCT dpc-4289 349 26 questionnaire questionnaire NOUN dpc-4289 349 27 : : PUNCT dpc-4289 349 28 a a DET dpc-4289 349 29 useful useful ADJ dpc-4289 349 30 tool tool NOUN dpc-4289 349 31 to to PART dpc-4289 349 32 reveal reveal VERB dpc-4289 349 33 misdiagnosed misdiagnose VERB dpc-4289 349 34 ocular ocular ADJ dpc-4289 349 35 involvement involvement NOUN dpc-4289 349 36 in in ADP dpc-4289 349 37 psoriasis psoriasis NOUN dpc-4289 349 38 . . PUNCT dpc-4289 350 1 j j PROPN dpc-4289 350 2 clin clin PROPN dpc-4289 350 3 med med PROPN dpc-4289 350 4 . . PUNCT dpc-4289 350 5 2021;10(5 2021;10(5 NUM dpc-4289 350 6 ) ) PUNCT dpc-4289 350 7 . . PUNCT dpc-4289 351 1 doi:10.3390 doi:10.3390 NOUN dpc-4289 351 2 / / SYM dpc-4289 351 3 jcm10051031 jcm10051031 NOUN dpc-4289 351 4 . . PUNCT dpc-4289 352 1 24 24 NUM dpc-4289 352 2 . . PUNCT dpc-4289 352 3 qureshi qureshi PROPN dpc-4289 352 4 aa aa PROPN dpc-4289 352 5 , , PUNCT dpc-4289 352 6 choi choi PROPN dpc-4289 352 7 hk hk PROPN dpc-4289 352 8 , , PUNCT dpc-4289 352 9 setty setty PROPN dpc-4289 352 10 ar ar PROPN dpc-4289 352 11 , , PUNCT dpc-4289 352 12 curhan curhan PROPN dpc-4289 352 13 gc gc PROPN dpc-4289 352 14 . . PUNCT dpc-4289 352 15 psoriasis psoriasis NOUN dpc-4289 352 16 and and CCONJ dpc-4289 352 17 the the DET dpc-4289 352 18 risk risk NOUN dpc-4289 352 19 of of ADP dpc-4289 352 20 diabetes diabetes NOUN dpc-4289 352 21 and and CCONJ dpc-4289 352 22 hypertension hypertension NOUN dpc-4289 352 23 : : PUNCT dpc-4289 352 24 a a DET dpc-4289 352 25 prospective prospective ADJ dpc-4289 352 26 study study NOUN dpc-4289 352 27 of of ADP dpc-4289 352 28 us us PROPN dpc-4289 352 29 female female ADJ dpc-4289 352 30 nurses nurse NOUN dpc-4289 352 31 . . PUNCT dpc-4289 353 1 arch arch ADJ dpc-4289 353 2 dermatol dermatol NOUN dpc-4289 353 3 . . PUNCT dpc-4289 354 1 2009;145(4):379 2009;145(4):379 NUM dpc-4289 354 2 - - SYM dpc-4289 354 3 82 82 NUM dpc-4289 354 4 . . PUNCT dpc-4289 355 1 doi:10.1001 doi:10.1001 PROPN dpc-4289 355 2 /archdermatol.2009.48 /archdermatol.2009.48 PUNCT dpc-4289 355 3 . . PUNCT dpc-4289 356 1 25 25 NUM dpc-4289 356 2 . . PUNCT dpc-4289 357 1 demerdjieva demerdjieva PROPN dpc-4289 357 2 z z PROPN dpc-4289 357 3 , , PUNCT dpc-4289 357 4 mazhdrakova mazhdrakova PROPN dpc-4289 357 5 i i PROPN dpc-4289 357 6 , , PUNCT dpc-4289 357 7 tsankov tsankov PROPN dpc-4289 357 8 n. n. NOUN dpc-4289 357 9 ocular ocular ADJ dpc-4289 357 10 changes change NOUN dpc-4289 357 11 in in ADP dpc-4289 357 12 patients patient NOUN dpc-4289 357 13 with with ADP dpc-4289 357 14 psoriasis psoriasis NOUN dpc-4289 357 15 . . PUNCT dpc-4289 358 1 clin clin PROPN dpc-4289 358 2 dermatol dermatol NOUN dpc-4289 358 3 . . PUNCT dpc-4289 359 1 2019;37(6):663 2019;37(6):663 NUM dpc-4289 359 2 - - PUNCT dpc-4289 359 3 7 7 NUM dpc-4289 359 4 . . PUNCT dpc-4289 359 5 doi:10.1016 doi:10.1016 PROPN dpc-4289 359 6 / / SYM dpc-4289 359 7 j.clindermatol.2019.07.029 j.clindermatol.2019.07.029 PROPN dpc-4289 359 8 . . PROPN dpc-4289 360 1 26 26 NUM dpc-4289 360 2 . . PUNCT dpc-4289 361 1 erbagci erbagci NOUN dpc-4289 361 2 i i NOUN dpc-4289 361 3 , , PUNCT dpc-4289 361 4 erbagci erbagci NOUN dpc-4289 361 5 z z PROPN dpc-4289 361 6 , , PUNCT dpc-4289 361 7 gungor gungor PROPN dpc-4289 361 8 k k NOUN dpc-4289 361 9 , , PUNCT dpc-4289 361 10 bekir bekir VERB dpc-4289 361 11 n. n. PROPN dpc-4289 361 12 ocular ocular ADJ dpc-4289 361 13 anterior anterior ADJ dpc-4289 361 14 segment segment NOUN dpc-4289 361 15 pathologies pathology NOUN dpc-4289 361 16 and and CCONJ dpc-4289 361 17 tear tear ADJ dpc-4289 361 18 film film NOUN dpc-4289 361 19 changes change NOUN dpc-4289 361 20 in in ADP dpc-4289 361 21 patients patient NOUN dpc-4289 361 22 with with ADP dpc-4289 361 23 psoriasis psoriasis NOUN dpc-4289 361 24 vulgaris vulgaris NOUN dpc-4289 361 25 . . PUNCT dpc-4289 362 1 acta acta PROPN dpc-4289 362 2 med med PROPN dpc-4289 362 3 okayama okayama PROPN dpc-4289 362 4 . . PUNCT dpc-4289 363 1 2003;57(6):299 2003;57(6):299 NUM dpc-4289 363 2 - - PUNCT dpc-4289 363 3 303 303 NUM dpc-4289 363 4 . . PUNCT dpc-4289 363 5 doi:10.18926 doi:10.18926 NOUN dpc-4289 363 6 /amo/32810 /amo/32810 PUNCT dpc-4289 363 7 . . PUNCT dpc-4289 364 1 27 27 NUM dpc-4289 364 2 . . PUNCT dpc-4289 365 1 zengin zengin VERB dpc-4289 365 2 n n CCONJ dpc-4289 365 3 , , PUNCT dpc-4289 365 4 tol tol NOUN dpc-4289 365 5 h h NOUN dpc-4289 365 6 , , PUNCT dpc-4289 365 7 balevi balevi PROPN dpc-4289 365 8 s s PROPN dpc-4289 365 9 , , PUNCT dpc-4289 365 10 gündüz gündüz NOUN dpc-4289 365 11 k k PROPN dpc-4289 365 12 , , PUNCT dpc-4289 365 13 okudan okudan PROPN dpc-4289 365 14 s s PROPN dpc-4289 365 15 , , PUNCT dpc-4289 365 16 endoğru endoğru PROPN dpc-4289 365 17 h. h. PROPN dpc-4289 365 18 tear tear ADJ dpc-4289 365 19 film film NOUN dpc-4289 365 20 and and CCONJ dpc-4289 365 21 meibomian meibomian ADJ dpc-4289 365 22 gland gland NOUN dpc-4289 365 23 functions function NOUN dpc-4289 365 24 in in ADP dpc-4289 365 25 psoriasis psoriasis NOUN dpc-4289 365 26 . . PUNCT dpc-4289 366 1 acta acta PROPN dpc-4289 366 2 ophthalmol ophthalmol PROPN dpc-4289 366 3 scand scand PROPN dpc-4289 366 4 . . PUNCT dpc-4289 367 1 1996;74(4):358 1996;74(4):358 NOUN dpc-4289 367 2 - - SYM dpc-4289 367 3 60 60 NUM dpc-4289 367 4 . . PUNCT dpc-4289 368 1 doi:10.1111 doi:10.1111 ADJ dpc-4289 368 2 / / SYM dpc-4289 368 3 j.1600 j.1600 NOUN dpc-4289 368 4 - - PUNCT dpc-4289 368 5 0420.1996 0420.1996 PROPN dpc-4289 368 6 . . PUNCT dpc-4289 369 1 tb00708.x tb00708.x NOUN dpc-4289 369 2 . . PUNCT dpc-4289 370 1 28 28 NUM dpc-4289 370 2 . . PUNCT dpc-4289 371 1 balamurugan balamurugan PROPN dpc-4289 371 2 ms ms PROPN dpc-4289 371 3 , , PUNCT dpc-4289 371 4 somanath somanath ADJ dpc-4289 371 5 a. a. NOUN dpc-4289 371 6 commentary commentary PROPN dpc-4289 371 7 : : PUNCT dpc-4289 371 8 a a DET dpc-4289 371 9 clinician clinician NOUN dpc-4289 371 10 should should AUX dpc-4289 371 11 know know VERB dpc-4289 371 12 about about ADP dpc-4289 371 13 systemic systemic ADJ dpc-4289 371 14 psoriasis psoriasis NOUN dpc-4289 371 15 and and CCONJ dpc-4289 371 16 eye eye NOUN dpc-4289 371 17 . . PUNCT dpc-4289 372 1 indian indian PROPN dpc-4289 372 2 j j PROPN dpc-4289 372 3 ophthalmol ophthalmol PROPN dpc-4289 372 4 . . PUNCT